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Abstract 
The principal aims of the work presented in this thesis were to further investigate the 
pathophysiology of the acute phase proteins in bovine mastitis and to document the changes in the 
protein composition of milk during mastitis using modem proteomic methods. 
Mastitis is one of the most important diseases affecting cattle worldwide. It has adverse effects on 
the economics of milk production through reducing the quality and quantity of milk. Acute phase 
proteins (APPs) are valuable markers of inflammatory lesions and are widely used in the veterinary 
field for disease diagnosis. This study further investigated the presence of APPs, haptoglobin (Hp) 1 I 
and mammary- associated serum amyloid A3 (M-SAA3) in the milk of cows with mastitis and 
evaluated the possibility of using these proteins to detect mastitis. 
An Enzyme linked immunosorbent assay (ELISA) was developed and validated for the 
measurement of milk Hp. A commercially available ELISA was used for the detection ofM-SAA3 
in milk. Both Hp and M-SAA3 showed similar kinetics to somatic cell counts and can be 
considered as sensitive and reliable markers of mastitis. 
Advanced proteomic methods were developed and used to further characterise the changes taking 
place in the proteins expressed in normal and mastitic milk. The methodology for analysis of the 
bovine milk proteome was successfully established. This part of the work concluded that the 
patterns of protein expression of clinically mastitic milk showed clear differences from that of 
normal milk. Further analysis of milk samples from a mild subclinical model of Staphylococcus 
aureus mastitis showed that alterations to the milk p:oteome were only minimal. However this 
study was useful in identifying areas worthy of future research. 
Recent publications on APP research speculate upon the local production ofM-SAA3 in the bovine 
mammary gland. The final objective of this study was therefore to investigate the expression ofM-
SAA3 in bovine mammary tissue. Our studies confirm the local production of M-SAA3 in the 
bovine mammary gland and its up-regulation during bovine mastitis. This finding may provide 
further information on a possible role for this protein. 
Overall the findings detailed in this thesis indicate that APPs in milk are valuable markers of 
mastitis and additionally that the ease of collection of milk by non-invasive methods suggest that 
milk has potential for the discovery of disease biomarkers. 
I I 
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1.1 Background 
Chapter I 
Introduction 
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Bovine mastitis, defined as 'inflammation of the mammary gland' has been described as 
the single most common cause of death in adult dairy cows (De Graves and Fetrow 1993; 
Menzies et al 1995; Kossaibati and Esslemont 1997), and usually arises as a result of 
intramammary infection by bacteria (Leigh 1999). Inflammation is induced in response to 
udder infection, by the release of inflammatory mediators, as part of the host defence 
mechanism, and can produce visible abnormalities in the milk accompanied by any of the 
following clinically recognisable signs of heat, pain, swelling and inflammation of the 
infected quarter within the udder (Blowey 1990). Many intramammary infections however 
produce no obvious abnormalites in the milk or udder and are termed by definition, sub-
clinical mastitis. In severe cases, this inflammatory response can cause irreversible damage 
to the milk secretory tissue of the udder, often before signs of the disease become obvious 
to the dairyman. Mastitis is a complex disease and has a considerable impact on the 
welfare of individual animals and on the economics of the dairy industry. Mastitis is, in 
theory, a preventable disease, however effective control strategies remain a major 
challenge to the farmer, veterinarian and research scientist. Early diagnosis of mastitis is 
of principal importance and achievement of this requires the availability of an accurate, 
sensitive and robust diagnostic test. Recent evidence has suggested that acute phase protein 
(APP) in milk could provide the analyte for such a test. The aetiology of bovine mastitis is 
reviewed in detail in chapter 3, which deals with investigation of the naturally occurring 
disease. Here the acute phase proteins (APP) are introduced, then the physiology of the 
bovine udder and milk production are discussed. 
1.2 Acute Phase Response 
The acute phase response (APR) is a non-specific inflammatory response affecting various 
host organs, which commences within a few hours of any tissue injury and can last for 
several days (Eckersall 1992). Stimuli, which commonly give rise to the APR, include 
bacterial infection, surgical or other trauma, bone fracture, neoplasms, bum injury, tissue 
infarction, various immunologically mediated inflammatory states, and child birth 
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(Kushner 1982). All of these conditions induce a local inflammatory response and the early 
release of soluble mediators, which in turn leads to a systemic APR encompassing 
metabolic and physiological changes, which provide the host with an optimal infection-
fighting environment. The purpose of the APR is to prevent ongoing tissue damage, to 
isolate and destroy the infective organisms, to remove harmful molecules and debris, and 
to activate the repair processes that are necessary to return the organ to normal function 
(Baumann and Gauldie 1994). The APR is a flexible response that helps host survival and 
aims to restore physiological homeostasis, as deviations from this stable situation impose a 
serious threat to the health of the living animal. The APR may be relatively transient, 
subsiding over 24-48h, with the host returning to normal function within a few days, 
demonstrating the protective and homeostatic nature of this host response. However, in 
chronic disease, the APR can be persistent (Baumann and Gauldie 1994). Among the 
changes in homeostatic mechanisms during the APR are fever, somnolence, anorexia, 
increased synthesis of a number of endocrine hormones, decreased erythropoiesis, 
thrombocytopaenia, alterations in plasma cation concentrations, inhibition of bone 
formation, negative nitrogen balance (largely resulting from proteolysis and decreased 
protein synthesis in skeletal muscle) with consequent gluconeogenesis, and alterations in 
lipid metabolism (Kushner and Mackiewicz 1987). 
The hepatocytes of the liver have a key role in the response to inflammation (Pepys 1989). 
They express a variety of receptors for cytokines, growth factors, and other inflammatory 
mediators, such as prostaglandins and are therefore the target of a multiple set of mediators 
involved in both the systemic and the local host response. Pro-inflammatory cytokines 
enter the liver via the bloodstream through the portal vein, and consequently reach the non-
parenchymal liver cells, such as the endothelial cells and the Kupffer cells, that express 
receptors for the main cytokines. 
One of the major components of the APR is the alteration in concentration of a large 
number of plasma proteins synthesized by the liver. These are termed acute phase proteins 
(APPs)(Kushner and Mackiewicz 1987), the focus ofthe studies detailed within this thesis. 
1.3 Acute Phase Proteins 
An APP has been defined as one whose concentration Increases (positive APPs) or 
decreases (negative APPs) by at least 25% during inflammatory disorders (Morley & 
Kushner, 1982). Following the initiation of the APR, the hepatocytes undergo dramatic 
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upregulation in the synthesis of positive APPs: a family of approximately 30 plasma 
proteins produced in increased amounts by the liver in inflammation. 
C-reactive protein (CRP) was the first APP to be described. It was identified in humans 
suffering from infections and named after its ability to precipitate pneumococcal C-
polysaccaride (Tillett and Francis 1930). 
Positive APPs can be subdivided based on their response pattern to inflammatory stimuli. 
Major APPs have very low or undetectable levels in serum of healthy animals, but increase 
more than 100 fold during an APR. Minor or moderate APPs are present in the serum of 
healthy animals and their concentrations do increase during an APR, but only an increase 
of up to 10 fold is observed (Conner et al 1988b; Gruys et al 1994; Eckersall 1995b). In 
man, the concentration of APPs serum amyloid A (SAA) and CRP, can increase up to 
1000-fold during acute disease states (Gruys et al 1993). Consequently these proteins are 
of diagnostic interest in clinical chemistry. However CRP is not considered an acute phase 
reactant in cattle. The major bovine acute phase proteins are haptoglobin (Hp) and SAA 
(Table 1.1). 
1.3.1 Haptoglobin 
Haptoglobin is a major plasma glycoprotein synthesized in the liver. It binds free 
haemoglobin (Hb) in the circulation of humans and other mammals. The binding of Hb to 
Hp is the strongest noncovalent interaction known among the transport proteins in plasma 
and is not reversible (Yang et al 1993). After Hp has bound free Hb and delivered it to the 
liver, the complex is degraded by lysosymes, leading to a decrease of Hp concentration in 
plasma following haemolysis. For example Hp was found to decrease in plasma to a non-
detectable level in severe haemolysis (Yang et al 2003). 
1.3.1.1 Structure of haptoglobin 
Haptoglobin is a genetically determined (X2 - acidic glycoprotein with Hb-binding capacity, 
present in most body fluids (serum, urine, saliva, cerebrospinal fluid, amniotic fluid, 
ascites etc.) of humans and other mammals. As a positive acute phase reactant, its plasma 
level is increased during inflammation, infections of different aetiology, trauma, tissue 
damage and malignancy (Dobryszycka 1997). 
! I 
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CLASSIFICATION ACUTE PHASE PROTEIN 
Major Serum amyloid A 
Haptoglobin 
Moderate cd -acid glycoprotein 
cd -proteinase inhibitor 
Minor Fibrinogen 
Ceruloplasmin 
LPS-binding protein 
a2-macroglobulin 
Complement C3 
Negative Albumin 
Constitutive C-reactive protein 
Table 1-1 Classification of acute phase protein in cattle (after Eckersall and Conner (1988), 
Gruys et al. (1994) and Eckersall (1995). Major = 10 to several hundred times increase, 
moderate = 5 to 10 times increase, minor = 1 to 5 times increase, negative = decrease, 
constitutive = no change 
I I 
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The protein is synthesized as a single chain, which is processed posttranslationally into an 
amino-terminal a-chain and a carboxy-terminal ,6-chain by proteolytic cleavage (Gordon 
2001). Mature Hp is composed of four polypeptide subunits, two a and two ,6 (a2 ,62), 
which are linked by disulphide bridges (Kim et a12001) resulting in the Hp af3 tetramer. 
Variations in the a subunit of Hp exists in humans, and gives rise to three major Hp 
phenotypes (Yee and Brown 1999). Several functional differences between Hp phenotypes 
have been demonstrated and appear to have important biological and clinical consequences 
(Langlois and Delanghe 1996). In the past decade, a direct link has been identified 
between Hp phenotype and susceptibility to cardiovascular diseases (Langlois and 
Delanghe 1996; Delanghe et al 1999; Bamm et al 2004). Individuals with the Hp 2-2 
phenotype suffer increased iron-related vascular pathologies in comparison to individuals 
with the Hp 1-1 phenotype (Bamm et al 2004). 
Hp in bovine serum is highly polymerized Biochemical studies have shown that Hp is 
composed of two chains, an a-chain and a ,6-chain. The molecular weight of the a-chain 
varies between 16Kda (Morimatsu et al 1991) and 23Kda (Eckersall and Conner 1990). 
The molecular weight of the ,6-chain varies between 35 Kda (Eckersall and Conner 1990) 
and 40 Kda (Morimatsu et al 1991). The two a-chains and two ,6-chains are linked by a 
disulphide bond, forming the basic tetrameric subunit. The basic tetrameric subunit of Hp 
associates in polymers with albumin (Eckersall and Conner 1990), in bovine serum 
resulting in large and heterogeneous molecular sizes (Morimatsu et aI1991). 
1.3.1.2 Association of haptoglobin with haemoglobin 
Haptoglobin is classified as a scavenger protein, indicating its involvement in the clearance 
of inflammatory products (Whicher and Evans 1992). In the normal situation, ageing red 
blood cells (RBC) are degraded in the bone marrow, liver or spleen however in certain 
circumstances, such as infection or inflammatory disorders, red cells may burst within 
blood vessels. Haemoglobin (Hb) released from ruptured RBC is toxic unless rapidly 
cleared from the circulation (Dennis 2001). The plasma protein Hp, is thought to be 
involved in promoting the clearance of plasma Hb because it strongly binds free Hb and is 
depleted during haemolysis (Kristiansen et al 2001). Haptoglobin binds Hb in a 1: 1 ratio 
with an association constant of greater than 10-15 mollL (Dobryszycka 1997). Efficient 
removal of free Hb is essential since Hb can accelerate lipid peroxidation, leading to 
production of toxic molecules. In case of highly accelerated intravascular hemolysis, as 
seen in various inherited, infectious, and autoimmune disorders, Hp may be depleted from 
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plasma, resulting in an excess of circulating Hb leading to tissue damage (Kushner and 
Mackiewicz 1987). 
The mechanisms leading to the removal of the Hp-Hb complex from the blood remained 
elusive until the recent discovery of a novel Hb scavenger receptor protein. The Hb 
scavenger receptor (HbSR) named CD163, was isolated as a virtually pure protein from 
solubilized membranes from liver, spleen, and placenta using Hp-Hb affinity and identified 
by mass spectrometry (Kristiansen et al 2001). CD163 is a transmembrane protein 
displaying an extracellular cysteine-rich domain (Graversen et al 2002), and has been 
identified as a receptor that engulfs Hb by mediating endocytosis of Hp-Hb complexes. 
CD 163 will only bind Hp and Hb in complex, suggesting that a neo-epitope is presented by 
this interaction. The receptor-ligand interaction is calcium dependent, and of high affinity., I 
CD 163 is expressed in monocytes/macrophages. Internalization of Hp-Hb in macrophages 
is followed by lysosomal proteolysis of globin and conversion of haem to iron and 
bilirubin. It has been suggested that approximately 10% of all Hb is cleared via this 
pathway. CD 1631HbSR is under acute phase regulation with mediators like IL-6 and 
glucocorticoids strongly inducing its expression (Gravers en et al 2002). During 
inflammatory conditions the Hp-Hb-CDI63 system might be coordinately induced, thereby 
enhancing the Hb clearance capacity in response to injury (Gordon 2001). 
Elucidation of the mechanism for Hb clearance through identification of CD 163 provides 
new perspectives for understanding the potential immunological properties of Hp during 
inflammatory conditions. 
1.3.2 Serum Amy/oid A 
Serum amyloid A, a 14KD apolipoprotein is the precursor of the Amyloid A protein, which 
is the principal component of secondary amyloid plaques, which may be deposited in 
major organs as an occasional consequence of chronic inflammatory disease (Husebekk et 
al 1986). During inflammation SAA associates predominantly with the third fraction of 
high-density lipoprotein (HDL3) (Benditt et al 1979), and constitutes as much as 30-50% 
of HDL3 protein during the APR. Serum amyloid A is synthesized primarily by the liver 
and although the major role of this protein is as an acute phase reactant, 'constitutive' 
SAAs have been described in two species, human and mouse. Serum amyloid A is now 
more commonly referred to as being part of a family of differentially expressed 
apolipoproteins, which have been characterized in many species including human, mouse, 
hamster, rabbit, dog, mink, cow, sheep and horse (Uhlar and Whitehead 1999). 
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A conclusive structure for SAA has not yet been reported, however early work based on 
predictive methods suggested that it is likely to contain two regions of a-helix in addition 
to ,B-sheet regions, the latter of which are common to all amyloid proteins (Uhlar and 
Whitehead 1999). It has since been reported that SAA forms a hexamer in solution, 
containing a putative central channel (Wang et al 2002). 
Several different isoforms of SAA have been shown to exist in acute phase serum from a 
number of species including horse (Hulten et al 1999), pig (Toussaint et al 1995) and 
cattle. In cattle, the different SAA isoforms seem to be induced by different disease states, 
however no functional significance of this has yet been derived (Alsemgeest et al 1995). 
An additional isoform of SAA termed mammary-associated or milk-associated SAA (M-
SAA3) has recently been detected in the bovine mammary gland (McDonald et al 2001) 
possibly due to local synthesis of this protein. The functions of M-SAA3 have yet to be 
established, however speculations on this subject and a more detailed account of this 
protein will be discussed in chapters 3 and 6. 
Few attempts have been made to elucidate the role of SAA; thus the normal physiological 
function of SAA remains unclear. However the high degree of conservation of the SAA 
genes and proteins, which has been maintained throughout the evolution of mammals, 
suggests the likelihood of an important biological role, perhaps in survival of the species 
(Hulten et al 1999) in the face of infection by pathogens. One member of the SAA family, 
SAA3, is constitutively expressed in a number of diseased tissues, in particular endothelial 
cells (Meek et al 1994; Urieli-Shoval et al 1998). This suggests that SAA plays an 
important role in the local defence mechanisms against invading microorganisms. 
1.3.3 Negative Acute Phase Proteins 
Another distinct class of liver proteins are the negative APPs, the concentration of which is 
down-regulated during the APR (Gruys et aI1994). The major negative acute phase protein 
in cattle is serum albumin. During the APR the demand for amino acids for APP synthesis 
is markedly increased, which necessitates reprioritization of the hepatic protein synthesis: 
albumin synthesis is down-regulated and amino acids are shunted into synthesis of APPs 
and other proteins needed for immediate survival (Aldred and Schreiber 1993). In vivo 
studies in rats with Streptococcus pneumoniae, have been used to study the effect of the 
APR on muscle metabolism and amino acid uptake by the liver (Powanda and Beisel 
2003). It has been proposed that during the APR, 30 to 40% of the hepatic protein 
synthesizing capacity is used for production of positive APPs (Whicher and Dieppe 1995), 
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and household functions thus need to be diminished. For example, drug metabolism in the 
liver is decreased during the APR (Van Miert 1995; Monshouwer and Witkamp 2000). 
1.3.4 Interspecies Variation in Acute Phase Proteins 
It is now recognised that there is considerable variety among species in the pattern of APP 
produced following stimulation (Eckersall 1995b). An early indication of this difference 
was identified when it was observed that not all APPs originally identified in man give a 
similar response in animals. Thus, while CRP is a major APP in man, dog and pig, in cattle 
the presence of infection or inflammation causes little change in its serum concentration. In 
contrast, Hp is a major APP in cattle with levels increasing from being undetectable in 
normal animals, to over 100 fold on stimulation (Eckersall 1995a). However, in dogs, Hp 
acts as a constitutive serum protein and is a moderate APP (Conner et al 1988a; Eckersall 
et aI1996). 
1.3.5 Functions of Acute Phase Proteins 
Although several functions have been ascribed to the APPs, numerous speculations still 
surround this topic. Generally, the APPs have a variety of roles in inflammation acting as 
mediators and inhibitors, as well as scavengers of cell derived products released from 
damaged tissue or macrophages. In addition, some members of the family may influence 
the immune response, which often accompanies inflammation and the release of 
autologous antigens, through direct protection of the host (Thompson et al 1992). For 
example the binding of free Hb by Hp, restricts the availability of free iron to invading 
bacteria (Dobryszycka 1997). An in vivo experiment in mice has shown that aI-acid 
glycoprotein increases resistance of the host to gram-negative bacteria (Hochepied et al 
2000). The fact that the APPs have been conserved throughout evolution, and that they are 
induced in large amounts in response to harmful stimuli, infers that they have a positive 
input to inflammatory and tissue repair processes. The different actions of various APPs 
are summarised in table 1.2. 
1.3.6 Possible Applications of Acute Phase Proteins in 
Veterinary Clinical Biochemistry 
The possible diagnostic use of APPs in veterinary clinical chemistry have been 
comprehensively reviewed, (Eckersall and Conner 1988a; Kent 1992; Gruys et al 1994; 
Eckersall 1995b; Pedersen et al 2004; Murata et al 2004). In the clinical field as well as 
! I 
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PROTEIN FUNCTION 1 I 
C-reactive protein Opsonin, complement activation, immunomodulation, 
binding of chromatin 
Serum amyloid A Cholesterol scavenger, leukocyte activation, 
chemotaxis, phagocytosis 
Haptoglobin Haemoglobin scavenger, antioxidant, bacteriostatic 
effect, immunomodulatory effect, stimulation of 
. . 
angIOgenesIs 
(Xl_antitrypsin Protease inhibitor, major inhibitor of elastase and 
trypsin 
(X2-antiplasmin Protease inhibitor, major inhibitor of fibrinolysis 
(Xl-acid glycoprotein Transport protein, steroid binding 
Ceruloplasmin Copper transport protein, Fe2+ oxidation 
Ferritin Iron transport protein 
Complement components: Opsonization, chemotaxis, mast cell degranulation 
CI,C2,C3,C4,C5,C9 
Factor VIII 
Fibrinogen Clotting formation of fibrin matrix for repair 
Prothrombin 
Plasminogen Proteolytic activation of complement, fibrinolysis and 
clotting 
Plasminogen activator inhibitor-1 Inhibits the activation of plasminogen 
Fibronectin Cell attachment, fibrin clot 
LPS-binding protein LPS binding to phagocytes via CD 14 
Table 1-2. Summary of acute phase proteins and their functions 
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being markers of infection or inflammation APPs may serve as indicators of prognosis and 
progress of the animal in response to treatment. In cattle as well as humans the scale and 
duration of the APP response reflect the severity of infection and underlying tissue damage 
(Conner et al1988b; Hirvonen et al1999). Bovine APPs have been utilized as nonspecific 
markers of clinical and subclinical disease (Saini and Webert 1991; Karreman et al 2000; 
Winter and Colditz 2002), to discriminate between acute and chronic disease (Horadagoda 
et al 1999) and for prognostic purposes, since the duration and magnitude of the response 
reflects severity of disease (Skinner et al1991; Hulten et al1997). 
Many studies have indicated the significance of Hp as a clinically useful parameter for 
measuring the incidence and severity of inflammatory responses in cattle with 
experimentally induced or naturally occurring infections, including mastitis, pneumonia, 
peritonitis, endometritis and foot and mouth disease (Conner et al1986; Skinner et al1991; 
Morimatsu et al 1992; Hofner et al 1994; Horadagoda et al 1994; Hirvonen et al 1996; 
Wittum et al1996). In pigs, Hp has been used to monitor the occurrence and development 
of inflammatory conditions following both natural and experimental infection, and pre-
treatment with turpentine (Lampreave et al 1994; Eckersall et al 1996; Lipperheide et al 
1997; Lipperheide et al 1998; Lipperheide et al 2000; Hulten et al 2003). Haptoglobin 
concentration has the ability to differentiate between healthy thriving pigs and those 
showing lack of weight gain due to the presence of sub-clinical infection (Lipperheide et al 
1998). Therefore, Hp assays may be applied in the pig production field to determine the 
health status of the herd and identify individuals suffering compromised welfare. 
Haptoglobin has also been used as a marker of various inflammatory conditions in equine 
veterinary medicine (Kent and Goodall 1991 ; Taira et al 1992; Hulten et al 2002). 
The application of SAA assays in veterinary diagnosis has not been as widespread as that 
of Hp assays, probably because of the difficulties surrounding the measurement of serum 
SAA (Eckersall 2000). However the measurement of SAA has proved a useful analyte in 
diagnosing cattle with infection and inflammation (Alsemgeest et al 1993; Horadagoda et 
al1994; Horadagoda et al1999; Heegaard et al2000; Eckersall et al2001). 
Until recently, the use of APPs in veterinary medicine required the measurement of the 
specific protein in the serum of the animal. Hence although APPs are useful tools for 
identifying the presence and status of inflammation, they remain non-specific markers of 
infection and should not be relied upon to make a specific diagnosis. However recently Hp 
and SAA have been detected in the milk from cows with clinical and subclinical mastitis 
(Eckersall et al 2001; Pedersen et al 2003; Gronlund et al 2003a; Nielsen et al 2004), 
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suggesting the possibility of using APPs in milk as specific markers for the presence of 
mastitis within the udder. 
The value of APP measurement has been severely hampered by the lack of readily 
available test systems that would allow the detection of the specific APP both quickly and 
cheaply and could preferably be used outwith the laboratory, i.e: in the field. Before APP 
measurement can be implemented into routine veterinary diagnostics, such test systems 
need to be developed. Furthermore, an international standardization of APP assays is 
essential if quantification of APPs is to become recognised as a reliable diagnostic tool by 
the worldwide veterinary community (EckersallI995b; Eckersall et aI1999b). 
1.4 Initiation and Progression of Acute Phase Response 
Following the discovery of CRP in the 1930s, APPs were simply used as markers of 
inflammation for many years, however, from the 1980's, research concentrated on the 
regulation of APP biosynthesis (Kushner 1982). In vitro model systems confirmed that the 
circulating mediators, capable of hepatocyte stimulation following local tissue injury, were 
small hormonal proteins named cytokines. Cytokines are intercellular signalling 
polypeptides produced by a variety of cell types, but the most important sources are tissue 
macrophages and blood monocytes at sites of inflammation. Mononuclear cells are most 
commonly associated with initiating the cascade of events during the APR. Pro-
inflammatory cytokines including interleukin-l (IL-l); interleukin-6 (IL-6) and tumour 
necrosis factor - ex. (TNF-ex.) are released from activated macrophages and monocytes at the 
site of inflammatory lesions or infection (Heinrich et al 1990) and are the maj or mediators 
of the APR in the liver. During the hepatic APR, these pro-inflammatory cytokines 
enhance the expression and secretion of plasma proteins, namely the positive APPs and 
decrease the expression and secretion of the negative APPs. The early release of these pro-
inflammatory cytokines acts to 'alarm' the immune system, through both local and distal 
activity. At the local reaction site, these cytokines activate stromal cells, including 
fibroblasts and endothelial cells, to cause a secondary release of cytokines (Baumann and 
Gauldie 1994). This results in the systemic release of cytokines and initiates the large, 
complex, signal transduction cascade leading ultimately to the systemic APR. Many 
cytokines can regulate the production of other cytokines and cytokine receptors, so that 
cells are seldom exposed to only a single cytokine. Combinations of cytokines have been 
found to have additive, inhibitory, synergistic, or cooperative effects (Gabay and Kushner 
1999). 
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1.4.1 Regulation of Acute Phase Protein Production 
One of the earliest detectable responses of cells to either IL-l or IL-6 family of cytokines 
involves changes in the phosphorylation state of different cellular proteins (Baumann and 
Gauldie 1994). Four major classes of factors regulate APP production: the IL-6/gp130 
family of cytokines, IL-I type pro-inflammatory cytokines (e.g. IL-I, TNF), growth 
factors, (e.g. hepatocyte growth factor (HGF), transforming growth factor-,B (TGF-,B) and 
corticosteroids. A critical role for IL-6 and IL-I in the APR has been demonstrated in vivo, 
in experiments with knockout mice (Suffredini et al 1999). The authors demonstrated in 
inflammatory models that IL-I is the pivotal mediator of the APR. Following local injury 
the induction of a systemic acute phase response relies upon the initiation of IL-6 cascade, 
and this is dependent on IL-I (Suffredini et al 1999). 
Acute phase proteins can be divided into two groups, based on the cytokines that induce 
them. Type I proteins include SAA, CRP (human), complement C3, Hp (rat) and cd- acid 
glycoprotein. This group of proteins are induced by IL-I type cytokines including TNF- a. 
Type IT proteins include fibrinogen, Hp (human), aI-antitrypsin and a1-antichymotrypsin, 
and are induced by IL-6 like cytokines (Suffredini et al1999). 
1.4.2 Interleukin-1 Induced Signalling 
Two types ofIL-1 receptor (IL-1R) exist, the SOkD IL-1R type I, and the 60-6SkD IL-1R 
type IT, both of which belong to the immunoglobulin (Ig) superfamily. The type I receptor 
is responsible for the transmission of the IL-l signal, including the induction of type I 
APPs. After ligand binding, the IL-1 R is rapidly phosphorylated at serine/threonine 
residues, the ligand-receptor complex is then internalised and translocated to the nucleus 
(Moshage 1997). Receptors for TNF - a. are present on hepatocytes, where their basal level 
of expression is low. However, during acute or chronic liver inflammation their expression 
is upregulated. There are two forms ofTNF- a receptors, both of which are members of the 
Ig superfamily of receptors, but which are not homologous with the IL-1 receptors. 
Activation of the IL-1 /TNF receptors initiates the conversion of membrane sphingomyelin 
to ceramide via sphingomyelinase. Subsequently, cerami de-activated protein kinases 
connect to several signalling pathways, which ultimately lead to activation and 
translocation to the nucleus of the transcription factors (activating protein), AP-1, c-junlc-
fos heterodimer and nuclear factor (NF)-KB, which stimulates the transcription of type I 
APP genes (Figure 1.1). Originally identified as a B-cell specific transcription factor that 
binds to the promoter of the K light chain of Ig, NF- KB is now recognised as one of the 
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main cellular factors involved in the induction of gene transcription during inflammation 
and the APR (Jensen and Whitehead 1998). Activation of NF- KB is initiated by the 
dissociation from its inhibitory subunit IK (3. In addition to the activation of the NF- K (3 
pathway, IL-1 type cytokines are also able to activate the Mitogen Activated Protein 
Kinase (MAPK) signalling cascade. The molecular mechanism whereby binding of IL-1 
type cytokines to their specific membrane receptors enables the transduction of the 
intercellular MAPK pathway is not well understood. However, examination of the 
induction of APR by IL-6 type cytokines highlights the MAPK signalling pathway as an 
area of convergence/overlap between the two subgroups. 
1.4.3 Interleukin-6 Induced Signalling 
Cytokines of the IL-6 family signal through a distinct functional receptor complex, which 
shares a common signalling membrane glycoprotein, the gp130 receptor. The IL-6 receptor 
is homologous to other cytokine receptors and to the Ig family. The IL-6 /IL-6R complex, 
associates extra-cellularly with gp 130 permitting downstream signalling events to take 
place (Figure 1.2). 
The gp 130 and its heterodimers do not possess intrinsic tyrosine kinase activity. This 
problem is solved through recruitment of cytoplasmic kinases. However, following 
dimerization of gp130, receptor-associated tyrosine kinases (Janus kinases or JAK) are 
activated, phosphorylating tyrosine residues in the cytoplasmic region of gp130. The JAK 
kinases subsequently modify latent signal transducers and activators of transcription 
(STAT proteins) by phosphorylation of tyrosine. After phosphorylation, the STAT proteins 
form homo- or heterodimers, the signal for nuclear translocation and for STAT dimer 
binding to target sequences in the promotor regions of type II acute phase protein genes, 
stimulating their expression. Stimulation of gp 130 also activates the ras/raf IMAPK 
pathway, which in tum activates transcription factor, nuclear factor (NF) IL-6, which then 
recognises target sequences in the promotor region of type I and II acute phase proteins 
(type 1 IL-6 response element) (Suffredini et aI1999). 
Caroline Hogarth, 2004 
IL-1 like cytokines 
NF- K (3 
AP1 (fos/jun) 
Type I 
Acute Phase Genes 
1 
MAP-Kinase 
Pathway 
C/EBP (3 
IL-6 like cytokines 
1 
JAKISTAT PATHWAY 
+ 
STAT3/5 
APRF 
Type II 
Acute Phase Genes 
Acute Phie Proteins 
Restoration of Homeostasis 
Chapter 1 , 34 
Membrane 
receptors 
Signal 
transduction 
Transcription 
factors 
Transcription 
Translation 
Figure 1-1: The signal transduction cascade leading to the acute phase response 
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Figure 1-2: The cytokine Interleukin-6 triggers downstream signalling through the 
transmembrane receptor complex of the IL-6 and gp130 receptor complex. 
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1.4.4 Counter-regulation of the Acute Phase Response 
Equally as intriguing and important as the initiation and propagation of the APR is the 
process whereby the APR is limited, as prolongation of this response and its accompanying 
inflammatory processes may have damaging consequences. Many of the cytokines 
involved in the APR have a short half-life, and hence prolonged stimulation of the 
response should not be a problem. However, active inhibition does still occur. Negative 
control mechanisms must be in place, to ensure that once the APR has fulfilled its host-
protective functions, its expression can be rapidly returned to baseline levels. Many 
different regulatory mechanisms are involved in the tight control of APP biosynthesis, 
although the complete picture is still rather unclear (Jensen and Whitehead 1998). The 
pathways which have been elucidated involve transcriptional repressors, glucocorticoids, 
receptor antagonists and cytokines which either directly or indirectly mediate down-
regulation of biosynthesis of APPs. Many cytokines have the ability to exert both positive 
and negative effects, depending on which cell types they interact with, and the context of 
the interaction. As described earlier, the pro-inflammatory cytokines (IL-l, IL-6 and TNF-
ex) are heavily involved in the initiation of the APR and generally have up-regulating 
effects on aspects of inflammation, whereas the anti-inflammatory cytokines IL-4 and IL-
l ° generally have down-regulating effects acting mainly through interference with the 
production of pro-inflammatory cytokines. Interleukin-4 is primarily released by T helper-
2 (Th-2) lymphocytes, and causes the down-regulation of pro-inflammatory cytokines such 
as TNF-a, IL-l and IL-8. Interleukin-l0, produced by Th-2 lymphocytes, monocytes, 
macrophages and B cells, inhibits monocyte/macrophage synthesis of IL-l, TNF-a, IL-6, 
IL-8 and the colony stimulating factors (CSFs) (Baumann and Gauldie 1994). 
The presence of cytokine receptor antagonists and soluble cytokine receptors, adds to the 
complexity of APR regulation. Soluble cytokine receptors have been described for IL-l, 
TNF - a, and IL-6 among others. Soluble IL-l receptors have been detected in plasma, 
urine and inflammatory fluids (Moshage 1997). Soluble receptors are released during the 
late stages of an APR, to prevent further activation through posing as a decoy for the 
specific agonist, binding of which would prolong the response. The naturally occurring IL-
l receptor antagonist (IL-IRa) acts as an extremely potent regulator of the APR by 
competing with IL-l for binding to cellular IL-1 receptors, in particular IL-1R type 1. This 
interaction interferes severely with the ongoing cascade of inflammation, as binding of IL-
IRa to the IL-1R does not elicit a signal (Figure 1.3). Interleukin-4 and IL-I0 have both 
been shown to upregulate the expression ofIL-IRa. 
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Figure 1-3: Counter-regulation of the acute phase response. Interleukin-1 receptor 
antagonist (IL-1 Ra) competes with IL-1 for binding to the IL-1 receptor (IL-1 R). IL-1 Ra in 
complex with the IL-1 R cannot transmit a downstream signal. 
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Glucocorticoids are synthesized in the adrenal cortex after induction by pro-inflammatory 
cytokines (e.g. IL-l) via the hypothalamus (CRR production) and the pituitary 
(adrenocorticotrophic hormone production) gland and transported to their 'effector sites', 
where they either enhance the effects of the pro-inflammatory cytokines in the liver, or 
provide a negative feedback loop by shutting down the inflammatory response and thereby 
preventing the continued generation of up-regulating signals to the hypothalamus, adrenal 
cortex, immune system and liver (Jensen and Whitehead 1998). Steroid hormones behave 
in an anti-inflammatory manner by the inhibition of the release of pro-inflammatory 
cytokines. IL-6 has been shown to regu~ate the anti-inflammatory response through the IL-
IRa. Recent evidence indicates that IL-6 counteracts the acute phase reaction in a negative 
feedback loop (Ramadori and Christ 1999). The pro-inflammatory cytokine is the major 
inducer of the hepatic acute phase reaction, but IL-6 simultaneously initiates a variety of 
shut-off mechanisms (Ramadori and Christ 1999). Control of the APR is therefore a 
complex network of up and down-regulating signals, involving numerous mechanisms. 
1.4.5 Extra-hepatic Synthesis of Acute Phase Protein 
For many years the liver has been considered to be the primary site of APP synthesis 
(Urieli-Shoval et al 1998). However numerous cases of extra-hepatic APP synthesis have 
also been reported. Yang et al (1995) carried out an experiment to investigate the presence 
of Hp mRNA in lung epithelium. This group reported results from an in vivo experiment 
in which an APR was stimulated in mice by treatment with lipopolysaccarride (LPS). 
Thirty hours after induction of inflammation with LPS, a four- fold increase in Hp mRNA 
was observed in the lung and was equivalent to the level observed in the normal 
unstimulated liver. In situ hybridization was used to investigate the cellular location of Hp 
mRNA expression. A strong signal for Hp mRNA was found on epithelial cells, while no 
significant signal was found in endothelium, smooth muscle cells, alveolar epithelium or 
macrophages. It was therefore concluded from this experiment, that Hp is synthesized in 
the respiratory epithelium. Another similar in vivo experiment examined the response of 
mouse adipose tissue subjected to LPS in order to induce inflammation, and demonstrated 
a significant increase in Hp mRNA. Thirty hours after LPS injection, a six-fold increase in 
the Hp mRNA was seen in the adipose tissue. In situ hybridization confirmed that the Hp 
expression within adipose tissue was confined to adipocytes (Friedrichs et al 1995). These 
findings suggest that adipose tissue may contribute to the presence of Hp in extravascular 
body fluids as well as in the serum. 
Caroline Hogarth, 2004 Chapter 1 , 39 
The presence of amyloid-A mRNA has been observed in brain tissue of patients suffering 
from Alzheimers disease (AD), in addition to that of patients with conditions with a known 
inflammatory component, but not in that of patients with other neurological diseases 
(Liang et al 1997). ApoSAA in the human comprises the acute phase apoSAA (A-
apoSAA), which is up regulated by the synergistic action of IL-l and IL-6, but also a 
constitutive isoform (C-apo SAA), which appears to be produced by the liver in the 
absence of inflammation. Reverse transcriptase polymerase chain reaction (RT-PCR) was 
used to analyse human brain tissue for the presence of A & C apoSAA mRNA. As local 
inflammation has been strongly implicated in AD brain, it was not surprising that only A-
apoSAA mRNA was detected in the AD brain tissue. 
The eye is very much exposed, making it highly susceptible to oxidative damage through 
the actions of reactive oxygen intermediates (ROI), including peroxides (Chen et al 1998). 
Other body tissues are protected from the detrimental effects of ROI through the 
production of protective proteins such as Hp and hemopexin synthesized by the liver. The 
previously described ability of Hp, to uptake free Hb in the circulation, enables Hp to act 
as an anti-oxidant, by preventing Hb from releasing its haem. However, the tight junctions 
between cells at the blood-retinal barrier leaves the retinal pigment epithelial cells (RPE) 
cut off from the circulation and hence inaccessible to plasma protective proteins 
synthesized by the liver. Thus local production of APP is essential. Haptoglobin was first 
identified as being present in the RPE through incubation of retinal sections with anti-
human Hp antibodies. Immunofluorescence identified Hp distributed throughout the neural 
retina. RT-PCR confirmed the presence of Hp mRNA in the retina, and in situ 
hybridization localized the site of haptoglobin mRNA more specifically (Chen et al 1998). 
Active endometriotic lesions exhibit an invasive growth pattern and intense 
vascularization. Peritoneal fluid from women with endometriosis contains growth factors 
and inflammatory mediators including IL-l, IL-6 and IL-8. While synthesis and secretion 
of a Hp-like protein (called ENDO-l) has been reported by these endometriotic lesions 
(Sharpe-Timms et al 1998). This study has demonstrated that ENDO-l shares significant 
amino acid and cDNA sequence homology with the (3 chain of rat and human Hp. The fact 
that Hp is stimulated by the synergistic action of IL-l and IL-6 and also has a known role 
in angiogenesis (Gabay and Kushner 1999), supports the case for ENDO-l being a 
'haptoglobin-like protein'. RT-PCR was used, as in all of the pre-mentioned experiments, 
to confirm the endometriotic origin of ENDO-l. Western blot analysis was used to 
demonstrate immunoreactivity of poly clonal anti-human Hp antibody with ENDO-l. 
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Urieli-Shoval et al (1998), demonstrated for the first time, that SAA mRNA and protein are 
widely expressed in many histologically normal human tissues, including stomach, small 
and large intestine, tonsil, breast, prostate, thyroid, lung, pancreas, kidney, skin epidermis, 
and brain neurons. SAA expression was localized predominantly to the epithelial 
components of these tissues. A strong in situ hybridization signal was observed in lobular 
epithelium and terminal duct epithelium in breast tissue. These findings suggest that, in 
addition to SAA release to the circulation by the liver during an acute phase response, 
constitutively expressed SAA may serve as an immunological defence molecule at local 
sites, thereby providing an immediate localized defence against inflammatory challenges 
during the time taken to mount a systemic response by increased hepatic synthesis. 
Thus although the liver is the major site of APP synthesis, expression of both Hp and SAA 
in a wide range of tissues has been documented and it could be possible that local 
production of APP occurs in the bovine mammary gland. The udder is regularly exposed to 
pathogenic challenge, especially following the introduction of housing and milking cattle 
leading to the hypothesis that APPs may be constitutively expressed in the normal udder, 
functioning as a general housekeeping molecule, which may be upregulated by infection 
and inflammation resulting from the introduction of bacteria into the mammary gland. 
1.5 The Bovine Udder 
The bovine mammary gland is derived from a highly modified sweat gland, so that the 
inside lining of the teats and ducts of the mammary gland are essentially modified skin 
(Frandson 1992). The udder of a cow has four separate mammary glands, each with its 
own distinct teat. There is no flow of milk from one quarter to another, neither is there any 
significant direct blood flow from one quarter to another. The alveoli are the functional 
units of the mammary gland. The alveoli are kept together by a thin layer of connective 
tissue, and contain the nerves and blood vessels. A group of alveoli surrounded by 
connective tissue forms a lobule. A group of lobules, with a common collective duct, 
surrounded by connective tissue, forms a lobe. The large ducts have an epithelium of two 
or more layers. Surrounding the alveoli are myoepithelial cells. When the stimulus for milk 
let down occurs these cells contract, squeezing milk from the alveoli into the ducts, from 
where it travels to the udder and into the teat itself. The teat wall consists of four layers, 
each having an important function in milk let-down and mastitis control (Sordillo and 
Streicher 2002). The outer layer or epidermis is lined with a thick layer ofkeratinised cells 
which produce a hostile environment for bacterial growth (Sordillo et al 1997). The 
'Ii 
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underlying dermis is the tissue of the teat wall that carries the blood vessels and nerves. 
There are a variety of muscles that are set in transverse, oblique and longitudinal planes in 
the dermis of the teat wall. These muscles are responsible for the opening of the teat during 
milking but, more importantly, for maintaining a tight closure of the teat end between 
milkings, and hence hindering bacterial entry (Sordillo and Streicher 2002). 
1.5.1 Innate and Specific Immune Mechanisms of the Udder 
The bovine mammary glands have many forms of defence against invasion by pathogenic 
organisms, combining non-specific and specific systems, including the anatomical features 
of the gland and the humoral and cellular defence mechanisms (Outteridge and Lee 1988). 
In the mammary gland it is necessary for both innate and acquired immunity to coordinate 
in a highly interactive fashion in order to utilize the range of defence mechanisms available 
providing optimal protection of the gland. 
1.5.1.1 Anatomical defences 
Mastitis occurs when bacteria gain entrance to the udder via the teat canal. The anatomy of 
the udder is therefore, an extremely important first line of defence against infection, with 
the teat itself representing a physical barrier to the penetration of bacteria. The keratinised 
teat canal presents a waxy surface derived from stratified squamous epithelium that enables 
the trapping of invading bacteria. In addition, fatty acids with bacteriostatic properties such 
as myristic acid and linoleic acid are present have been identified within the teat lining 
(Sordillo et al 1997). These antibacterial properties are most effective when the teat canal 
is closed, when the contracted muscle has caused the adjoining folds of stratified squamous 
epithelium to interlock and form a tight seal (Nickerson 1985). The teat canal is of vital 
importance in the prevention of new cases of mastitis and clearly, it follows that any 
damage to the teat end will compromise the defence mechanisms. 
1.5.1.2 Soluble defences 
When bacteria successfully overcome the defence mechanisms of the teat canal, they are 
then confronted with the internal defences of the udder. A number of antibacterial soluble 
factors are present in milk, and have a concerted action. The functions of the main non-
specific soluble components of the mammary defence mechanisms are outlined below. 
However it is difficult to judge the relative importance of an individual factor. 
I I 
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Lactoferrin, a protein of molecular weight of 76Kd is the most important iron binding 
protein of various secretions, including milk (Diarra et al 2003). In the healthy mammary 
gland, the concentration of lactoferrin is low but increases during involution and 
inflammation (Sordillo et al 1997). In the dry, non-lactating udder, lactoferrin prevents 
bacterial growth through removing iron from udder secretions, and hence limiting iron 
uptake of bacteria. Aerobic bacteria such as Escherichia coli (E. coli) in particular require 
an abundance of iron. However the bacteriostatic effects of lactoferrin can be abolished in 
the presence of citrate, a buffer produced by epithelial cells. Citrate concentration varies 
greatly depending on the stage of lactation, but is highest during lactation and lowest in the 
dry period (Kutila et al 2003). High citrate concentrations in milk compete with lactoferrin 
for iron, producing iron citrate that can readily be utilised for bacterial growth. 
Transferrin, another iron binding protein IS released from the liver in increased 
concentrations during infection. As a result of the increased tissue permeability during 
mastitis, transferrin is able to pass from blood to milk, thus increasing the iron binding 
capacity of milk. Thus the increase of lactoferrin and transferrin in milk demonstrates the 
immune system's attempt to prevent bacterial growth, through sequestering iron. 
All milk contains the enzyme lactoperoxidase (LPO) (Kussendrager and van Hooijdonk 
2000). Lactoperoxidase is a heam protein that prevents the growth of bacteria by catalysing 
the oxidation of thiocyanate to hypothiocyanate (Ostdal et al 2000). In the presence of 
thiocyanate (SCN) and hydrogen peroxide, LPO can inhibit the growth of some bacteria 
(gram-positive) and kill others (gram-negative). Lactoperoxidase is highly abundant in 
bovine milk, but the concentrations ofH20 2 and thiocyanate in fresh milk are dependent on 
the plane of nutrition, which can cause variation in the effectiveness of LPO as an 
indigenous antimicrobial agent (Sordillo et al 1997). 
Lysozyme is a low molecular weight (15KDa) basic protein, which causes osmotic lysis of 
bacterial cell walls through cleavage of peptidoglycans. In comparison with other 
secretions, the lysozyme content of bovine milk is low and its direct bacteriolytic effect in 
milk is weak, however lysozyme intensifies the bactericidal activity of lactoferrin (Sordillo 
et al 1997). The impact of these antibacterial soluble factors in the defence of the udder is 
not entirely clear, however they represent another hurdle for bacteria to overcome if an 
infection is to be successfully established. 
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1.5.1.3 Cellular defences 
Specific immunological factors are also involved in the defence of the teat canal. 
Lymphocytes and plasma cells accumulate beneath and between the epithelium of the teat 
canal wall, indicating local immunological activity. Neutrophils directly penetrate the teat 
wall to the infected and inflamed teat canal. 
Bacterial pathogens that are able to elude the anatomical defence provided by the teat end 
must then evade the further anti-bacterial activities within the mammary gland in order to 
establish an infection (Sordillo and Streicher 2002). 
Mastitis researchers have long recognised the biological importance of the different types 
of cells found in bovine milk (Paape et al 2002) (Table 1.3). These consist primarily of 
white blood cells, including neutrophils, macrophages and lymphocytes and also a small 
percentage of epithelial cells (Nickerson 1985), and termed milk somatic cells. Milk 
somatic cells are probably the best recognised components of mammary gland immunity, 
and depending on the status of the gland, in terms of infection, Somatic Cell Counts 
(SCCs) vary in number and composition depending on the physiological status of the udder 
(Table 1.4). 
Macrophages are the predominant cell type in milk tissues of healthy mammary gland and 
their primary function is phagocytosis and intracellular killing of invading microorganisms 
and also removal of milk fat from involuting glands (Outteridge and Lee 1981). Pro-
inflammatory cytokines released from macrophages in response to infection have both 
local and systemic effects. As previously discussed, at the systemic level they mediate the 
acute phase reaction. At the local level, macrophages facilitate the migration and 
bactericidal effects of neutrophils, thereby amplifying the inflammatory response (Riollet 
et al 2000). Activated macrophages are triggered to release prostaglandins, leukotrienes, 
and cytokines that can greatly augment the local inflammatory process (Persson et a11993; 
Kehrli et al 1999). 
Neutrophils are non-specific leukocytes and the principal cell type present in mammary 
tissues and secretions during early inflammation (Sordillo and Streicher 2002). Following 
bacterial invasion, inflammatory mediators produced by cells in the infected gland elicit 
neutrophil recruitment. This can lead to neutrophil numbers rising from relatively low 
normal levels observed in the healthy udder to constitute greater than 90% of the total 
mammary leukocyte population during mastitis (Sordillo et aI1997). 
I 
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FACTOR BIOLOGICAL FUNCTION 
Neutrophils Phagocytosis and intracellular killing of bacteria; secretion of antibacterial 
factors 
Macrophages Phagocytosis and intracellular killing of bacteria; antigen presentation in 
conjunction with MHC 
Natural killer cells Nonimmune lymphocytes that secrete antibacterial proteins upon activation 
T lymphocytes 
CD4+ (T helper) Production of immunoregulatory cytokines following antigen recognition with 
MHC class II molecules; memory cells following antigen recognition 
CD8+ (T cytotoxic) Lysis of altered or damaged host cells when complexed with MHC class I 
molecules; production of cytokines that can down regulate certain leukocyte 
functions 
y8 T lymphocytes Biological role in the mammary gland is speculative 
B lymphocytes 
Mature B cells Display membrance bound antibody molecules to facilitate antigen presentation; 
memory cells following antigen interactions 
Plasma cell Terminally differentiated B lymphocytes that synthesize and secrete antibody 
against a specific antigen 
Table 1-3: Summary of mammary gland cellular defences. Reproduced from (Sordillo and 
Streicher 2002) 
1 .. 1 
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SCC COMPOSITION (%) 
SCC Neutrophils Macrophages Lymphocytes Epithelial (CELLS/ML cells OF MILK) 
Healthy <200,000 0-11 66-88 10-27 0-7 
Quarter 
Infected >200,000 50-95 9-32 14-24 0-9 
Quarter 
Table 1-4: Somatic cell count (SCC) in healthy and infected bovine mammary gland (Riollet 
et aI2000). 
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In order to reach the inflammatory site from the blood compartment, leukocytes have to 
evade the circulatory system. The endothelium is key to this process of extravasation. 
Endothelial cells have a potent inflammatory role, through their ability to secrete 
inflammatory mediators and modulate the adhesion of leukocytes to their surface. This 
process involves the interaction between adhesion molecules expressed by both endothelial 
cells and leukocytes. Following exposure to cytokines (IL-l, TNF and IL-6) , vascular 
endothelial cells increase their expression of adhesion molecules including E-selectin, 
ICAM-l and VCAM-l. These molecules interact specifically with neutrophils and other 
circulating leukocytes and act initially to slow their rate of flow. At this stage the 
leukocytes can be seen to 'roll' along the endothelial surface. The neutrophils then attach 
securely to the endothelial cells through tight binding between leukocyte integrins (LF A-I) 
and endothelial adhesion molecules (ICAM-l). This interaction increases the affinity of 
neutrophils for endothelial adhesion molecules enabling the leukocyte to squeeze between 
the endothelial cells in a process known as diapedesis (Janeway 2001). Finally, the 
leukocytes migrate through the tissue under the influence of chemokines such as IL-S. 
Neutrophil recruitment from the circulation to the focus of infection is essential in the 
defence of the mammary gland against invading bacteria. If the APR facilitates elimination 
of the bacteria which act as inflammatory stimuli, then neutrophil recruitment ceases and 
SCC returns to healthy levels. This is observed during clinical mastitis where E. coli is the 
causative agent and a spontaneous cure of the infected gland occurs within a few days of 
the infection commencing (Shuster et al 1996). If the bacteria are able to survive this 
immediate host response, then inflammation and leukocyte migration continues (Kehrli et 
al 1999). Prolonged diapedesis of leukocytes causes damage to mammary parenchyma 
tissue resulting in decreased production of milk. This is the case in S. aureus mastitis 
which tends to be chronic and are often subclinical. Several months after the beginning of 
infection, neutrophils are still the major cells in the infected gland (Rainard and Riollet 
2003). 
The specific immune mechanisms of the mammary gland are generally less well 
understood than that of the innate immune mechanisms. Recently attention has been paid 
to the role of the specific immunity, particularly to the role of the lymphocyte population in 
the protection of the mammary gland against bacterial infections. 
Lymphocytes are the only cells of the immune system that recognize antigens through 
specific membrane receptors (Sordillo et al 1997). There are two distinct subsets of 
lymphocytes, which differ in function and protein products, T and B lymphocytes. The T 
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lymphocytes can be classified further into a~ T lymphocytes, which include CD4+ (T-
helper) and CD8+ (T -cytotoxic or T -suppressor) lymphocytes and y8 T cells. In the healthy 
lactating gland CD8+ T cells are the predominant phenotype of the T lymphocyte 
population, in contrast to infected mammary glands where CD4+ T cells prevail (Sordillo 
and Streicher 2002). The T -helper lymphocytes are activated to produce cytokines in 
response to recognition of antigen-major histocompatibility complex (MHC) class II 
complex on antigen presenting cells such as B cells or macrophages. Depending on the 
repertoire of cytokines produced, the T helper cell response can facilitate either a cell-
mediated (Th1 type) or a humoral (Th2 type) response (Brown et al 1998). Interleukin-2 
(IL-2) and interferon-y (IFN-y) are the major cytokines characterized during the Th1 
response, and IL-4, IL-5 and IL-10 dominate during the Th-2 response. Interleukin-10 
however can be produced by and regulate all, Th cells (Brown et aI1998). 
CD8+ T cells can exert either a cytotoxic or suppressor function. It has been suggested that 
CD8+ cytotoxic cells may act as scavengers, removing old or damaged secretory cells, the 
presence of which could increase the susceptibility of the mammary gland to infections 
(Taylor et a11994; Sordillo et aI1997). Suppressor T lymphocytes are thought to control or 
modulate the immune response to bacterial infections. Researchers have demonstrated the 
ability of CD8+ lymphocytes to alter or suppress the proliferative response of CD4+ 
lymphocytes, through evaluation of lacteal secretions from cows infected with S. aureus 
(Park et al 1993). The biological function of y8 T cells, is as yet still unknown, so their 
contribution to mammary gland immunity largely remains speculative, although they have 
been associated with the protection of epithelial surfaces (Sordillo et al 1997). The 
functional significance of the variation of lymphocyte subpopulations found in the 
mammary gland remains unclear (Riollet et al2000). 
The primary role for B lymphocytes is to produce antibodies against invading pathogens. 
Unlike macrophages and neutrophils, B lymphocytes utilize their cell surface receptors to 
recognize specific pathogens. Through their ability to act as antigen presenting cells, B 
lymphocytes stimulate the production of IL-2 from T-Iymphocytes which in turn induces 
proliferation and differentiation of the B lymphocyte, into either plasma cells that produce 
antibody, or memory cells. Unlike T lymphocytes, the proportion of B cells among the 
total lymphocyte population remains fairly constant throughout the different stages of 
lactation and does not increase when infection occurs (Riollet et al 2000). 
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1.6 Bovine Milk 
Milk is a food with excellent nutritional properties, the quality of which decreases 
markedly with mastitis. Of the five constituents of milk, the largest in quantity is water 
(87%), followed by lactose (5%), fats (3.9%) and proteins (3.2%) (Paquin 1998). It is the 
protein component of milk that is of most interest to this study. Approximately 80% of 
milk protein is casein and the remaining 20% is whey protein. Caseins are grouped 
together in micelles: spherical structures containing ex, {3, and K casein, and calcium 
phosphate. It is the casein fraction that gives milk its white-blue colour. It can be removed 
from milk through acid precipitation at pH 4.6, and is essential to the manufacture of 
cheese (Wong et aI1996). The whey proteins are soluble globular proteins, transparent in 
solution. Beta-lactoglobulin ({3-Lg) is the most abundant whey protein, followed by a-
lactalbumin. {3-lactoglobulin is a member of the lipocalin family, and although no 
biological role for this protein has yet been unveiled, its family origin and its identified 
similarity to retinol-binding protein have led to suggestions of it having a role in transport 
of retinal or fatty acids (Sawyer et al 1998; Kontopidis et al 2002). Present on the outer 
surface of this protein is a cavity lined with hydrophobic residues. This hydrophobic cleft 
is able to accommodate fatty acids like palmitate and stearate, a property which could be 
exploited for the removal of this protein from solution. Alpha-lactalbumin (a-LA) is a 
small (Mr 14200), acidic (isoelectric point (PI) 4-5), Ca 2+ binding protein, which is 
essential for lactose biosynthesis. Alpha-lactalbumin is one of two components of lactose 
synthase, which catalyses the final step in lactose biosynthesis in the lactating mammary 
gland (Permyakov and Berliner 2000). 
Inflammatory reactions in the udder alter the quantity of milk produced and change the 
composition of milk in terms of quality. Reduction in milk yield is one of the clearest 
results of mastitis (Hortet and Seegers 1998; Hortet et al 1999; Yalcin et al 2000). Table 
1.5 outlines the total loss in milk throughout lactation in association with SCC. The ratio 
between the different proteins of milk change with an elevated SCC indicative of infection. 
Casein concentrations decrease greatly during mastitis (Munro et al 1984). This is a 
consequence of the increased enzymatic and biochemical activity in mastitic milk. The 
activity of the major oxidizing lipolytic and proteolytic enzymes is noticeably higher in 
mastitic milk than in normal milk. The casein is degraded by proteinases originating from 
bacteria, leukocytes or blood. {3-casein is hydrolysed into smaller fragments by plasmin, 
resulting not only in a decrease of total casein, but also an abnormally high ratio of K-
casein to {3-casein. As casein is essential for the coagulation of cheese, mastitic milk is 
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CELL COUNT DROP IN PRODUCTION 
(X103/ML) (LiTRES/LACT ATION) 
<250 
250-499 -191 
500-749 -336 
750-999 -768 
>1000 -895 
Table 1-5: An increase in milk somatic cell count (SCC) is associated with a decrease in 
yield. The estimated drop in yield per lactation is outlined above. This table was reproduced 
from the Department for Environment Food and Rural Affairs (DEFRA) web site: 
http://www.defra.gov.uk/animalh/welfare/farmed/advice/calendar/housing.asp?id=cells 
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useless for manufacture of this particular dairy product. Bearing in mind that casein 
constitutes 80% of the total protein, its degradation is of concern to producers in receipt of 
payment systems for milk based particularly on total protein concentration (Auldist and 
Hubble 1998). 
The concentrations of {3-LG and a-LA can drop by more than 70% of their normal level 
during mastitis (Auldist and Hubble 1998). The decrease in a-LA leads to a proportional 
decrease in lactose: the osmotic regulator of milk volume. The decrease in both these whey 
proteins is probably due to leakage of these proteins out of milk and into the extracellular 
fluid. As the degree of inflammation increases the chemical composition of milk 
approaches more and more that of blood. This is largely due to the disruption of the 
integrity of the mammary epithelia by bacterial toxins coupled with the customary increase 
in vascular permeability at inflammatory sites (Watanabe et al 2000). Depending on the 
severity of the blood-mammary breakdown, differing degrees (if any) of blood-milk 
mixing can occur, accounting for the presence of blood in mastitic milk. An increase in 
proteins of blood serum origin including lactoferrin and albumin has been reported in cows 
with mastitis. 
The ionic composition of mastitic milk differs from that of normal milk, with Na2+ and Ce-
ions both becoming more concentrated, in contrast to the levels of Ca2+ and PO/- both of 
which are reduced. In addition to the biochemical changes, the physical properties of 
mastitic milk also change. The pH increases from 6.6 to over 7, mainly due to the transfer 
of bicarbonate ions from blood to milk. An increase in the cell numbers and serum protein 
content are responsible for an increase in the viscosity of mastitic milk. 
1.7 Diagnosis of Mastitis 
The dairy industry is challenged by the increasing demand to produce high quality dairy 
products from a milk supply that is inconsistent in its processing characteristics across the 
season. The relationship between bulk milk somatic cell counts (BMSCC) and the 
prevalence of mastitis has been the focus of numerous studies. Holdaway et al (1996) 
reported a correlation of 0.84 (p<0.001) between BMSCC and the percentage of infected 
quarters. Consequently BMSCC have become universally adopted as a screening test for 
mastitis in herds. The EC directive requires bulk milk to have a total bacteria count 
<100,000 bacteria /ml and SCC <400,000 cells/m!. Milk quality incentive schemes for 
BMSCC are routinely in place by dairy companies around the world, and are based on 
penalties and premiums. Payment schemes differ between milk companies. (Table 1.6) 
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SCC (CELLS/ML) GAIN/LOSS (PENCE/L) 
<150,000 + 0.2 
151-250,000 + 0.1 
250-350,000 nil 
351 - 400,000 -1 
>400,000 -5 
Table 1-6: Financial penalities currently employed by Scottish Milk for high bulk milk 
somatic cell count (SCC) levels 
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A BMsee of <250,000 cells/ml is now considered to be a realistic upper limit for UK 
herds with good mastitis control (Blowey and Collis 1992). Individual cow somatic cell 
count (IeSee) has been identified as the most efficient way of identifying high sec cows. 
Although not routinely used on all farms, some carry out monthly recordings of IeSee, in 
an attempt to try and lower BMSee through identifying infected animals within the herd. 
Much variation still remains over deciding on a threshold sec at which cows should be 
classified either as normal or infected. Variation between pathogen type has been one of 
the main problems in setting a sec threshold. Mean sees for Streptococcus sp. are much 
higher than they are for Staphylococcus sp. (Holdaway et al 1996). Various other factors 
influence sec, including breed, nutrition, age, management, stage of lactation and also 
physiological stresses such as excitement, high temperatures and trauma (Holdaway et al 
1996). Somatic cell count is known to increase towards the end of lactation. For farmers 
who employ a 'block calving' system, where a high percentage of the herd will 
simultaneously be at their lactation end, inevitably BMSee will be raised at this time. Use 
of sec as an indication of infection should be exercised with caution in such a situation. 
Bulk milk sec is decreasing in several countries, but the decline in BMSee has not been 
accompanied by a decrease in incidence of clinical mastitis (Peeler et al 2000). On the 
contrary, studies on clinical mastitis in herds with low BMSee have led to the suggestion 
that low sec may be associated with increased risk or severity of mastitis (Barkema et al 
1998; Peeler et aI2000). 
Automatic milking systems (AMS) are now commercially available and their growth in 
popularity is likely to have a considerable effect on udder health (Hamann 1999; Pyorala 
2002). Due to the reduced contact time between stock and dairy personnel, physical 
diagnosis of mastitis by the herdsman in the milking parlour needs to be replaced by other 
systems. Automated detection of mastitis has become feasible, because several parameters 
which change in relation to mastitis such as milk production, milk electrical conductivity, 
N-acetyl ~-D-glucosamide (NAGase) , lactate and milk temperature, can be measured 
automatically by sensors during milking (http://www.sensortec.co.nz). The goal of 
automation is to detect in advance of the clinical signs, thereby allowing early intervention 
(Nielen et al 1995). Electrical conductivity is currently being used for automated detection 
of mastitis but is insufficiently accurate to be used as the sole criterion for mastitis 
detection and further treatment decisions (Mottram 1997; Biggadike et aI2002). Automatic 
milking systems offer an improved quality of life for the farmer and the possibility of 
increased performance of the cow, however deficiencies in fulfilling the milk hygiene 
regulations through identification of abnormal milk remain (Hamann 2001). 
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The recent detection of APPs, Hp and SAA, in the milk from cows affected with mastitis 
has led to the possibility of such proteins being applied to the development of an online 
sensor system for the automatic detection of mastitis in robotic milking systems (Eckersall 
et a12001; Pedersen et a12003; Gronlund et a12003a; Nielsen et aI2004). 
The overall objectives of the work presented in this thesis are 1) To establish the 
concentrations and earliest time point of appearance of APPs, Hp and SAA, in milk of 
cows with naturally occurring mastitis, and to determine their relationship with 
conventional markers of mastitis such as SCC. 2) To establish a protocol using advanced 
proteomic methodology allowing investigation of the total protein repertoire of normal 
bovine milk. 3) To use these established proteomic methods to further characterize the 
alterations in the bovine milk proteome as induced by mastitis. 4) To identify further 
biomarkers for bovine mastitis by analysis of protein spots differentially expressed in 
normal and mastitic milk. 5) To determine the origin of APPs in milk through examination 
of bovine mammary tissue. 
Chapter II 
Development of an Immunoassay for the 
Quantification of Bovine Milk Haptoglobin 
2.1 Introduction 
2.1.1 Haptoglobin in Cattle 
54 
The APR when measured in serum is non-specific and therefore measurement of an 
increased concentration of Hp in serum is not a specific diagnostic test for mastitis. 
Recently investigations have been focused on the local inflammatory process in the 
mammary gland and APP measurements in milk (Eckersall et al 2001; McDonald et al 
2001; Pedersen et a12003; Gronlund et a12003a; Nielsen et aI2004). 
Haptoglobin is a major APP in cattle in which it has a negligible circulating level in blood 
of normal animals (Conner et aI1988b), but increases up to 300 fold during the APR from 
a concentration of less than 0.01g/L to reach 2-3 gIL within 48hrs of infection (Eckersall 
1999). Contrary to humans where Hp is a normal blood protein, it is absent from the 
plasma of healthy cattle (Eckersall and Conner 1988b). Previous investigation of a variety 
of diseases in cattle have shown that Hp has an APR in pasteurellosis (Conner et al 1989) 
(Horadagoda et al 1994); pneumonia (Wittum et al 1996); mastitis (Hirvonen et al 1996); 
foot and mouth disease virus (Hofner et aI1994); bovine respiratory disease (Godson et al 
1996); fatty liver (Nakagawa et a11997) and salmonella (Deignan et aI2000). In cattle and 
other ruminants, Hp has been the acute phase protein most commonly monitored as a 
marker of inflammation (Skinner et al 1991; Wittum et al 1996). Hp has the disadvantage 
of being reduced during haemolytic crises (Kent 1992), resulting in the need for caution in 
the use of Hp for the diagnosis or monitoring of disease involving inflammation if 
simultaneously there is haemolytic crisis in the animal. In such a situation where free Hb 
is present in the circulation, all available Hp binds to the Hb with the resulting complex 
being removed by the liver. In this case, even if production of Hp has been stimulated by 
inflammation, all the Hp binds to the excess Hb and Hp is effectively removed from the 
circulation (Eckersall and Conner 1988a). In veterinary clinical chemistry measurement of 
Hp is particularly important in assessing the health status of cattle, and has been reported 
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as a more specific variable to monitor animals with inflammatory lesions, than SAA 
(Gruys et al1994). 
2.2 Measurement of Acute Phase Proteins 
The methods used to analyse APP have developed considerably over the past few years. 
Originally, most of the proteins were estimated by use of their biochemical activity, 
however with advances in technology, immunoassays have become the method of choice 
for the measurement of animal APP. Although the majority of assays for APPs lie within 
these two main groups, there are still a few exceptions, including the use of capillary zone 
electrophoresis (CZE), for the determination of bovine Hp (Alvarez et a12001). 
2.2.1 Activity Assays 
By the early 1980s, it was recognized that Hp could be a useful diagnostic tool particularly 
in cattle but that the difficulties in quantitative determination by conventional methods was 
a limitation (Makimura and Suzuki 1982). Haptoglobin (Hp), which has the ability to bind 
to haemoglobin (Hb), thus preserving the peroxidase activity of the Hb from inactivation at 
an acidic pH, can be measured by quantification of this activity (Conner et al1988b). 
In veterinary diagnostics the original assays depended on the formation of the Hb-Hp 
complex altering the absorbance characteristics of Hb (as used in a study to assess the 
potential of Hp as a diagnostic indicator of feline disease), in proportion to the 
concentration of Hp in the serum sample (Harvey and Gaskin 1978). In this study, the 
concentration of Hp was determined by Hb binding method using cyanmethaemoglobin as 
a more stable derivative of Hb, and is widely accepted as the method of choice for the 
haemoglobinometry of whole blood (Harvey and Gaskin 1978). Makimura and Suzuki 
(1982) reported the use of the Hb-Hp complex in the quantification ofHp but modified the 
previously reported method (Tarukoski 1966), by using methaemoglobin (Hb +) as a more 
stable alternative to oxy-haemoglobin. This method was employed as the assay of choice in 
veterinary diagnostic laboratories, and at the time held the advantage over immunoassays 
because of its convenience and ability to be performed on all species (Eckersall et al 
1999a). An automated version of this assay was developed (Skinner and Roberts 1994), but 
a major drawback of this procedure was the necessity to use guaiacol, a reagent with a very 
strong odour. Hence the goal of developing an automated assay for Hp, using stable and 
convenient reagents, was not yet achieved. In 1999 Eckersall et al successfully developed a 
robust biochemical assay for serum Hp. A major finding in this development was that 
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serum albumin interfered with the assay system, particularly at low normal levels, which 
had led to the consistent problem in estimating zero control samples. The effects of 
albumin were overcome through the development of a chromogen reagent cocktail (SB-7), 
which inhibited this interfering effect of albumin. This assay is now available as a 
commercially available kit and is being widely used in the measurement of Hp in a range 
of species. 
Using a subcutaneous injection of turpentine as inflammatory stimuli to produce an acute 
phase response results in an increase in the APPs: aI-antitrypsin, ceruloplasmin, 
fibrinogen, Hp and seromucoid (Conner et al 1988b). aI-antitrypsin, Hp and seromucoid 
were all measured using activity based assays. The anti-protease activity of aI-antitrypsin 
is measured through its ability to inhibit the action of trypsin, on the synthetic substrate N-
benzoyl-arginine-p-nitroanalide. Not only was this aforementioned method used for the 
measurement of serum APPs in this study, but aI-antitrypsin was actually measured in 
mastitic milk (Sandholm et al 1984), but the authors concluded that this APP was not a 
reliable and sensitive marker of mastitis because not only was the percentage increase 
small but the levels also showed no dose-related variation. 
2.2.2 Immunoassays 
In the early to mid 1990s the trend moved towards the usage of antibody based systems for 
the measurement of APPs. 
2.2.2.1 General 
The term 'immunoassay' is used to describe a diverse range of techniques for the detection 
and quantification of the antibody-antigen interaction, encompassing a wide array of 
different labels and detection systems (Ronald and Stimson 1998). The basic principle of 
immunoassay is based on the reversible reaction between an antigen and its specific 
antibody. The introduction of monoclonal antibodies and advances in labeling 
methodologies, combined with the speed, simplicity and relatively low cost of 
Immunoassays, have contributed to their employment for the detection of clinically 
important analytes (Gosling 1990). An advantage of these systems is that antibody-based 
methods allow development of immunoassays of differing format i.e: immunodiffusion, 
immunoturbidimetry, latex agglutination and enzyme linked immunosorbent assay 
(ELISA),(Eckersall 1995a). The preparation of monoclonal antibodies for bovine Hp 
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(Sheffield et al 1994), was the stimuli for numerous publications, reporting the use of 
various formats of ELISA for the quantification of APP. 
A number of assays have been described where antiserum raised against one species has 
been used to quantify the same protein in a different species (EckersallI995a). This is not 
ideal but acceptable so long as the assay has been validated for the species under 
investigation. 
The earliest immunoassays in the 1960s and 70s utilized primarily radioisoptope labels 
(Berson and Yalow 1971), which had disadvantages of their short half-life, potential health 
hazard and waste disposal problems. Continual developments in the field of immunoassay, 
all aimed towards improving the utility, sensitivity, accuracy and specificity of the assay. 
One of the first advances in this direction was the replacement of the radioisotope labels 
with alternative labels, primarily enzyme labels although a whole variety of different labels 
have now been developed, including fluorescent and chemiluminescent compounds. The 
advent of these new labels and the instrumentation to use them has given rise to a wide 
range of robust immunoassays with differing formats. The most commonly used assay 
formats are described below, with examples being given of their application in 
measurement of APP. 
Single radial immunodiffusion (SRID) is a precipitation method employing diffusion of the 
antigen, in antibody containing agar gels (Mancini et al 1965). SRID has been developed 
as a simple, cheap and practical method for the quantitative determination of antigens. The 
method of Mancini et al (1965) was employed for the measurement of bovine serum Hp 
under various physiological and pathological conditions, and the levels obtained were 
found to be comparable to those obtained by methods based on haemoglobin binding 
activity (Morimatsu et aI1992). SRID was used to demonstrate increased levels ofHp in 
horses with clinical signs of inflammatory disease (Taira et al 1992). Single radial 
immunodiffusion has previously been demonstrated as an accurate and easy to use means 
of measuring serum Hp, however one drawback of this method is the requirement that the 
gel must be incubated for a period of 24-48hrs before reading the results. Another 
disadvantage of SRID is its sensitivity and the possibility of introducing error through 
manual measurement of the precipitin ring. Many of the studies using ELISA for 
determination of serum Hp (Young et a11995; McNair et a11997; Nakagawa et aI1997), 
report that SRID was first used but the levels of sensitivity required were not achieved, 
hence the need to develop an assay with increased sensitivity. 
f I 
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Ligand labelled assays. In this procedure, it is the analyte/ligand of interest that is 
conjugated to the label. Free, unlabelled ligand in the sample will compete with the labeled 
ligand for the limited number of available antibody binding sites, hence the reason why 
this ELISA format is commonly referred to as a 'competitive assay'. Removal of the free 
ligand with a washing step, and detection of the signal generated by the bound labeled 
analyte, will produce an inverse relationship. i.e The higher the concentration of the 
analyte of interest in the sample, the less labelled ligand will be able to bind. Competitive 
immunoassays have been evaluated for the measurement of bovine Hp by comparison with 
Hb binding methods (Young et al 1995; McNair et al 1997). The authors of these studies 
conclude improved sensitivity as the main advantage of this immunoassay format, but also 
the ability of this assay to measure Hp in the presence of haemolysed red blood cells. 
However, Young et aI, also compared the method of competitive inhibition, with two other 
ELISA formats and although this assay format gave the best correlation with the Hb 
binding methods, it was concluded to be the most time consuming method and not suitable 
for routine processing of samples. 
Antibody labelled assays. In these assays the specific antibody is conjugated with the label. 
The most common approach to this method is by direct detection, where the antigen in the 
sample is bound/captured onto the solid support, and subsequently detected by the addition 
of a labelled antibody. This gives a direct relationship of signal to levels of antigen. A 
variation of this method is where a limited amount of antigen is bound/captured onto the 
solid support and the binding of a labelled antibody is made to compete with free antigen 
in the sample. This competitive assay gives an inverse relationship between signal and the 
level of antigen in the sample. 
Sandwich assays. This assay utilizes two antibodies, which bind independent epitopes on 
the antigen. The capture antibody is immobilized on a solid support, binding any antigen 
present in the sample. The antigen is then detected by addition of a second labeled 
antibody. A major advantage of using the two-site sandwich assay is that the specificity of 
the assay is improved, as signal generation requires the binding of both antibodies. The 
double antibody method has been employed in the measurement of APPs (Nakagawa et al 
1997; Kanno and Katoh 2001; Schroedl et al 2001). A common aim in the experimental 
design of these studies is to develop a method with the sensitivity required to measure APP 
in the serum of healthy cattle, as earlier investigations failed to detect Hp in the serum of 
healthy cattle (Spooner and Miller 1971; Makimura and Suzuki 1982; Conner et a11988b; 
Morimatsu et aI1992). 
Caroline Hogarth, 2004 Chapter 2, 59 
Ligand binding assays. Eckersall et al (1989) described an ELISA for canine CRP, that 
utilizes the binding affinity of CRP to phosphorylcholine (PC). The plate was coated with 
PC conjugated to albumin, and CRP from positive serum samples was hence bound to the 
plate. The concentration of CRP in the serum sample was then quantified through 
incubation with a primary antiboby (anti-CRP), followed by a secondary peroxidase 
labeled antibody (Eckersall et aI1989). 
Immune complex particle assays. Assays in this group include precipitation, 
nephelometric, and turbidimetric immunoassays. The basic principle of these assays is the 
reaction of a specific polyclonal antibody with a multivalent antigen, which leads to the 
formation of a visible precipitate. Nephelometry and turbidimetry increase the sensitivity 
of the assay by utilizing the light scattering properties of the antigen-antibody complexes. 
An immunoturbidimetric method has been used to measure serum Hp in the horse (Kent 
and Goodall 1991). The authors of this study concluded that the immunoturbidimetric 
assay for equine Hp was quick and easy to perform, and showed a good correlation with 
the more traditional haemoglobin binding methods, but with better precision. An 
immunoturbidimetric assay developed for the measurement of canine CRP, correlated with 
results obtained using an ELISA method and was recommended by the authors of the study 
as the method of choice for the routine analysis of canine CRP (Eckersall et aI1991). 
Another study used an automated immunonephelometric detection system, to determine 
the Hp concentration in the plasma of fattening pigs (Lipperheide et aI1998). Single radial 
immunodiffusion (SRID) was used as a reference method to determine the Hp 
concentration in 27 out of the 100 plasma samples and led to the conclusion that optimal 
'I. ! 
accuracy was only obtained when an animal-relevant standard was used, reinforcing the , I 
need for an international standardization of all methods to quantify APPs in animal serum 
by use of antibody-based assays (Eckersall et al 1999b). 
2.3 Measuring Hp in Milk 
Serum Hp can be measured by peroxidase activity of Hp-Hb complex, electrophoresis, 
immunodiffusion, differential acid denaturation of Hb and Hp-Hb complex, 
immunonephelometry. However all of these methods lose precision when Hp is present in 
low amounts (Katnik and Dobryszycka 1990). 
In preliminary studies attempts to measure the concentration of Hp in milk by the 
haemoglobin-binding method were not successful because the sample contained 
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peroxidase activity, probably due to lactoperoxidase, which interfered with the assay 
(Eckersall et a12001). 
The aIm of this work was therefore to develop and validate an immunoassay for 
quantitative determination of bovine Hp in milk with a limit of detection to allow 
quantification oflow concentration. The initial method for the measurement of haptoglobin 
in milk was by SRID assay, as used by Eckersall and others (2001) to measure the 
concentration of Hp in this fluid. However, Hp was only detectable in a few milk samples 
from cows with mastitis, a possible reason being that the limit of detection of the SRID 
assay was too high to allow low level changes to be detected, so a new more sensitive 
method had to be developed. An ELISA based method using a ligand binding approach 
was developed and validated and compared to SRID. The ELISA was then used in a 
collaborative study with the Swedish University of Agricultural Sciences, Uppsala, to 
determine the concentration of Hp in milk, from dairy cows experimentally challenged 
with S. aureus. 
2.4 Materials and Methods 
2.4.1 General Reagents and Equipment 
Reagents were obtained from Sigma Chemical Company Ltd, unless otherwise stated. 
Microtitre plates used were from Nunc. Plate incubator/ shaker and plate reader connected 
to a computer, with Revelation™ immunoassay software (Dynex Technologies Inc, 
Virginia, USA) installed. 
2.4.1.1 Milk samples 
The milk samples from this study were from the Swedish University of Agricultural 
Sciences, Faculty of Veterinary Medicine, Uppsala, Sweden. A model of an experimentally 
induced Staphylococcus aureus mastitis in six dairy cows, was used, in which an acute 
inflammation was transformed to a chronic phase by controlled use of antibiotics. 
Stripping milk samples were aseptically collected from the infected and the control 
quarters from each animal at, day 2 and day 1 before infection, and at 6, 24, 32, 48, 54, 72, 
80, 96, 104, 120, 128, 144, 168, 192 hours post-infection (h.pj), and on days 12, 15, 19, 
22, 26, 29, 33 and 36 post-infection (Pj). For further information refer to Gronlund et al 
(2003a). 
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2.4.2 Single Radial Immunodiffusion 
2.4.2.1 Antisera 
The ovine antiserum against bovine Hp (anti-Hp) was selected from a group of antisera 
raised in sheep immunized against this antigen (Eckersall and Conner 1990). The antisera 
having the strongest cross-reaction with antigen or high acute phase serum, was selected by 
screening this cross-reaction using Ouchterlony plates. 
2.4.2.2 Immunodifusion methods 
Single radial immunodiffusion (SRID) was initially used to measure Hp in the milk 
samples from an experimental model of S. aureus mastitis. The standards and the internal 
controls for the final ELISA assay were quantified using SRID. 
Single radial immunodifusion agarose plates (w/v 1.5%) were prepared in 0.05M tris 
buffered saline (TBS, pH 7.4), which contained 4% (v/v) antisera to bovine Hp. A milk 
sample with a high concentration of Hp was calibrated for use as a standard by comparison 
to a bovine serum Hp standard. For the SRID the milk standard was diluted in NaCl in 
0.9% w/v sodium chloride to give standard concentrations over the range, of 680 to 5.3 
JLg/ml. Samples or standards (7111) were transferred into wells (2.5mm diameter) in the 
antisera containing agarose, which was incubated in a humidity chamber for up to 48 hours 
at 4°C. The diameter of the circles of precipitation was measured and the results from the 
standards plotted against concentration on log-linear graph paper. The test results were 
read off the standard curve. 
2.4.3 ELISA 
An ELISA based on the affinity ofHp with Hb has been developed for the measurement of 
Hp in milk. In this method, Hb is initially coated onto the micro titre plates and Hp in milk 
specifically binds to Hb attached to the surface of the plate 
2.4.3.1 Haemoglobin preparation 
Canine erythrocytes were washed five times with 0.9% saline. An equal volume of the 
washed red cells was then added to an equal volume of distilled water, and toluene was 
layered on top (roughly 10% of total volume). The mixture was shaken vigorously for 15 
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mins, and then centrifuged for 15mins at 3500rpm. The lower layer obtained was the 
haemolysate: very dark red, almost black in colour, and should not contain any cell debris 
(Makimura and Suzuki 1982). The concentration of haemoglobin was determined 
according to manufacturers instructions using the Abbott 3500 Analyser (Abbott 
Diagnostics, Berkshire, UK). The haemolysate was aliquoted and stored at -20°C. Each 
aliquot was centrifuged for 2 mins before use. 
2.4.3.2 Reagents and buffers 
The different buffers used at various stages throughout the assay are detailed below. The 
coating buffer consisted of 10mM sodium bicarbonate (NaHC03) and 10mM sodium 
carbonate buffer (Na2C03) at pH 9.6. Tris buffered saline was used to wash the plate 
between steps. In order to inhibit non-specific binding, a blocking buffer consisting of 5% 
w/v dried skimmed milk powder in TBS containing 0.1 % sodium azide was used. The 
antibody that was used for the SRID (see section 2.4.2.1) was conjugated to streptavidin 
using heterobifunctional methods which utilize the cross-linker, succinimidyl (4-N-
maleimidomethyl) cyc1ohexane-l-carboxylate (SMCC), to form a stable amide/thioether 
linkage between antibody and streptavidin. Conjugation of the antibody was carried out by 
Tridelta Development Ltd, Dublin, Ireland. 
2.4.4 Assay Procedure 
An optimisation procedure was performed to determine the best concentration for reagents. 
The following are the final 'optimised' conditions. 
2.4.4.1 Coating 
The Hb was diluted to a final concentration of 2.5mglml in bicarbonate buffer (10mM, pH 
9.6) and then 100~1 was dispensed into each well of a Nunc-Immuno™ 96 MicroWell™ 
Plate (Nunc International, Rochester,. NY) and incubated at 4°C overnight. 
2.4.4.2 Washing 
The ELISA plate was washed, by adding 300~1 of TBS to each well, shaking the plate and 
the liquid decanted. This was repeated 3 times. 
Caroline Hogarth, 2004 Chapter 2, 63 
2.4.4.3 Blocking 
Unoccupied binding sites were blocked by adding 300~1 of 5% w/v dried skimmed milk in 
blocking buffer to each well and incubating the plate at 37°C with gentle shaking for 
1 hour. 
2.4.4.4 Washing 
The plate was again washed as in 2.4.4.2, but the TBS this time contained 0.1 % (v/v) 
Tween-20 (TBST) 
2.4.4.5 Sample dilution and loading volume 
Standards, controls and test milk samples were diluted 1 :20 in TBST containing blocking 
agent (1 % w/v of dried skimmed milk) and 1 00~1 of each sample was added to separate 
wells in duplicate and the plate was incubated at 37°C with gentle shaking for Ihour. The 
plate was then washed as in section 2.4.4.4. For further information refer to Gronlund et al 
(2003). 
2.4.4.6 Addition of antibody 
After washing, 1 00~1 of conjugated antibody diluted 1 :400 (in TBS-Tween + 1 % w/v dried 
skim milk) was dispensed to each well and the plate was incubated at 37°C with gentle 
shaking for 1 hour. 
2.4.4.7 Addition of substrate 
After decanting the plate was again washed 3 times as in 2.4.4.4. Tetra methyl benzidine 
(TMB) peroxidase substrate was freshly prepared according to manufacturers instructions 
(KPL, Maryland USA), and 200~1 was added to each well. The plate was then left at room 
temperature to allow the colour to develop (approximately 20mins). The peroxidase-
enzyme reaction was terminated by the addition of 50~1 of 2M H2S04 to each well. 
2.4.4.8 Absorbance 
The absorbance was measured at 450nm using an ELISA plate reader, and the results were 
analysed using the RevelationTM immunoassay software (Dynex Technologies Inc, 
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Virginia, USA), which employed a linear-logarithmic transformation in the calculation of 
the ELISA results. 
2.4.5 Assay Optimisation 
Assay validation was carried out as described by Sipe et al (1999) in several steps. Each 
step was carried out a minimum of 3 times and the mean values are presented in the 
following results section. 
2.4.5.1 Titration of the horseradish peroxidase conjugated antibody 
The optimal dilutions of antisera were determined by demonstration of the effect of 
varying antibody dilutions whilst keeping all other conditions constant. Three plates were 
reacted with all possible variables being kept constant, while HRP-conjugated antibody 
concentrations were varied. The objective was to identify the concentration of antibody 
that gave the maximum optical density for the highest standard while also giving a steep 
standard curve. 
2.4.5.2 Optimisation of the standard and sample dilution 
A standard curve was prepared by diluting the working standard in the coating buffer. The 
top standard with a known amount of Hp (340j.lg/ml), determined by radial 
immunodiffusion was diluted serially to give standards of: 340, 170, 85, 42, 21 and 10 
j.lg/ml, respectively. In calibration of the standard, milk and serum were used in the 
beginning of development to demonstrate through parallelism of the standard curves, that 
the same analyte was being measured regardless of the matrix being used. Standards and 
samples were diluted 1 :20 in TBST containing blocking agent (1 % w/v of dried skimmed 
milk), to give an optimal balance between diluting out the matrix effect of the milk, 
without compromising the sensitivity ofthe assay. 
2.4.5.3 Assessment of blocking agents 
The ELISA was carried out, using, 5% dried milk, 5% dried milk and 0.1 % bovine serum 
albumin (BSA); and also 5% porcine gelatin as blocking agents in TBS. Normal BSA was 
added to reduce any non-specific binding that may be present. 
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2.4.6 Assay Validation 
Assay validation was carried out using methods described by (Sipe et al 1989) on the 
bovine Hp ELISA assay which was perfonned according to section 2.4.4. 
2.4.6.1 Precision 
The reproducibility of the ELISA was demonstrated by intra-assay and interassay 
coefficients of variation (CV%). Interassay precision was estimated by deriving the CV of 
low (25 /Lglml) and high (219 /Lg/ml) quality controls and was calculated by the standard 
deviation as a percentage of the mean of the results from 25 different assays. The intra-
assay CV was detennined by calculation of the CV of duplicate pairs for each 
immunoassay plate according to (Fraser 1986). 
2.4.6.2 Accuracy 
In analytical measurements accuracy is defined as how close the average measured value is 
to the true value. In the absence of purified Hp for recovery studies, the accuracy of the 
assay was assessed through a dilution experiment, to see whether or not the dilutions of 
sample lie parallel to the calibration curve. 
2.4.6.3 The limit of detection 
The limit of detection was detennined as the lowest amount of Hp that could be 
distinguished from the zero standard. This was detennined as the Hp concentrations at 2 
SD away from the mean (mean ± 2 x SD) of the zero standard. 
2.4.6.4 Comparison to other methods 
In order to confinn that the assay developed for bovine Hp in milk offered increased 
sensitivity to existing methods, the concentration of Hp in 288 milk samples from infected 
and control animals which had been assayed first by SRID were also assayed by the 
ELISA. A regression analysis was carried out on the results of these assays. 
2.4.6.5 Detection of pathophysiological change 
The milk samples described in section 2.4.1.1 were assayed using the ELISA with assay 
optimisation as per section 2.4.5. 
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2.5 Results 
2.5.1 Assay optimisation 
2.5.1.1 Titration of the horseradish peroxidase conjugated antibody 
Throughout the optimisation procedure a wide range of antibody dilutions were screened, 
however final optimisation covered a range of 1 :400 to 1: 1600. Figure 2.1 shows the 
antibody dilution of 1 :400 gave the best results with the maximum standard giving a high 
optical density of 1.6 and a steep curve with still a reasonably low background. 
2.5.1.2 Standard and sample dilution 
Assay development included calibration of a suitable standard. Milk and serum were both 
diluted serially in assay buffer and are shown to display parallelism (Figure 2.2) indicating 
that the same analyte is being measured regardless of the matrix being used. For the final 
assay protocol milk, diluted in assay buffer was chosen as the working standard to keep 
variation to a minimum. 
2.5.1.3 Influence of the blocking agents 
The results of the OD of the zero standard with different blocking agents are shown in 
figure 2.3. The 5% w/v dried milk; 2% w/v BSA and 1 % w/v porcine gelatin all give a 
suitable low OD. The porcine gelatin was discounted because it was more difficult to wash 
from the wells (due to its gel-like consistency), than the other two blocking agents. 5% w/v 
dried milk was chosen over BSA due to the convenience in preparation and lower cost. 
2.5.2 Assay validation 
2.5.2.1 Intra- and interassay precision and the assay repeatability 
The inter-assay coefficients of variance were 9.8% and 26% at Hp concentrations of 
219~g/ml and 25.5~g/ml, respectively in 25 assays. The intra-assay CV was determined by 
calculation of the CV of 40 duplicate pairs for each immunoassay plate according to Fraser 
(1986) and had a median value of7.3% and a range of3.4-10.1 %. 
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Figure 2-1: Optimisation of the ELISA for bovine Hp. The effect of the HRP conjugated 
antibody di lutions at 1 :400; 1 :800 and 1 :1600 on the Hp standard curve. 1 :400 dilution 
produced a steep standard curve and the highest optical density (1.595) of the 3 antibody 
dilutions 
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Figure 2-3: Effect of different blocking agents on the milk Haptoglobin standard curve 
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2.5.2.2 Accuracy 
The accuracy of the assay was tested by diluting a Hp containing milk sample in 2 different 
analyte-free matrices (normal milk and buffer), to show that the results display parallelism 
(Figure 2-4) 
2.5.2.3 The lower limit of detection 
The minimum detection limit significantly different from the zero standard was determined 
as the Hp concentrations at 2 SD away from the mean (mean ± 2 x SD) of the zero 
standard resulting in a limit of detection for Hp in milk at a concentration of 1.2 ,ug/ml. 
2.5.2.4 Comparison to previous method 
The Hp concentrations of the bovine milk samples measured by both SRID and ELISA are 
displayed as a scatter graph in figure 2.S. A total of 288 milk samples were assayed by 
both SRID and ELISA, and Hp was detected in 39 and 109 samples respectively. The 
ELISA method was therefore shown to be 64% more efficient in detecting Hp in milk than 
SRID. This comparison give a correlation coeffiecient (r) of 0.69 which confirms a 
significant correlation between methods (p<0.001). 
2.5.3 Milk Haptoglobin Concentration 
The ELISA was used to measure Hp concentration in milk samples from both control and 
infected quarters from six animals during the acute and chronic phases of experimentally 
induced s'aureus mastitis. As this study was in collaboration with the Faculty of 
Veterinary Medicine, Uppsala Sweden, results from the other parameters measured (SAA 
in milk, Hp and SAA in serum, and SCC), including clinical observations of the animals, 
were provided by U. Gronlund (Uppsala, Sweden) and are included in the results section 
below, in order to aid interpretation of data at later stages in this chapter and in chapter 
three. The concentration ofHp in milk was determined in Glasgow as part ofthis thesis. 
2.5.3.1 Milk and serum from infected quarters 
The samples were taken from an experimental model that used antibiotic treatment to 
successfully transform acute clinical mastitis to chronic subclinical mastitis. Milk samples 
were analysed for bacteriology and SCC. In addition milk and serum samples were 
I ! 
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Figure 2-4: The accuracy of the ELISA was tested with a dilution experiment. The milk 
standard was diluted in a normal milk sample containing no haptoglobin (Hp) and also in 
buffer. 
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Figure 2-5: Correlation between parallel measurements of Hp in 108 milk samples using 
ELISA (y axis) and radial immunodiffusion (RID) (x axis). 
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analysed for the concentrations ofHp and SAA. In the acute phase, serum levels ofHp and 
SAA were higher than pre-infection and chronic phase levels (Figure 2.6). The highest 
concentrations of serum Hp and SAA were found at 72-80h p.i. and 54-104h p.i., 
respectively and ranged from 960 to 2190 mg/l for Hp, and from 487 to >1200 mg/l for 
SAA. Additionally, Hp and MAA were higher than both pre-infection and control samples 
in milk (Figure 2.7) during the acute phase. 
In milk from udder quarters inoculated with S. aureus (n= 6 cows), Hp was detectable in a 
100% of the samples at 24h p.i .. Maximal values of Hp and SAA were found in the milk 
samples during the acute phase of infection at 54-80 h p.i. and 48-120h p.i., respectively. 
They ranged from 52-323 mg/l for Hp and from 34 to 286 mg/l for SAA (Figure 2.7). 
Clinical signs including abnormalities in the milk and swelling was observed in all of the 
infected quarters during the acute phase of infection. Somatic cell counts in this phase 
ranged from 56 x103 to 22 x106 cells/ml. . 
In the chronic phase all serum samples had supra-normal Hp concentrations while 77% had 
increased levels of SAA. Maximal chronic phase concentrations for Hp and SAA in serum 
ranged from 70 to 320 mg/l and 6.4 to 41.2 mg/l respectively (Figure 2.6), and were 
randomly distributed throughout the chronic phase. Sixty two percent of the infected milk 
samples had increased Hp during the chronic phase, 91 % had increased concentrations of 
SAA. Maximal concentrations of milk Hp and SAA during the chronic phase ranged from 
17 to 26 mg/l and 10.8 to 43 mg/l, respectively. Somatic cell counts during the chronic 
phase ranged from 607 xl 03 to 26 xl 06 cells/ml. 
2.5.3.2 Milk from control quarters 
Haptoglobin was detected by ELISA in only 6 out of 118 milk samples from control 
quarter samples, the concentration of which ranged from 8.3 to 63 /-tg/ml. Elevated SAA 
was found in 7 samples out of 123 samples and ranged from 1.8 to 20 /-tg/ml. Control udder 
quarters remained normal throughout the study, i.e, with no changes in the appearance of 
the milk or the udder. During the study their SCC ranged from 22 xl 03 to 445 x 103 
cells/ml. 
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Figure 2-6: Median serum concentrations of haptoglobin (-0 -) and serum amyloid A (-e-) 
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Figure 2-7: Median concentrations of haptoglobin (-0-) and serum amyloid A (-.) in milk 
samples from udder quarters inoculated with S.aureus at day 0 (n=6cows). Taken from 
(Gronlund et al 2003a). 
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2.5.4 Discussion 
Haptoglobin is the most widely studied APP in cattle (Gruys et al 1994; Eckersall 1995b; 
Schroedl et al 2001), and has been found to be increased in a number of disease situations 
(Makimura and Suzuki 1982; Conner et a11986; Conner et a11989; Hirvonen et a11996; 
Horadagoda et al 1999). However the majority of studies reporting the potential of Hp in 
veterinary clinical biochemistry relate to its measurement in serum. Availability of 
convenient and reliable assays of differing formats, for measurement of serum Hp, have 
been the backbone of advances in this area. The method of choice for estimation of bovine 
serum Hp is a sensitive and robust, commercially available assay based on the peroxidase 
activity of the Hb-Hp complex, but unfortunately it cannot be used to measure Hp in milk 
due to a lack of sensitivity and interference from other substances in milk (Eckersall et al 
1999a; Eckersall et aI2001). 
The method reported in this chapter is the first ELISA to measure Hp in bovine milk. The 
ELISA method, based on the affinity of Hp with Hb, was developed and validated, and was 
used to evaluate Hp concentrations in milk during experimental mastitis infection. This in 
itself is a final stage of assay validation in that it is important that a method can be used to 
detect real pathophysiological changes. 
Milk Hp has previously been determined by SRID, however this method is time 
consuming, lacks sensitivity and can have substantial interassay variation, due to the need 
for manual measurement of the diameter of the precipitin rings. The speed and 
practicability of assay procedures are major criteria for the acceptance of an analyte for 
routine estimation in clinical practice. With regard to this, the ELISA described in this 
chapter for the detection of bovine milk Hp, holds distinct advantages to previously 
described methods. First Hp is measured in milk not serum, hence specificity is greatly 
increased in the diagnosis of milk-related diseases. Second, the method described is 
sensitive even at low concentrations of Hp, and has been optimised to produce a quick and 
reliable assay. Third, an ELISA format involves many washing steps and is therefore not 
affected by the opacity of milk. Finally, milk is a much easier fluid to obtain than serum. 
Unlike blood vessels, the mammary glands can be accessed with ease, even by unskilled 
personnel, so that obtaining a milk sample is less traumatic to a cow than obtaining a 
serum sample and, with a routine diagnostic test in mind, that is extremely important 
particularly when dealing with lactating dairy cows. 
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During development of the final assay protocol (section 2.4.4) several stages had to be 
optimised. Investigations relating to the optimisation of the antibody found that a dilution 
of 1 :400 gave a good result, with a high optical density for maximum values of Hp, but 
still reasonably low background, giving rise to a steep standard curve (Figure 2.1). Initially 
serum was considered as a possible standard, so during optimisation both serum and milk 
were diluted serially in order to determine the effects of these different matrices on the 
standard curve. Figure 2.2 shows that the slope of the curves for serum and milk 
demonstrate parallelism, indicating that Hp is being detected in both. It was possible for 
either serum or milk to be used as the source of standard material in our assay. Milk was 
chosen in order to eliminate the occurrence of any matrix effect that may be present in 
serum, although our results show that this is unlikely. In order to optimise assay 
performance it is essential to prevent non-specific binding. This was achieved by blocking 
with 5% dried milk powder (Figure 2.3). 
Assay validation revealed that the performance of the assay was within acceptable limits 
for ELISA with an intra-assay CV% of 7.3% and interassay CV% of 9.8% and 26%, the 
latter was rather high but was at high milk Hp concentration and samples with such high 
levels were generally diluted to read off a more precise section of the curve. The preferred 
method for determining the analytical accuracy of an assay is by spiking the test sample 
with a known amount of a pure homogenous form of the analyte and measuring the 
recovery. However, as purified bovine Hp was not available, in this experiment the 
accuracy of the assay was assessed through a dilution experiment. Traditionally new assay 
studies include a correlation study against an alternative method, quoting the Pearson 
product moment correlation coefficient, r, as an index of the degree of agreement. The 
regression analysis (Figure 2.5) gives a correlation coefficient, which is highly significant 
although there is an obvious bias between the two methods. The significance of the r value 
can therefore be misleading, in that it does not identify the strength of the relationship 
between the two parameters, but merely that they are measuring the same substance. It is 
possible that a strong agreement was not observed between the ELISA and the SRID 
method because there is already a degree of imprecision associated with the latter. 
Additionally the slope, intercept and regression coefficient are all heavily influenced by 
extreme values such as that recorded at 680I-lg/ml for SRID. Previous studies have used 
immunoprecipitation in agarose gels to measure bovine Hp but this method gives, at best, 
semi-quantitative results, is time consuming and requires large volumes of antiserum 
(Eckersall et aI1989). This, in addition to the high detection limit of SRID, concluded the 
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ELISA to be a more sensitive and convenient method for the detection of milk Hp in this 
study. 
Clinical validation of the assay showed milk Hp is a prominent marker of acute clinical S 
.aureus mastitis. Moreover, the increase of Hp in milk was specific for the infected udder 
quarters because levels in the control quarters were unaffected or, on a few occasions only 
slightly raised. The S. aureus mastitis model from which the milk samples were obtained 
for use in this study was successfully established. All infected quarters developed acute 
clinical mastitis, and most of them later progressed to chronic subclinical mastitis. The 
model was therefore suitable for the longitudinal studies of acute and chronic inflammatory 
responses in the mammary gland. Pre-infection levels of Hp in milk were below the 
detection limit of the assay, in agreement with the result of previous findings (Eckersall et 
al 2001). During acute mastitis Hp levels increased rapidly in milk from infected quarters 
and results from SAA in milk and both Hp and SAA in serum report similar kinetic 
profiles. The start of the increase coincided with the onset of clinical signs of acute mastitis 
and the increase in SCC. This study has identified potential for milk Hp as a marker of 
mastitis. Further studies are needed including investigation of APR during mastitis induced 
by pathogens other than S. aureus and also during naturally occurring mastitis to eliminate 
any artefacts introduced by the experimental model. 
One drawback of the milk Hp ELISA is in the quantification of severely mastitic milk 
samples with clots in milk causing problems with pipetting, and solubility of the sample. 
Centrifugation is not advisable, as it is not yet known in what fraction of the milk Hp is 
present. However, although the method showed some variability, particularly whilst 
measuring high levels of Hp, the results measured by the developed ELISA still gave an 
accurate reflection of the clinical situation and were backed up by SCC, SAA and 
bacteriology, and could aid the diagnosis of clinical mastitis. 
The assay for bovine milk Hp described in this study was further developed and 
commercialised by Tridelta Development Ltd, Dublin, Ireland 
(http://www.trideltaltd.coml). 
The results from this study conclude that both Hp and SAA are sensitive markers of acute 
clinical mastitis but only SAA is indicative of chronic sub-clinical mastitis. Haptoglobin 
reached higher concentrations in the milk during the acute phase than SAA, but it is not yet 
clear if one particular protein is better at detecting mastitis than the other. Further study is 
required to assess the potential of these APPs as biomarkers of mastitis both together and 
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individually. Additionally the influence of the experimental model on the kinetics of milk 
APPs should be addressed by detennining the concentration of milk APPs across a time 
course of naturally occurring mastitis. 
Chapter III 
Acute Phase Proteins in Milk in Health and 
Mastitis 
3.1 Introduction 
3.1. 1 Clinical Mastitis 
79 
Clinical mastitis is characterised by abnormal milk of varying degrees, depending on the 
severity of mammary gland inflammation (Figure 3.1 a and 3.1 b) (Sears et a1 1993; Cullor 
1996). Signs of inflammation include heat, pain, redness, swelling (Figures 3.2a and 3.2b) 
and loss of function of the mammary gland (O'Rourke 1992). Clinical mastitis can be 
further classified as peracute, acute, subacute or chronic (Cullor 1996) depending on the 
additional signs. Peracute mastitis is categorised by a marked systemic reaction which can 
include the clinical signs of depression, anorexia, pyrexia and recumbency (Cullor 1996). 
Clinical signs alone are considered to be insufficient to differentiate between infections 
caused by Gram positive and Gram negative bacteria with certainty, although recent work 
indicates that some clinical signs are more likely to be associated with certain types of 
pathogens than others (Milne et al2002). 
3.1.2 Subclinical Mastitis 
Subclinical mastitis occurs when the mammary gland is infected and the number of 
leucocytes is increased, but where there is no visible abnormality of the milk and there are 
no clinically detectable signs of inflammation in the mammary gland (Philpot 1984; Sears 
et al 1993; Cullor et al 1996). Subclinical infections are therefore, difficult to detect and 
repeated or persistent bouts may lead to fibrosis of the mammary tissue, resulting in a 
reduction in milk production (Cullor et a11996). 
3.1.3 Mastitis Pathogens 
Many different pathogenic bacteria can infect the mammary gland and there are 
considerable differences in epidemiological and predisposing factors with different types 
of infection (Dodd 1970). 'Contagious mastitis' and 'environmental mastitis' are labels 
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Figure 3-1: Example of the c linical abnormalities of milk resulting from mastitis The milk in 
picture a) has a slightly pink tinge and also contains true blood c lots. The milk shown in 
picture b) demonstrates the total absence of normal milk, and shows a secretion consisting 
of thick clots suspended in a c lear serous fluid. 
Figure 3-2: Example of the clinica l abnormalities of the udder associated with mastitis. a) an 
enlarged, hard, hot and painful quarter can occur in some cases of c linica l mastitis. b) 
chronic abscessation of mammary tissue 
I 
-I 
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used to classify the epidemiology of pathogens that cause intramammary infections in 
dairy cows (Bramley and Dodd 1984; Smith and Hogan 1993). Contagious mastitis is 
transmitted from cow to cow during milking, whereas exposure to environmental 
pathogens can occur at any time during a cow's life either during the lactating or non-
lactating period (Fox and Gay 1993; Smith and Hogan 1993). 
3.1.3.1 Contagious Pathogens 
Contagious mastitis is caused by organisms that colonise the mammary gland and can be 
spread by the milking procedure, contaminated machinery, the hands of the milker and 
nursing calves (Cullor et al 1996). The main contagious pathogens are Staphylococcus 
aureus, Streptococcus agalactiae, Streptococcus dysgalactiae (Bramley 1984). 
Staphylococcus aureus is a gram-positive, aerobic, pathogen which can be found on the 
skin of the udder, on the teats, and in the intramammary tissue (Cullor et al 1996). Most 
infections due to S. aureus are chronic subclinical infections, although occasional clinical 
cases of mild to moderate severity do occur (Cullor et al 1996). Such intramammary 
infections tend to be of long duration (Bramley 1984). Staphylococcus aureus is difficult to 
eliminate, it can survive for extended periods of time on the skin (McDonald 1977) or 
within neutrophils in the gland, where it is protected from antibiotics (Sandholm et al 
1990). Staphylococcus aureus is contagious and spreads easily within herds (Fox and Gay 
1993). When a number of cows in a herd are infected, bulk milk somatic cell count 
(BMSCC) increases and legal limits for BMSCC may be violated, or thresholds for 
premium bonus may not be met (Dekkers et al 1996; Adkinson et al 2001). Hence the 
control of S. aureus mastitis is both necessary and important. 
Streptococcus agalactiae is a highly contagious pathogen of the bovine mammary gland 
(Cullor et aI1996). The primary site of colonisation is in the udder tissue, but teat lesions 
and teat ducts can also be colonised. Streptococcus agalactiae infection can be eradicated 
from a herd due to the micro-organisms continued sensitivity to treatment with penicillin 
during lactation (Philpot 1984). 
Streptococcus dysgalactiae is not as infectious as S. agalactiae (Cullor et al 1996). 
Streptococcus dysgalactiae, found naturally in the udder and skin teat lesions is frequently 
transmitted during the milking process (Blowey 1990), and often follows teat injury 
(Cullor et aI1996). 
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3.1.3.2 Environmental Pathogens 
Environmental mastitis IS caused by environmental pathogens that do not generally 
colonise the mammary gland, but can do so when contamination of the cow's environment, 
teats, udder or milking machine occurs, and the organisms gain access to the teat cistern 
(Rendos et al 1975). The primary reservoir of environmental pathogens is the dairy cow's 
environment, but in contrast to contagious mastitis, exposure is not limited to the milking 
process (Smith and Hogan 1993), and invasion of uninfected quarters by environmental 
pathogens can occur at any time during the life of a cow (Smith and Hogan 1993). Gram-
negative enterobacteriaceae and environmental streptococci, I.e. coliforms and 
Streptococcus uberis are the primary environmental pathogens (Smith et al 1985). 
The gram-negative coliform, Escherichia coli, is a natural inhabitant of the large intestine 
and is found surviving in faecal matter (Blowey 1990). Escherichia coli can induce severe 
peracute infection which can occasionally lead to death of the cow (eullor et al 1996), 
however, acute mastitis characterised by hard swollen quarters with brief periods of 
pyrexia and anorexia, is more commonly induced by this micro-organism (Eberhart 1984). 
Streptococcus uberis (s. uberis) is a widely occurring causative agent of mastitis in modem 
dairy herds. It is responsible for the majority of clinical and subclinical cases of mastitis in 
the UK (Hillerton et al 1993). Streptococcus uberis is found naturally on mucous 
membranes, skin and in faeces (Blowey 1990), and generally causes less severe infection 
than E. coli. Streptococcus uberis is considered to be an opportunistic pathogen that can 
survive and mUltiply in extramammary sites (Sandholm et al 1990), including lips, 
haircoat, tonsils and the rectum of cows (Bramley et al 1979). Streptococcus uberis 
multiplies in most bedding material but especially in straw (Ward et al 2002). 
Streptococcus uberis is difficult to control due to its Ubiquitous nature and a lack of 
knowledge of the pathogenesis of S. uberis infections (Leigh 1999). The prevalence of S. 
uberis infections is reported to be high during early and late lactation (Todhunter et al 
1995), and there has been little reduction in the incidence of S. uberis mastitis over the past 
30 years (Leigh 1999). 
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3. 1.4 Detection of Mastitis 
Due to the problems of using clinical signs alone for diagnosing mastitis, a number of other 
methods have been developed and tested for their ability to detect mastitis. Diagnostic tests 
are used to identify the nature and extent of a mastitis problem in a dairy herd, or to 
identify an individual animal for segregation, treatment or culling (Bramley 1992). 
3.1.4.1 Somatic Cell Count 
An increase in somatic cells in the milk gives a good indication as to the degree of 
inflammation present in the udder (Sears et aI1993)). Milk somatic cells consist of white 
blood cells and epithelial cells (Nickerson 1985) and the somatic cell count (SCC) is a 
measure of the number of these cells per ml of milk. Somatic cell counting is a practical 
and effective method to evaluate the mastitis status of a herd and gives a good indication of 
the prevalence of infection within a herd, since intramammary infection is the most 
important factor influencing the number of somatic cells in milk (Reneau 1986). Other 
factors which influence SCC include breed, age, stage of lactation and physiological 
stresses such as excitement, high temperatures and trauma (Philpot 1984). Somatic cell 
count is always elevated shortly after calving. The post-partum period has physiologically 
elevated foremilk SCC; the duration of which being reported with a range of between 5 
and 35 days (Philpot 1984; Blowey and Edmondson 1995; Barkema et al 1999). An 
elevated SCC in early lactation may also be caused by the fact that a high percentage of 
udder quarters are infected at calving (Fox and Gay 1993; Todhunter et aI1995). 
Somatic cell counting can be done at the quarter level when individual milk samples are 
collected from each quarter i.e. individual quarter somatic cell count (IQSCC), or at the 
cow level, when a composite sample of equal volumes of milk is collected from all 
quarters of the cow i.e. individual cow somatic cell count (ICSCC), or at the bulk tank 
level i.e. bulk milk somatic cell count (BMSCC). Bulk milk somatic cell count is used as a 
measure of bulk milk quality as it gives a good indication of the prevalence of infection 
within a herd (Logue 1997; Booth 1997). Financial penalties for high BMSCC act as an 
incentive for farmers to control mastitis and are a useful means to assess progress of 
control programmes (Booth 1981). There is currently no widely accepted definition of a 
low BMSCC or ICSCC. Published studies have used SCC of less than 250 x103/ml (de 
Haas et a12002) 150 x103/ml (Barkema et al 1999) and 100 x103/ml (Peeler et al 2000; 
Sargeant et al 2001) to define both low cell count herds and individual cows. However 
previous studies have indicated that ICSCC masks the impact of IQSCC. 
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3.1.4.2 California Mastitis Test 
The California Mastitis Test (CMT) is a qualitative method of estimating SCC. It is based 
on an anionic detergent containing bromcresol-violet as an indicator reacting with the 
nuclear content of the somatic cells of milk when mixed to form a viscous gel (Bramley, 
1992). The viscosity of the gel allows the SCC of the milk sample to be estimated. 
Although not very sensitive or specific, the CMT is a cheap, practical and useful on-farm 
test to identify individual cows with subclinical mastitis (Cullor et aI1996). 
3.1.4.3 Bacteriology 
Bacteriology can be performed at the bulk tank, individual cow and individual quarter 
levels. Bulk milk bacteriological examinations have a high specificity but low sensitivity 
as a test for mastitis, with the result that some infected herds may not be detected on bulk 
milk samples (Sears et aI1993). 
An infected quarter is defined as one producing milk from which bacteria are recovered in 
pure culture (Newbould 1984). Reliance solely on isolation of bacteriological pathogens to 
identify mastitis however can give false negative results. This may occur due to variation 
in the shedding of bacteria, in certain cows and with certain pathogens (Sears et al 1993). 
Twenty five percent of S. aureus infected cows will have a single negative culture result, 
but with repeated sampling, sensitivity is increased to 94-98% (Sears et aI1993). Accuracy 
in identification of environmental pathogens by bacteriological culture is also poor. This is 
thought to be due to the low numbers of environmental pathogens in milk (Neave 1975), 
and the fact that contamination is likely to be due to the environmental reservoir of 
infection (Smith 1983). 
3.1.4.4 Electrical Conductivity 
Increases in the electrical conductivity (EC) of milk are frequently caused by 
intramammary infection and such changes have formed the basis of various mastitis 
detection instruments (Woolford et al 1998). Increased EC during mastitis is a result of 
increased levels of sodium and chloride ions in the milk as a consequence of damage to the 
epithelium of the udder (Wheelock et al 1966). 
In studies using a commercially available instrument, Hillerton & Walton (1991), found 
subclinical S. aureus infections were effectively detected, but EC levels for samples from 
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subclinical S. uberis infections were indistinguishable from uninfected quarters. Using 
conductivity data for individual quarters, (Nielen et al 1995), found that not all incidences 
of intramammary infection could be detected before clinical signs occurred. 
The conductivity of milk is not considered sufficiently sensitive or reliable for use 
routinely in automatically detecting both clinical and subclinical mastitis in dairy cows 
(Mottram 1997). 
3.1.4.5 N-acetyl ~-D-glucosaminidase (NAGase) 
Enzymes are released as a result of tissue damage when the animal's immune responses are 
reacting to infection. N-acetyl ~-D-glucosaminidase (NAGase) is a leukocyte-associated 
enzyme in milk, and a high concentration indicates a high SCc. The NAGase test can be 
automated and is therefore suited to high-throughput analysis of samples (Ball and Greer 
1991). It is reputed to be the most accurate of the indirect tests, performing similarily to 
SCC in predicting the infection status ofthe quarter (Pyorala 1988). 
3.1.4.6 Acute Phase Proteins 
Two decades ago, scientists recognised the limitations of using standard parameters such 
as SCC and bacteriology for diagnosis of mastitis (Sandholm et aI1984). It was known that 
mastitis led to increased permeability of the blood-mammary barrier, so measuring the 
concentration of blood proteins that leak from the intravascular compartment and into the 
milk was potentially a new method for detecting mastitis. Bovine serum albumin and lXI-
antitrypsin were both considered as potential markers of mastitis, however, limitations in 
the available methodology for detection at this time led to the measurement of lXI-
antitrypsin alone, and this did show a good correlation with SCC (Sandholm et aI1984). C-
reactive protein (CRP) has also been reported in the milk of cows with mastitis (Hamann et 
a11997). 
Concurrent research, and field studies in bovine APPs indicated that measurement of Hp 
and SAA was likely to be more successful in the detection of mastitis, as these proteins 
were known to increase in serum over 100 times during the APR, whilst lXI-antitrypsin 
increases by only two to three fold (Conner et al 1988b), while CRP is not generally 
recognised as an acute phase reactant in cattle (Eckersall and Conner 1988a). 
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Recently retrospective analysis of 29 milk samples from cows with naturally occurring 
clinical mastitis, reported the presence of APPs in milk, including SAA and Hp at 
concentrations of 0.05 to 0.55 J.lg/ml and 0.02 to 2 mg/ml respectively (Eckersall et al 
2001). In this study the diagnostic values of APPs in differentiating between healthy cows 
and those with mastitis gave sensitivities and specificities of 86% and 100% respectively 
for milk Hp and 93% and 100% respectively for milk SAA. Both Hp and SAA also 
showed correlation with the severity of clinical signs of mastitis. The cases of mastitis 
were classified as 'mild' ifthere were clots visible in the milk, and 'moderate' if the clots 
in the milk were accompanied by changes in the udder including heat, pain, redness, and 
swelling. In this study, milk SAA was able to distinguish between cows with mild and 
moderate mastitis, whereas Hp was not. The ability to differentiate the severity of mastitis 
is very important, as it is likely to influence the therapeutic decisions taken by the farmer 
or veterinarian. The authors of the study suggested the possibility that a difference in the 
source of the two proteins could be the reason for this and further speculated on the 
possibility of local synthesis of SAA within the mammary gland itself. In the same year a 
mammary-associated form of SAA (M-SAA3)\ likely to be produced within the mammary 
gland itself, was described in milk from clinical cases of bovine mastitis and in bovine, 
equine and ovine colostrum (McDonald et al 2001). Following from the initial reports of 
SAA and Hp in mastitic milk, the use of APPs in the diagnosis of mastitis was quickly 
recognised and there have been a number of studies established to investigate further the 
role of APPs, in both naturally occurring and experimentally induced clinical and 
subclinical mastitis (Sorensen et al 2002; Winter and Colditz 2002; Pedersen et al 2003; 
Nguyen et a12003; Jacobsen et a12003; Gronlund et a12003a; Gronlund et aI2003b). 
The milk samples used in the clinical validation of the milk Hp ELISA described in 
chapter 2, were from an experimentally induced S. aureus model of mastitis, designed to 
determine the concentration ofM-SAA3 and Hp in the milk and serum of cows with acute 
clinical and chronic subclinical mastitis (Gronlund et aI2003a). Maximal values ofHp and 
M-SAA3 in milk were reported 54-80h post infection (Pj.) and 48-120h pj., respectively. 
These ranged from 52-323jLg/ml for Hp and from 34-286 jLg/ml for M-SAA3. 
Interestingly, maximum concentrations of Hp and M-SAA3, measured during the acute 
phase in serum, peaked later and for a shorter period of time (72-80 hours pi and 54-104 
hours pi, respectively) than in milk. An important part of this study was the controlled use 
of antibiotics, to transform an acute inflammation into a chronic phase. Maximum 
1 From this point onwards SM secreted in milk will be referred to as M-SM3 
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concentrations of milk Hp and M-SAA3 during the chronic phase were 17JLg/ml to 
26JLg/ml and 10 JLg/ml to 43 JLg/ml, respectively. In the chronic phase, Hp concentrations in 
infected quarters were not significantly different from either pre-infection or control 
quarters, however, M-SAA3 concentrations were significantly different, indicating the 
potential for milk M-SAA3 analyses in the diagnosis of chronic subclinical S. aureus 
mastitis. 
Pedersen et aI, (2003), used an experimental model of acute clinical mastitis to elucidate 
the pathogenesis and the kinetics of Hp and M-SAA3 in milk within the first 12h of 
intramammary inoculation with S. uberis. Mammary associated serum amyloid A in 
infected quarters began to rise 6h pi, with maximal values recorded 12h after inoculation. 
The range of M-SAA3 concentrations in milk was 0.47 to 4.6 JLg/ml. Haptoglobin ranged 
from 11 to 92 JLg/ml, but no increase was seen until 10h pi, while peak concentrations were 
found at 12h pi. Haptoglobin was detected only in milk and not in serum, whereas M-
SAA3 was detected in both milk and serum. Maximal clinical response, based on 
measurement of rectal temperature, and heat and oedema of the udder, was reached 11 
hours pi. In infected quarters see peaked at 8h pi., and a minor initial rise was also 
observed in the control quarters. The authors concluded that milk M-SAA3 was an 
appropriate marker for the early detection of mastitis, as the increase in milk M-SAA3 
levels at 6h preceded that of see (7h) and the development of clinical signs (8-9h). 
Gronlund et al (2003b) performed a field study to evaluate the potential for Hp and M-
SAA3 as indicators of naturally occurring subclinical mastitis. One hundred and eighty 
quarter milk samples from cows with subclinical mastitis were assayed for Hp and M-
SAA3, using ELISA with detection limits of 0.5 and 0.6 JLg/ml, respectively. In 116 
samples at least one of the APPs were detected, where SAA ranged from 0.8-151 JLg/ml, 
and Hp concentration ranged from 0.53-358 JLg/ml. Five control animals with see of 
<100,000 cells/ml were used in this study, and Hp and SAA were not detected in the milk 
from any of these animals. 
The studies outlined above conclude that the measurement of APPs in bovine milk has 
good accuracy for the diagnosis of mastitis, thus it was considered appropriate to further 
characterise the milk APR in mastitis, to establish a time course of APR changes during an 
infection, and to determine the association between APP in milk and conventional markers 
of mastitis such as see. 
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3.2 Materials and Methods 
3.2.1 Farm Selection 
Two commercial dairy farms in the west of Scotland were used in this study; Farm A had a 
rolling monthly geometric mean BTSCC of 140,000 cells/ml and an annual incidence of 
clinical mastitis of 17 cases per 100 cows, and farm B had a rolling monthly geometric 
mean BTSCC of 40,000 cells/ml and an annual incidence of clinical mastitis of 7 cases per 
100 cows. 
3.2.2 Cow Selection 
3.2.2.1 Clinical 
Initially the cows were selected on the basis of calving date, with daily sampling beginning 
at the first milking post-calving, as the incidence of mastitis is higher in early lactation. If 
the selected cow showed no sign of mastitis within the first four weeks post-calving, then 
sampling was discontinued and another cow was recruited into the study. Recruited cows 
that did not complete the study were used as control animals in order to compare 
parameters with mastitic cows. Forty-seven cows were followed post-calving. 
3.2.2.2 Subclinical 
An additional 4 cows were recruited to the study mid-lactation, and were identified as 
having subclinical mastitis by IQSCC of > 60,000 cells/ml and a positive CMT score. 
Three of the 4 cows were identified as having subclinical mastitis in 2 quarters, accounting 
for the 7 cases described in the results (Section 3.3.3). Milk samples were taken from the 4 
cows for a period of up to 17 days. 
3.2.3 Milk Sample Collection 
Milk samples were collected into sterile plastic containers daily from all four quarters of 
each cow, 5 days per week, using an aseptic technique. In order to minimize the risk of 
contamination of milk samples fastidious attention was paid to teat preparation, as 
described by Bramley (1992) and Cullor et al (1996). The udders and teats were washed, 
dried and prepared, as normally performed prior to milking, and the teat ends were 
swabbed with 70% alcohol, prior to sample collection. The furthest away teats were 
Caroline Hogarth, 2004 Chapter 3, 89 
cleaned first and the nearest teats were cleaned last with the samples being collected in the 
opposite order, to reduce the chance of contamination by the milk: collector. The first 4-6 
squirts of milk were discarded to avoid contamination of the milk sample by bacteria from 
the teat canal. After preparation of the teats, clean disposable gloves were worn by the 
sampler. For collection of milk the container was held as close to horizontal as possible 
and the lid of the container was held face down in the same hand in order to minimise 
contamination. Approximately 20ml of milk sample was taken from each quarter, which 
was an adequate volume for bacteriological culture, APP assays and somatic cell counting. 
In between sampling cows, the sampler washed his/her hands with a germicidal solution 
and, used a new pair of clean disposable gloves for each cow. Samples were collected 
Monday to Friday. 
3.2.4 California Mastitis Test 
The California Mastitis Test (CMT) was performed on every cow immediately after the 
sterile sample was taken. The technique for CMT as described by Cullor et al (1996) and 
Philpot et al (1984) was followed. An equal volume of quarter milk and the CMT reagent 
were placed in each of the four wells of the CMT paddles. The paddles were rocked gently 
for a few seconds and observed for any gel formation. The viscosity of the gel was scored 
from 0-3 (Table 3.1). The CMT score for each quarter was noted on the daily record sheet. 
3.2.5 Somatic Cell Count 
In this study a threshold of 60,000 cells/ml or below was selected as an IQSCC that can be 
considered as a healthy quarter and free of mastitis pathogens. This threshold was chosen 
based on previously published studies described in detail in section 3.1.4.1 
Milk samples for somatic cell counting were sent, by post to the Veterinary Science 
Division, Scottish Agricultural College (SAC), Ayrshire, Scotland, where SCCs were 
determined using a Fossamatic cell counter. Prior to despatch milk samples were preserved 
with a Lactab milk preservative tablet (Thomson and Capper Ltd, Runcorn, Cheshire, UK). 
3.2.6 Acute Phase Protein Assays 
The concentration of M-SAA3 in milk was determined using a commercially available 
ELISA, (Phase Serum Amyloid A, Tridelta Development Ltd, Ireland) according 
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CMT Score 
N (Negative) 
T (Trace) 
1 (weak: positive) 
2 (distinct positive) 
3 (strong positive) 
Description of visible reaction 
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Relative Range of Somatic 
cells (cells/ml) 
Mixture remains liquid, homogeneous, with < 200,000 
no evidence of thickening. 
The slight thickening that forms is seen best 150,000 to 500,000 
by tipping the paddle back and forth and 
observing the mixture as it flows over the 
bottom of the cup. Trace reactions tend to 
disappear with continued rotation of the 
paddle. 
A distinct thickening of the liquid forms, but 400,000 to 1,500,000 
there is no tendency toward a gel formation. 
With some milk, the thickening may disappear 
after prolonged rotation of the paddle 
Mixture thickens immediately, and a gel 800,000 to 5,000,000 
formation is suggested. As the mixture is 
swirled, it tends to move in toward the center, 
exposing the bottom of the outer edge of the 
cup. When the motion is stopped, the mixture 
levels out and covers the bottom of the cup. 
A gel is formed, which causes the surface of generally> 5,000,000 
the mixture to become elevated like a partially 
fried egg. There is usually a central peak that 
remains projecting above the main mass, even 
after the rotation of the paddle is stopped 
Table 3-1: Interpretation and scoring of the CMT test and broad estimates of somatic cell 
levels that may be associated with each score. http://ianrpubs.unl.edu/dairy/g556.htm 
I 
I 
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to the manufacturer's instructions. The milk samples were diluted 1 :50 in assay buffer. 
The newly developed ELISA based method (see section 2.3.3) was used to determine the 
concentration ofHp in the milk samples. 
3.2.7 Bacteriology 
The Department of Veterinary Pathology, at the University of Glasgow Veterinary School, 
carried out all bacteriological examination using standard laboratory techniques. 
3.2.8 Clinical Examination 
Examination of the milk and palpation of the udder was carried out if the cow gave a 
positive CMT, or showed any other signs of being abnormaL Any abnormalities in the milk 
(clots or blood) or udder (heat or swelling) were noted on the daily record sheet. 
3.3 Results 
3.3.1 Control Animals 
A total of 47 cows (188 quarters) were followed from calving during this study, out of 
which 35 were classified as control cows based on results of SCC, CMT, bacteriology and 
the observation of lack of clinical signs. The profiles of SCC and M-SAA3 and SCC and 
Hp for the normal post-calving cows are shown in figures 3.3 and 3.4. The control cows 
presented with a raised SCC, M-SAA3 and Hp post-calving (911 xl03 cells/ml, 2.6 J.lg/ml 
and 0.8 J.lg/ml respectively), all three of which fell rapidly between days 1-3 post-calving. 
By day 7 post-calving, M-SAA3 and Hp were undetectable in all quarters «0.02J.lg/ml) 
and «0.5/lg/ml), respectively (Figures 3-3 and 3-4). The SCCs in figure 3.3 are different 
to those in 3.4, owing to the fact that these results are taken from a subset (n=9 cows) of 
the total number of control cows. Somatic cell counts had fallen to <60,000 cells/ml in all 
control animals by day 10 post-calving. Results for CMT were consistently negative 
throughout the duration of the sampling period and no bacteria were isolated in milk from 
any quarters of the control cows. 
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3.3.2 Cows with Clinical Mastitis 
Of the 47 cows followed during this study 6 cows developed clinical mastitis with 5 cows 
having a single quarter affected and 1 cow having 2 quarters affected, caused through the 
invasion of the host udder by different pathogens including S. uberis, E. coli and S. aureus. 
Each of the 7 cases is described individually below, (with reference to figures), including 
details on clinical signs, levels of SCC, concentration of M-SAA3 and Hp, bacteriological 
results and duration of infection. There was considerable variation in the concentration of 
M-SAA3 and Hp measured, so note that it was not possible to maintain a consistent scale 
in the axes between cases. 
Case 1 was followed from calving for a period of 28 days. The first episode of clinical 
mastitis was diagnosed on day 8 post-calving, by the presence of clots in the milk. Figures 
3-5 and 3-6 show the results for SCC and for milk M-SAA3 and Hp. This cow had a high 
post-calving SCC on day 1 (6036 xl03 cells/ml), which reached a peak at almost 13 xl06 
cells/ml on day 8, falling gradually for the next 6 days, and reaching normal levels by day 
14. The SCC rose again from day 14 to day 16 with a secondary peak at 7 xl06 cells/ml, 
then continued to decrease, again reaching normal levels by day 22. Another increase was 
recorded between days 22 and 23 where a final peak was observed (3165 x103/ml). 
Concentrations of M-SAA3, are compared to SCC in figure 3-5. Mammary-associated 
SAA3 was undetected until day 2 post-calving when the levels rose steadily to a peak 
concentration of 5.6 p,g/ml on day 7, then fell gradually for the next 6 days but rose again 
on day 14 peaking on day 15 at 3 p,g/ml, then continues to decrease between days 15 to 21 
before showing a final increase to 1.4 p,g/ml on day 22. Milk Hp was raised (108 p,g/ml) 
from day 1 post-calving and peaked at 139 p,g/ml on day 6 before falling to undetectable 
levels by day 13 (Figure 3-6). Haptoglobin then rose between days 13 and 15 and peaked 
at 87 p,g/ml, and continued to decrease between days 15 and 21 before showing a final 
increase to 70 p,g/ml on day 22. Bacteriological culture indicated S. uberis as the causative 
agent of the clinical mastitis. 
Case 2 was followed from calving for a period of 56 days. Clinical mastitis was diagnosed 
on day 15 post-calving by the presence of clots in the milk. Figures 3-7 and 3-8 show the 
results for SCC and for milk M-SAA3 and Hp. This cow had a high post-calving SCC on 
day 2 (12184 xl03/ml), which fell steadily until day 8 at which point an initial increase to 
6305 x103/ml on day 9 was followed by a sharp increase to the maximum level for this 
case of 42750 x103/ml. Somatic cell count showed a steady decrease from day 14 reaching 
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normal levels by day 21 and remained at less than 60,000 cells/ml for the duration of the 
sampling period. Concentrations of M-SAA3, are compared to SCC in figure 3-7. 
Mammary associated SAA3 was raised (11.4 JLg/ml) day 2 post-calving but concentrations 
fell steadily until day 8 where M-SAA3 begins to rise reaching 6.5 JLg/ml on day 9. The 
concentration of M-SAA3 decreases within the next 24hrs but then rises from day 12 
peaking on day 15 at 6.5 JLg/ml. Milk amyloid A was undetectable by day 23 and for the 
remainder of the sampling period apart from a slight rise from days 43 to 50. 
Concentrations of Hp, are compared to SCC in figure 3-8. Milk Hp was undetectable on 
day 2 post-calving, however it was present in low concentrations (8-19 JLg/ml) on days 5 to 
8. Haptoglobin then showed an initial rise on day 8 to 48 JLg/ml on day 9 followed by a 
sharp increase to maximum levels of 198 JLg/ml on day 15. The concentration of Hp 
decreased steadily and was undetectable by day 23 and for the remainder of the sampling 
period apart from a slight rise at day 34 and from days 43 to 54. Bacteriological culture 
indicated E. coli as the causative agent of the clinical mastitis. 
Case 3 was followed from calving for a period of 26 days. Clinical mastitis was diagnosed 
on day 22 post-calving by the presence of clots in the milk. Figures 3-9 and 3-10 show the 
results for SCC and for milk M-SAA3 and Hp. This cow had an elevated SCC on day 1 (85 
x103/ml), which fell to normal levels by day 2 and apart from 3 slight rises shown at days 
5, 11 and 16, SCC remained <60,000 cells/ml until day 22. Somatic cell count rose 
steadily from day 19 to a peak concentration of 7643 x103/ml on day 22, from which point 
it decreased steadily for the remainder of the sampling period. Concentrations of M -SAA3 
are compared to SCC in figure 3-9. Mammary-associated SAA3 was detected (1 JLg/ml) on 
day 1 post-calving, and remained present at very low concentrations (0.07 to 1.5 JLg/ml) 
until day 19 when M-SAA3 concentration rose sharply reaching a peak on day 24 at 49 
JLg/ml. From day 22, the concentration ofM-SAA3 in this cow decreases for the remainder 
of the sampling period. Concentrations of Hp are compared to SCC in figure 3-10. 
Haptoglobin was undetected in the milk on day 1 post-calving and remained so until day 
22. On day 23, milk Hp concentration peaked at 11 JLg/ml and then decreased for the 
remainder of the sampling period. Bacterialogical culture indicated S. aureus as the 
causative agent of the clinical mastitis. 
Case 4 was followed from calving for a period of 26 days. Clinical mastitis was diagnosed 
on day 3 post-calving by the presence of clots in the milk. Figures 3-11 and 3-12 show the 
results for SCC and for milk M-SAA3 and Hp. This cow had an elevated SCC on day 1 
(6629 x103/ml), which remained raised and fluctuating from 1500 x103/ml to 10000 
x103/ml until day 11, at which point the SCC rose sharply and peaked on day 12 at 21554 
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xI 03/ml. Somatic cell count continued to fluctuate at elevated levels for the remainder of 
the sampling period. Concentrations of M-SAA3 are compared to SCC in figure 3-1l. 
Mammary-associated SAA3 was increased (17.6 p,g/ml) on day 1 post-calving and 
increased sharply in the next 24hrs reaching 45.6 p,g/ml by day 2. The concentration ofM-
SAA3 then decreased slightly for the next 3 days before it rose to a maximum 
concentration of 82 p,g/ml on day 8, after which M-SAA3 levels remained raised and 
fluctuating (19 p,g/ml to 55 p,g/ml) for the remainder of the sampling period. 
Concentrations ofHp are compared to SCC in figure 3-12. Haptoglobin was detected (7.7 
p,g/ml) on day 1 post-calving, and continued to rise reaching its first peak on day 5, with a 
concentration of 53 p,g/ml. The levels of Hp then fell until day 9 when another rise was 
seen, which peaked at a concentration of 57 p,g/ml on day 15. The concentration decreases, 
but is again increasing for the remainder of the sampling period with a milk Hp 
concentration of 83 p,g/ml being detected on the final day of sampling. Bacteriological 
culture indicated S. aureus as the causative agent of the clinical mastitis. 
Case 5 was followed from calving for a period of 56 days. Clinical mastitis was diagnosed 
on day 16 post-calving by the presence of clots in the milk. Figures 3-13 and 3-14 show the 
results for SCC and for milk M-SAA3 and Hp. This cow had an elevated SCC on day 2 
(439 xl03/ml), which remained moderately raised and fluctuating (130 xl03/ml to 650 
xI 03/ml) for the duration of the sampling period with the exception of sharp peaks on days 
5 and 16 at 1460 x103/ml and 1185 xl03/ml respectively. Concentrations ofM-SAA3 are 
compared to SCC in figure 3-13. Mammary-associated SAA3 was detected (1.4 p,g/ml) on 
day 2 post-calving and showed an initial peak at 2.5 p,g/ml on day 9, followed by a 
decrease to day 13, at which point the concentration of M-SAA3 rose to 2.3 p,g/ml on day 
16, from which point the concentration of M -SAA3 in milk decreased gradually and was 
undetectable by day 29, but rose again to 2 p,g/ml on day 47, but fell to undetectable levels 
for the final 2 days of the sampling period. Concentrations of Hp are compared to SCC in 
figure 3-14. Haptoglobin was detected (14 p,g/ml) on day 2 post-calving, but fell to 
undetectable levels by day 7 before rising to give the first of 3 prolonged periods (days 9 to 
20; 23 to 34 and 41 to 54) where the concentration ofHp was moderately elevated to levels 
of 13 to 24 p,g/ml; 11 to 23 p,g/ml and 12 to 29 p,g/ml respectively. Bacteriological culture 
indicated S. aureus as the causative agent of the clinical mastitis. 
Case 6 was followed from calving for a period of up to 26 days. Clinical mastitis was 
diagnosed on day 4 post-calving by the presence of clots in the milk, and a hot and swollen 
quarter. Figures 3-15 and 3-16 show the results for SCC and for milk M-SAA3 and Hp. 
This cow had a high SCC on day 3 post-calving (6822 xI03/ml), which increased almost 
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five fold in the next 24hrs to reach 33699 x103/ml by day 4, from which point SCC 
decreased, but remained elevated above normal levels for the remainder of the sampling 
period. Concentrations of M-SAA3 are compared to SCC in figure 3-15. Mammary-
associated SAA3 was high (42.1 fLg/ml) on day 3 post-calving, and rose sharply in the next 
24hrs to reach a peak: concentration of 255 fLg/ml on day 4 post-calving. The concentration 
ofM-SAA3 falls sharply for the next 5 days, but was still detectable in the milk from day 9 
for the remainder of the sampling period at concentrations ranging from 0.1 fLg/ml to 1.5 
fLg/ml. Concentrations of Hp are compared to SCC in figure 3-16. Haptoglobin was high 
(24.4 fLg/ml) on day 3 post-calving, but almost a seven-fold increase was recorded over the 
next 24hrs, and Hp peaked at 161 fLg/ml on day 4 post-calving. The concentration ofHp in 
milk decreased steadily, and was undetected for the remainder of the sampling period from 
day 15 post-calving. Bacteriological culture indicated E. coli as the causative agent of the 
clinical mastitis. 
Case 7 was followed from calving for a period of up to 26 days. Clinical mastitis was 
diagnosed on day 5 post-calving by the presence of clots in the milk. Figures 3-17 and 3-18 
show the results for SCC and for the milk M-SAA3 and Hp. This cow had a high SCC on 
day 1 post-calving (37174 x103/ml), which had fallen sharply by day 2 post-calving (5313 
x103/ml) but rose again to peak at 12385 x103/ml on day 5 post-calving. Somatic cell 
counts in this cow are elevated for the remainder of the sampling period and range from 
365 x103/ml to 3921 x103/ml. Concentrations ofM-SAA3 are compared to SCC in figure 
3-17. Mammary-associated SAA3 was high (285fLg/ml) on day 1 post-calving, but fell 
sharply over the next 3 days, before rising to a peak concentration of 68fLg/ml on day 5. 
The concentration ofM-SAA3 fell between days 5-10, but remained detected from day 10 
onwards at concentrations ranging from 4fLg/ml to 32fLg/ml. Concentrations of Hp are 
compared to SCC in figure 3-18. Haptoglobin was high (87fLg/ml) on day 1 post-calving, 
but fell sharply over the next 3 days before rising slightly to lOA fLg/ml on day 5.With the 
exception of days 19 and 25, Hp was present in the milk at concentrations of 0.7 fLg/ml to 
4.3 fLg/ml from day 5 onwards. Bacteriological culture indicated E. coli as the causative 
agent of the clinical mastitis. 
3.3.3 Cows with subclinical mastitis 
Two quarters of one cow from the initial group of 47 cows followed post-calving 
developed subclinical mastitis, both infections being caused by S. aureus. Figures 3-19 and 
3-21 show the results for milk M-SAA3 as compared to SCC in both cases. The results for 
Hp as compared to SCC are shown in figures 3-20 and 3-22. As shown in all four figures 
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this cow presents with an elevated SCC in both quarters on day 1 (89 and 45 xl 03/ml) 
respectively. In both case 1 and 2, the SCC rises sharply and falls again on 3 occasions, 
reaching peaks on days 4, 8 and 15 with levels of 330, 2044 and 2001 x103/ml in case 1 
and 360,1617 and 1855 x103/ml in case 2. Concentrations ofM-SAA3 are compared to 
SCC in figures 3-19 and 3-21. Mammary-associated SAA3 was detectable on day 1 post-
calving in both case 1 and 2 (0.2 and 0.1 lLg/ml) respectively. In case 1 M-SAA3 was 
detectable at low concentrations throughout the sampling period with the exception of day 
10, and showed peak levels of 0.46, 0.31, 0.24 and 0.43 ILg/ml on days 4,9,17, and 23 
respectively. In case 3 M-SAA3 was detectable throughout the sampling period with the 
exception of days 8-10, and showed peak levels of 1.1 lLg/ml on day 2. Concentrations of 
Hp are compared to SCC in figures 3-20 and 3-22. In case 4 Hp was detected (1.3ILg/ml) 
on day 1 post-calving, and continued to rise fall throughout the sampling period showing 
peaks on days 4,7, 10, 13 and 17 with concentrations ranging from 0.85 to 1.86 lLg/ml. In 
case 2 Hp was undetected on day 1 post-calving but rises sharply to give the first peak on 
day 2 at 0.59ILg/ml. Another sharp peak was observed on day 19 at a concentration of 
0.481Lg/ml. The levels of Hp are rising steadily for the last 5 days of sampling (days 22-
26). 
The 4 cows in mid-lactation, identified as having subclinical mastitis in 1 or more quarters 
by a positive CMT, and IQSCC > 60,000 cells/ml. Somatic cell count and M-SAA3 for the 
7 cases of subclinical mastitis ranged from 964 to 24735 x103/ml and 1.84 to 3.45 lLg/ml 
respectively (Figures 3-23 to 3.29). The milk Hp assay was not performed on these 
samples. Bacteriological culture indicated S. aureus was the causative agent for the 
subclinical mastitis in all 7 cases. 
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Figure 3-3: The mean somatic cell count (See) ( --- ) and mammary-associated serum 
amyloid A3 (M-SAA3) ( --+-- ) for normal post-calving cows (n=35). see and M-SAA3 reach 
normal levels of <60,000 cells/m l and <500ng/ml respectively by day 10 post-calving. 
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Figure 3-4: The mean somatic cell count (See) (------) and Haptoglobin (Hp) (---+-- ) for a 
subset of the normal post-calving cows (n=9). see and Hp reach normal levels of <60,000 
cells/ml and <0.5 jJg/ml respectively by day 10 post-calving. 
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Figure 3-5: Profiles for somatic cell count (SCC) ( -----t and mammary-associated serum 
amyloid A3 (M-SAA3) {----+--} in case 1. Clinical mastitis developed on day 8 and again on 
day 16 (as indicated by the arrows). Streptococcus uberis was isolated from the milk of this 
case. 
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Figure 3-6: Profiles for somatic cell count (SCC) (---------) and haptoglobin (Hp) (-+-) in case 
1. Clinical mastitis developed on day 8 and again on day 16 (as indicated by the arrows). 
Streptococcus uberis was isolated from the milk of this case. 
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Figure 3-7: Profiles for somatic cell count (SCC) (-------1 and mammary-associated serum 
amyloid A3 (M-SAA3) (---+----) in case 2. Clinical mastitis developed on day 15 (as indicated 
by the arrows). E. coli was isolated from the milk of this case. 
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Figure 3-8: Profiles for somatic cell count (SCC) (-----.) and haptoglobin (Hp) ( __ ) in case 
2. Clinical mastitis developed on day 15 (as indicated by the arrows). E. coli was isolated 
from the milk of this case. 
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Figure 3-9: Profiles for somatic cell count (SCC) ( ----) and mammary-associated serum 
amyloid A3 (M-SAA3) (-+--) in case 3, Clinical mastitis developed on day 22 (as indicated 
by the arrow). Staphylococcus aureus was isolated from the milk of this case. 
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Figure 3-10: Profiles for somatic cell count (SCC) (--*--) and haptoglobin (Hp) (--) in 
case 3. Clinical mastitis developed on day 22 (as indicated by the arrow). Staphylococcus 
aureus was isolated from the milk of this case. 
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Figure 3-11: Profiles for somatic cell count (SCC) (--------1 and mammary-associated serum 
amyloid A3 (M-SAA3) (-+-) in case 4. Clinical mastitis developed on day 3 (as indicated by 
the arrow). Staphylococcus aureus was isolated from the milk of this case. 
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Figure 3-12: Profiles for somatic cell count (SCC) (----) and haptoglobin (Hp) (----+---) in 
case 4. Clinical mastitis developed on day 3 (as indicated by the arrow). Staphylococcus 
aureus was isolated from the milk of this case. 
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Figure 3-13: Profiles for somatic cell count (SCC) (---) and mammary-associated serum 
amyloid A3 (M-SAA3) (--+--) in case 5. Clinical mastitis developed on day 16 (as indicated 
by the arrow). Staphylococcus aureus was isolated from the milk of this case. 
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Figure 3-14: Profiles for somatic cell count (SCC) (---) and haptoglobin (Hp) f--+- ) case 
5. Clinical mastitis developed on day 16 (as indicated by the arrow). Staphylococcus aureus 
was isolated from the milk of this case. 
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Figure 3-15: Profiles for somatic cell count (SCC) (-.- ) and mammary-associated serum 
amyloid A3 (M-SAA3) (-+--) in case 6. Clinical mastitis developed on day 4 (as indicated by 
the arrow). E. Coli was isolated from the milk of this case. 
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Figure 3-16: The Profiles for somatic cell count (SCC) (~ and haptoglobin (Hp) (-+--) 
in case 6. Clinical mastitis developed on day 4 (as indicated by the arrow). E.coli was 
isolated from the milk of this case. 
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Figure 3-17: Profiles for somatic cell count (SCC) ( --------) and mammary-associated serum 
amyloid A3 (M-SAA3) (-+-) in case 7. Clinical mastitis developed on day 5 (as indicated by 
the arrow). E.Coliwas isolated from the milk of this case. 
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Figure 3-18: Profiles for somatic cell count (SCC) (------1 and haptoglobin (Hp) (~ in 
case 7. Clinical mastitis developed on day 5 (as indicated by the arrow). E.Coliwas isolated 
from the milk of this case. 
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Figure 3-19: Profiles for somatic cell count (SCC) (------) and mammary-associated serum 
amyloid A3 (M-SAA3) (-+---i in cow 1, CASE 1 SUBCLINICAL. S.aureus was isolated from 
the milk of this cow. 
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Figure 3-20: Profiles for somatic cell count (SCC) t--------) and haptoglobin (Hp) f--+--i in cow 
1, CASE 1 SUBCLINICAL. S.aureus was isolated from the milk of this case. 
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Figure 3-21: Profiles for somatic cell count (SCC) (----------) and mammary-associated serum 
amyloid A3 (M-SAA3) (-+-") in cow 1, CASE 2 SUBCLINICAL. S.aureus was isolated from 
the milk of this cow. 
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Figure 3-22: Profiles for somatic cell count (SCC) (----------) and haptoglobin (Hp) (-+-) in cow 
1, CASE 2 SUBCLINICAL. S.aureus was isolated from the milk of this case. 
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Figure 3-23: Profiles for somatic cell count (SCC) (-------) and mammary-associated serum 
amyloid A3 (M-SAA3) (---) in cow 2, CASE 3 SUBCLINICAL. S.aureus was isolated from 
the milk of this cow. 
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Figure 3-24: Profiles for somatic cell count (SCC) (-------) and mammary-associated serum 
amyloid A3 (M-SAA3) r--+-) in cow 2, CASE 4 SUBCLINICAL. S.aureus was isolated from 
the milk of this cow. 
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Figure 3-25: Profiles for somatic cell count (SCC) (------*---) and mammary-associated serum 
amyloid A3 (M-SAA3) (-+---) in cow 3, CASE 5 SUBCLINICAL. S.aureus was isolated from 
the milk of cow 3. 
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Figure 3-26: Profiles for somatic cell count (SCC) (---+-) and mammary-associated serum 
amyloid A3 (M-SAA3) (--+-) in cow 3, CASE 6 SUBCLINICAL. S.aureus was isolated from 
the mi lk of cow 3. 
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Figure 3-27: Profiles for somatic cell count (SCC) (-------} and mammary-associated serum 
amyloid A3 (M-SAA3) (--+-) in cow 4, CASE 7 SUBCLINICAL. S.aureus was isolated from 
the milk of cow 4. 
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Figure 3-28: Profiles for somatic cell count (SCC) t------) and mammary-associated serum 
amyloid A3 (M-SAA3) (--+-) in cow 4, CASE 8 SUBCLINICAL. S.aureus was isolated from 
the milk of case 8 subclinical. 
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Figure 3-29: Profiles for somatic cell count (SCC) r------i and mammary-associated serum 
amyloid A3 (M-SAA3) {---+-t in cow 5, CASE 9 SUBCLINICAL. S.aureus was isolated from 
the milk of case 9 subclinical. 
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3.4 Discussion 
Mastitis continues to be the most economically important disease of dairy cattle, and has 
been identified as the most common cause of death in adult dairy cows (Esslemont and 
Kossaibati 1997). Earlier diagnosis of mastitis would result in earlier treatment, possibly 
reducing the adverse effects of mastitis in both economic and welfare terms. 
Acute phase proteins have been used as biological markers in a range of inflammatory 
conditions and in a variety of species, including cattle (Gruys et al 1994). However the 
recent detection of the major APPs, M-SAA3 and Hp in bovine milk (Eckersall et a12001; 
McDonald et a12001; Pedersen et a12003; Gronlund et a12003a) has added further support 
to their application in a rapid, specific and non-invasive routine diagnostic test for mastitis. 
The present study investigated the presence of Hp and SAA in individual quarter milk 
samples from commercial dairy cows in early lactation, and compared their kinetics to 
those of conventional markers of inflammation such as Sec. Unlike any previous 
investigations this project involved taking milk samples from post-calving cows prior to 
infection in order to establish the earliest time-point of appearance of APP in milk during 
naturally occurring mastitis. For the purpose of this study it was concluded that early 
lactation would be the most desirable time to begin sampling as the incidence of clinical 
mastitis is high during the first month oflactation (Barkema et aI1999). 
Somatic cell count is physiologically elevated after calving but then decreases at a rapid 
rate, particularly during the first 2 weeks of lactation, (Dohoo 1993). In this study, see 
was raised in all cows post-calving, but fell rapidly in the control cows 1-3 days post-
calving reaching normal levels of < 60,000 cells/ml by day 10 post-calving. The post-
calving levels of see in cows that developed clinical mastitis were higher than those of 
the control cows. The mean see on the first milk sample taken post-calving from cows 
that went on to develop clinical mastitis caused by S. aureus, S. uberis and E. coli were 
2383, 6036 and 18706 x103 cells/ml, respectively, whereas the maximum post-calving 
see recorded on the first sample in the control cows was 1000 xI03cells/ml. These 
findings are in agreement with previous studies investigating the association between the 
incidence of pathogen-specific clinical mastitis and BMSee, which concluded that 
different pathogens are associated with different baseline levels for see (de Haas et al 
2002). 
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Milk Hp and M-SAA3 were elevated in all control cows post-calving but fell rapidly 
between days 1-3 post-calving and were undetectable in all quarters by day 6 and 10 for 
Hp and M-SAA3 respectively. In the 7 cases of clinical mastitis, both M-SAA3 and Hp 
were detected together in 4 cases and individually in another 2 cases on the first day of 
sampling post-calving. The concentrations of M-SAA3 and Hp detected at the first 
sampling post-calving ranged from lllglmi to 2851lg/ml and llllglmi to 108Ilg/ml, 
respectively. The highest post-calving concentration ofM-SAA3 was recorded in a clinical 
case that developed E. coli mastitis (case 7, Figure 3.11a), whereas the highest 
concentration of Hp was recorded in a cow that developed S. uberis mastitis (case 1, Figure 
3.5b). The lowest post-calving concentrations of APPs in milk were found in the cows that 
subsequently developed clinical mastitis caused by S. aureus mastitis. With the exception 
of the highest post-calving Hp levels being found in the S. uberis mastitis case, the results 
for milk APP at calving in relation to pathogen type were in agreement with the see 
results, namely S. aureus resulted in the lowest levels of see and E. coli the highest. 
Somatic cell count decreased more rapidly in uninfected quarters than in infected quarters 
in early lactation, indicating that using see early postpartum gives a reliable indication of 
intra-mammary infection status (Barkema et al 1999). Accordingly, determination of APP 
levels in milk at calving may be used to give an indication of the infection status of the 
mammary gland, and possibly APPs may give an indication of the probable day of onset of 
clinical mastitis in early lactation, and may indicate the pathogen responsible, although 
further work is required to substantiate this. 
A key part of this study was to determine the relationship between milk APPs and 
conventional markers of mastitis. Somatic cell counts were measured in milk and used 
essentially to validate the use of milk APPs as a new diagnostic tool for mastitis. On 
analysis of the profiles of APP in relation to see, before and after clinical mastitis both 
M-SAA3 and Hp showed similar kinetics and are similar to see. Peak concentrations of 
M-SAA3 and Hp occurred in conjunction with see and on the same day as clinical signs 
were detected, in 3 of the 7 cases of clinical mastitis. Examination, of the profiles for case 
1 (Figures 3.5a and 3.5b), showed that maximum values of M-SAA3 and Hp, clearly 
preceded that of see and clinical signs on both episodes of mastitis recorded. The 
situation for the remaining 3 cases is slightly more complex, and although the APP did not 
reach maximum values before the detection of clinical signs, they rose in concentration 
either prior to (case 4 and 5) or in conjunction with (case 2 and 3) Sec. 
Of the 7 cases of clinical mastitis 3 were caused by E. coli, 3 by S. aureus and 1 by S. 
uberis. On examination of the APP concentrations within the pathogen specific groups (E. 
II 
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coli and S. aureus), it appears that the pathogen responsible for the mastitis could influence 
the APP concentration. The concentrations of both M-SAA3 and Hp in E. coli infection are 
much higher than those seen in S. aureus infections. The pathogen-specific effects on the 
APP curves showed clearly differential effects for S. aureus and E. coli. Staphylococcus 
aureus, is known to cause chronic mastitis with periodic episodes and is often present 
subclinically for some time before clinical symptoms are observed (Harmon 1994). This is 
considered the likely situation in clinical cases 5 and 6 where the overall patterns of see 
and APPs showed daily fluctuations and were elevated for a prolonged period of time, 
before and after the onset of clinical signs. In contrast are the 3 clinical cases 2, 6 and 7 
where E. coli was the pathogen responsible, all 3 parameters (See, M-SAA3 and Hp) 
increased sharply over the 24h period prior to the onset of clinical signs and decreased 
rapidly post-infection in each of the 3 cases. The presence of a low see prior to the onset 
of E. coli clinical mastitis and the fact that such infections are rarely persistent has been 
studied previously (Peeler et al 2003). However see reached baseline levels before both 
APPs fell to undetectable levels. A rapid decline in see post-infection has previously been 
reported in E.coli mastitis (de Haas et aI2002). Over the years pressure to reduce BMSee 
has led to recent suggestions that cows with a very low see might be more susceptible to 
clinical mastitis because their ability to respond to intra-mammary infection would be 
reduced, and hence when a pathogen does successfully colonise the udder and establish an 
infection it is likely to be more severe. More than 50% of the clinical cases of mastitis 
isolated in this study were caused by environmental pathogens, which is likely to be due to 
the fact that samples were collected during early lactation, when the prevalence of such 
pathogens is at its highest (Dingwell et al 2003). 
From the results both M-SAA3 and Hp can be considered as sensitive and reliable markers 
of clinical mastitis, and also show potential as an early bio-marker of the disease prior to 
the onset of clinical signs. There is much speculation on the mechanisms involved which 
lead to the presence of M-SAA3 and Hp in milk. However the recent discovery of a 
mammary- associated SAA3 expressed and secreted in colostrum (McDonald et al 2001), 
supports the theory that APP may be locally produced within the udder rather than entering 
the mammary gland by traversing the blood-mammary barrier. The production of Hp and 
M-SAA3 may be associated with different cytokine profiles, which in tum may be 
dependent on the duration and type of inflammatory stimuli in the mammary gland. In 
four of the seven clinical cases, the concentrations of Hp were higher than that of M-
SAA3. Although comparisons to the few other studies reporting the presence of APP in 
milk are useful they must be treated with caution due to very different experimental 
designs and techniques applied. The experimental infection with S. aureus by Gronlund et 
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al (2003a), for acute clinical mastitis gave a range of 1.2 to 323 Ilg/ml and 1.4 to 286 
Ilg/ml for Hp and M-SAA3 respectively. The maximum values are higher than the 
maximum values ofM-SAA3 and Hp recorded for S. aureus clinical cases in this study: 49 
and 83 Ilg/ml, respectively. The methods used to determine both APPs in the study by 
Gronlund et al (2003a) were exactly the same as in the present study, however in an 
experimental infection the first line of defence is circumvented which may explain why the 
values of milk APP were substantially higher in experimental infection than those obtained 
from infection caused by natural exposure of the teat end. The second published study 
involving an experimental infection, although in this case with S. uberis (Pedersen et al 
2003), found a low range of results for M-SAA3 (0.47 to 4.62 Ilg/ml), however this is 
likely due to the fact that the cows were culled only 12h after inoculation at which time the 
APPs in milk were still rising. The APP results from the initial findings of M-SAA3 and 
Hp in milk during naturally occurring mastitis (Eckersall et al 2001), reported high 
concentrations of Hp in milk as compared to M-SAA3. The Hp was determined in the 
previous study by SRID, and may have resulted in the high values due to methodological 
differences. Further research is needed to clarify the difference between the characteristics 
of these two APPs and to umavel the biological relationship between them, before it could 
be concluded that either one is a more desirable biomarker of mastitis than the other. 
The results from this study suggest the concentration of APP varies with the occurrence of 
different pathogens, and could therefore be used to predict the pathogen involved in a case 
of clinical mastitis. Mastitis control measures are aimed at the management of specific 
pathogen types (Sargeant et al 2001), and the earlier they are identified the sooner 
appropriate treatment may be administered. At present, bacteriological culture of milk 
samples is the standard method for identifying pathogen type, which takes 2-3 days, this 
delay alongside financial considerations involved with bacteriological sampling have 
precluded this technique from being widely adopted as a screening method for mastitis by 
the dairy industry. 
Two cases of subclinical mastitis were diagnosed from the original group of 47 cows that 
were sampled in early lactation. Mammary-associated SAA3 and Hp were detecting in a 
fluctuating cycle similar to the pattern observed in the cases of clinical mastitis induced by 
S. aureus. The concentrations were however, much lower than those on the clinical cases: 
0.1 to 0.46Ilg/ml and 0.6 to 1.861lg/ml for M-SAA3 and Hp respectively. Although the 
focus of this study was clinical mastitis, the two cases of subclinical mastitis did provide 
interesting results, and therefore additional cows were recruited to the study mid-lactation, 
in order to further characterise the APP response in subclinical mastitis. These 7 cases 
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were only tested for M-SAA3 as detennination of its concentration was easier than that of 
Hp due to the ready availability of the commercial assay for the fonner. The levels of M-
SAA3 in these cases showed very similar kinetics to the early lactation subclinical cows, 
with daily fluctuations at low levels, and the maximum value of M-SAA3 recorded being 
3.4~g/ml. Staphylococcus aureus was isolated as the major pathogen causing subclinical 
mastitis in each of the nine cases. This finding is in agreement with the most recent annual 
Veterinary Investigation Diagnosis Analysis Database (VIDA) statistics compiled by the 
Veterinary Laboratories Agency which give an insight into the current profile of mastitis 
pathogens, and confinned S. aureus as the most common cause of subclinical mastitis in 
the UK (Bradley 2002). Quarters within cows are not independent; infection within one 
quarter increases the probability that additional quarters in the same cow will be positive 
(Barkema et al 1997), hence the finding that 9 cases of subclinical mastitis identified in this 
study were isolated from different quarters of only 5 cows is not unexpected. This may be 
due to increased susceptibility of certain cows or to within-cow transmission of pathogens 
(Barkema et al 1997). Intracellular survival and resistance to host immune responses 
results in a poor cure rate of S. aureus infections (Fox and Gay 1993). At present, an 
increased see is often the only means of detecting chronic subclinical mastitis. Monthly 
screening of most dairy herds using see at the cow level is routine. However this can lead 
to false negative results when pooling of the milk from all 4 quarters may mask a high 
IQSee. Therefore validation of an effective means for identifying intra-mammary 
infection at the quarter level would be beneficial to the welfare and productivity of the 
lactating dairy cow as this could potentially result in faster and more targeted therapy 
increasing cure rates and decreasing premature culling. 
The continued development of robotic milking systems in which the daily contact between 
the cow and stock worker is lost means that manual diagnosis of mastitis through 
examination is no longer practical, so a need for new monitoring systems has been created. 
The results of this study show that the major APPs, M-SAA3 and Hp can be detected in the 
milk of cows with clinical and subclinical mastitis. Based on results presented, the 
concentration of APP present in milk at calving is indicative of the risk of the cow 
developing mastitis during early lactation. Additionally, should further work support the 
findings from this study, measurement of APP in milk could provide infonnation on the 
pathogen type. This has very important implications on treatment of the cow leading to 
improved targeting of therapy and earlier treatment as the time-consuming and costly 
procedure of bacterial culturing could be phased out. The concentrations of APP in milk 
may be used to differentiate between clinical and subclinical mastitis, and may also be a 
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more sensitive marker of intra-mammary infection than SCC, due to the fact levels take 
longer to return to baseline levels after the occurrence of an infection, possibly indicating 
that the pathogen has not yet been eradicated from the udder. Based on the results of our 
study milk APP, have considerable potential for the use as biomarkers of mastitis. The fact 
that they can be measured in the milk, eliminates the need for invasive intervention, which 
usually involves skilled personnel, and presents the basis for a quick, reliable and sensitive 
diagnostic test for mastitis which could greatly improve the health and welfare of dairy 
cows. 
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Chapter IV 
Investigation of the Bovine Milk Proteome in 
Health and Mastitis 
4.1 Introduction 
Control of mastitis remams a major problem to the dairy industry worldwide. Early 
diagnosis is paramount if economic loses and adverse animal welfare resulting from 
mastitis, are to be reduced. Recent studies have identified the presence of APPs such as Hp 
and M-SAA3 in the milk from cows with mastitis (Eckersall et al 2001; McDonald et al 
2001; Pedersen et al 2003; Gronlund et al 2003a) and have prompted further investigation 
of the effect of this disease on the bovine milk proteome. Using milk as the analyte in a 
diagnostic test is highly advantageous because of the relative ease of collection by non-
invasive methods. Therefore identification and characterization of milk proteins is 
important in the development of new, clinically useful biomarkers as well as for studying 
the biochemistry and pathogenesis of disease processes in the mammary gland. 
4.1.1 Mastitis Induced Changes in Bovine Milk 
Changes in milk composition during mastitis have been widely studied (Kitchen 1981; 
Watanabe et al 2000). Somatic cell count (SCC) in bovine milk is used as a measurement 
of mammary-gland health and of milk quality (Munro et al 1984). During infection of the 
mammary gland SCCs increase as an integral part of the cow's immune defence 
mechanisms. This occurs alongside alterations in the protein constituents of milk, which 
includes an influx of serum proteins, such as bovine serum albumin (BSA), due to the 
increased capillary permeability of the infected gland, resulting in changes which are 
among the principal features of mastitic milk (Kehrli, Jr. and Shuster 1994; Lindmark-
Mansson et aI2000). 
Bovine milk from a healthy gland contains 3.9% fat, 3.3% protein, 5% lactose, and 0.7% 
minerals (Wong et al 1996). Milk proteins include as!, as2 and K-caseins, ,6-lactoglobulin 
(,6-LG), a-lactalbumin (a-LA), BSA, lactoferrin and immunoglobulins (Wong et al 1996). 
Caseins are the principal proteins in milk comprising approximately 80% of the total 
protein content. They are grouped together in micelles: spherical structures containing ex, ,6, 
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and K casein, and calcium phosphate. It is the casein fraction that gives milk its white-blue 
colour. It can be removed from milk through acid precipitation at pH 4.6, and is essential 
to the manufacture of cheese. After precipitation of casein the supernatant is known as 
'whey' and {3-LG and a-LA are the major whey proteins found in bovine milk accounting 
for between 7 to 12% and 2-5% respectively of the skim milk total protein. The whey 
proteins are soluble globular proteins, transparent in solution. {3-Lactoglobulin is the most 
abundant whey protein, followed by a-LA. {3-Lactoglobulin is a member of the lipocalin 
family, and although no biological role for this protein has yet been confirmed, its family 
origin and its identified similarity to retinol-binding protein have led to suggestions of it 
having a role in transport (Sawyer et al 1998). Present on the outer surface of this protein 
is a cavity lined with hydrophobic residues. This hydrophobic cleft is able to accommodate 
fatty acids like palmitate and stearate, a property, which would be exploited for the 
removal of this protein from solution. a-Lactalbumin is a small (Mr 14 200), acidic (PI 4-
5), ea2+ binding protein, which is essential for lactose biosynthesis. It is one of two 
components of lactose synthase, which catalyses the final step in lactose biosynthesis in the 
lactating mammary gland (Permyakov and Berliner 2000). 
The reviews of Kitchen (1981) and Munro et al (1984) both noted that there was a decrease 
in casein concentrations during mastitis, largely due to post-secretory degradation of casein 
by proteinases originating from bacteria, leucocytes or the blood. The activity of the major 
oxidizing lipolytic and proteolytic enzymes is noticeably higher in mastitic milk than in 
normal milk. {3-casein is hydrolysed into smaller fragments by plasmin, resulting not only 
in a decrease of total casein, but also an abnormally high ratio of K-casein to {3-casein. 
However, coupled with the increase in proteins of blood origin entering in milk with high 
see, the overall change in total milk protein is often negligible (Auldist and Hubble 
1998). The concentrations of {3-Lg and a-LA can drop by more than 70% of their normal 
level during mastitis. Unlike caseins however the major whey proteins are relatively 
resistant to proteolytic attack. Their reduction could be due in part to impaired cellular 
synthetic and secretory function, but is more likely due to leakage of these proteins out of 
the milk and into the extracellular fluid (Auldist and Hubble 1998). This theory is 
supported in a study which reported elevated concentrations of a-LA in the blood of cows 
with increased see (Mcfadden et al 1988). Reduction in milk yield is one of the clearest 
clinical signs of mastitis. The decrease in a-LA leads to a proportional decrease in lactose: 
the osmotic regulator of milk volume. Inflammatory reactions change the composition of 
milk in terms of quality and quantity. As the degree of inflammation increases the 
chemical composition of milk approaches that of blood. This is largely due to the 
disruption of the integrity of the mammary epithelia by bacterial toxins coupled with the 
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customary increase in vascular permeability at inflammatory sites and inflammation 
induced changes in the regulation of milk protein secretion (Watanabe et aI2000). 
4.1.2 Proteomics 
The term proteome describes the 'total protein complement of a genome'(Wasinger et al 
1995) and was coined in 1994 as the linguistic equivalent to the concept of the genome by 
Wilkins and Williams of Macquarie University, Sydney, Australia. This definition implies 
a static nature of the proteome similar to that of the genome. In fact the proteome is a 
highly dynamic system, with the subset of expressed proteins changing in abundance, state 
of modification, subcellular location etc, in accordance to the physiological state of the cell 
or tissue (Aebersold and Goodlett 2001). This dynamic range of protein expression makes 
the identification of the entire proteome a far bigger and more complex challenge than 
sequencing of the genome (Naaby-Hansen et al 2001). Proteomic studies can be used to 
obtain a global, integrated view of disease processes leading to the identification of disease 
specific proteins and discovery of novel drug targets (Page et al 1999; Banks et al 2000). 
Currently the best established applications of proteomics are in the clinical and biomedical 
fields where expression differences in the proteomes of tissues or body fluids such as 
serum can be measured directly and correlated with a particular disease (Blackstock and 
Weir 1999). Proteomics is a technology that integrates the significant advances in two-
dimensional electrophoretic separation of proteins, mass spectrometry and bioinformatics 
(Page et aI1999), (Figure 4-1). 
4.1.2.1 Two-dimensional electrophoresis 
Study of the proteome dates back to the 1970s when it was demonstrated that it was 
possible to separate proteins based on their isoelectric points (pI) and molecular weights 
(Mr) by electrophoresis on polyacrylamide gels (O'Farrell 1975). Although the techniques 
have been available for over 2 decades, recent advancements in the technology including 
the availability of immobilized pH gradients (IPG) in the first dimension have led to the 
production of reproducible two-dimensional gels, suitable for large scale analysis of 
protein expression and termed two-dimensional electrophoresis (2-DE) (Gorg et al 2000; 
Chich 2001). Immobilised pH gradient gels are prepared by covalently linking a small 
number of chemically defined molecules to the polyacrylamide backbone, resulting on a 
series of buffers distributed throughout the pH range of the strip. These allow attainment of 
true equilibrium throughout the focusing stage, which greatly increases the reproducibility 
i ! 
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Figure 4-1: Two- dimensional Electrophoresis coupled with mass spectrometry and 
database searching. The proteins are separated in the first dimension by isoelectric 
focusing on a plastic backed polyacrylamide strip containing an immobilized pH gradient. 
On application of a current the polypeptide subunits migrate in an electric field until they 
reach their isoelectric point resulting in an IPG strip with protein bands across its length. 
The strip is then applied to a SOS-PAGE gel and the proteins are separated in the second 
dimension by molecular weight. The 2-0E gel is stained with colloidal Coomassie and the 
spots of interest are excised from the gel, digested with trypsin and analysed by MALOI-MS. 
The resultant peak list from the peptide mass fingerprint is subjected to computer database 
searching. 
L 
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of 2-DE (Gorg et al 2000; Pennington and Dunn 2001). Separation by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) in the second dimension is 
based on the original method (Laemmli 1970). Reproducibility and resolution have been 
increased with the introduction of ready-made pre-cast gels, including gradient gels, 
however financial considerations and relatively short shelf-life frequently drive researchers 
to cast their own gels (Lefkovits 2003). Two-dimensional electrophoresis can potentially 
resolve up to 10,000 protein spots, dependent on sample preparation and detection strategy 
(Jenkins and Pennington 2001). The protocol for 2-DE is very well developed and has 
recently been reviewed (Gorg et al 2000). However, no single method of sample 
preparation can be applied universally due to the diverse nature of samples that are 
analysed by 2-DE. In general pre-fractionation procedures for 2-DE should be kept as 
simple as possible, target different molecular properties, and employ solutions that are 
compatible with downstream separation methods in order to minimize sample loss and the 
chance of degradation or introduction of artefactual protein modifications (Naaby-Hansen 
et al 2001). It is now generally accepted that a combination of chaotropes (ie. urea and 
thiourea) and zwitterionic detergents (i.e. CHAPS) are essential in the extraction buffer to 
solubilise most proteins from a wide range of organisms (Rabilloud et al 1997). Two-
dimensional electrophoresis (2-DE) is a powerful tool for analysing complex protein 
mixtures and remains the core technology of choice in the majority of proteome projects, 
however there are limitations with the usage of this technology, including the analysis of 
hydrophobic and/or membrane proteins, low abundance proteins and very basic proteins 
(Blackstock and Weir 1999). Additionally, 2-DE includes many steps of manual handling 
(sample preparation, gel casting and gel staining). Furthermore the complete analysis of 1 
gel including mass spectrometry and data analysis can take up to 3 days (Hille et al 2001). 
Automated proteome analysis is necessary to improve speed but also to reduce human 
contamination of samples (e.g. by keratin) (Rabilloud 2002). 
4.1.2.2 Mass Spectrometry 
Mass spectrometry (MS) is an essential tool in the field of proteomics. Identification of 
protein spots separated by 2-DE remained laborious until the 1990s when biological MS 
had developed into a sufficiently sensitive and robust technique (Mann et al 2001). The 
introduction in the late 1980s of two new 'soft' ionization methods: electro spray ionization 
(ESI) and matrix-assisted laser desorption ionization (MALDI) fundamentally changed the 
analysis of proteins (Blackstock and Weir 1999; Aebersold and Goodlett 2001; Mann et al 
2001; Pennington and Dunn 2001; Aebersold and Mann 2003). 
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Mass spectrometers have 3 basic components 1) an ionization source, 2) a mass analyzer, 
and 3) a detector. They measure the mass to charge ratios (mlz) of ions under vacuum, and 
various combinations of ionization sources and mass analyzers are available. The time-of-
flight (TOF) mass analyzer most commonly used with MALDI is robust, simple and 
sensitive and has a large mass range (Aebersold and Goodlett 2001). Matrix-assisted laser 
desorption ionization time of flight (MALDI-TOF) mass spectrometry is the method of 
choice for obtaining a peptide mass fingerprint (PMF), which in conjunction with a protein 
database is a powerful method for the identification of protein spots (Blackstock and Weir 
1999). The set of masses generated by mass spectrometric analysis of a digestion of a 
protein with a specific protease (i.e trypsin) can act as a fingerprint, and this property is 
unique to that protein (Yates et al 1993; Pappin et al 1993). Trypsin, specifically cleaves 
the peptide bond at the C-terminus of arginine and lysine residues, except if they are 
followed by a proline and is the enzyme commonly used for the digestion of proteins. To 
generate gas phase, protonated molecules, the analyte is dissolved in a large excess of 
matrix, typically a small organic energy-absorbing molecule, most commonly a-cyano-4-
hydroxycinnamic acid (CHCA). The mixture is then irradiated, by a pulse laser to generate 
a short burst of ions. The ions are accelerated to a fixed amount of kinetic energy and 
travel down a flight tube, therefore the arrival time of the ions at the detector is inversely 
proportional to their mlz ratio, producing the TOF spectrum (Mann et a12001; Pennington 
and Dunn 2001). 
4.1.2.3 Database searching 
In order to identify the proteins, the set of peptide masses (PMF) obtained from MALDI-
MS are extracted and subjected to database searches (Yates 1998). A number of search 
engines have been developed to enable the rapid searching of protein and nucleotide 
sequence databases with PMF data. They all work on the common principles of comparing 
the masses of the measured proteolytic peptides to the theoretically expected tryptic 
peptide masses for each entry in the database. A score is then calculated which reflects the 
accuracy of the peptide matching (Fenyo 2000; Mann et al 2001). There are a number of 
search engines available on the internet (Table 4.1), each of which is continually evolving 
in size and technology. All are based on the principles outlined above, the recent addition 
of more sophisticated scoring algorithms, has increased the sensitivity and specificity of 
protein identification (Perkins et al 1999; Mann et al 2001). The MOWSE scoring system 
implemented in the MS-FIT, MASCOT® search engine takes into account the relative 
abundances of the peptides of a given mass in the database when calculating the score, so 
that the chance of getting a random match to a larger peptide is lower and therefore it will 
I 
I 
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Name Internet Location 
PepSea http://www.pepsea.protana.eom/PA_PepSeaForm.html 
PeptIdentlMultident http://www.ex:Qasy.eh/tools/:Qe:Qtident.html 
MS-Fit htlIr/ /:Qros:Qeetor. ue sf. edulucsfhtm13 .2/msfit.html 
ProFound http://www.proteometrics.comiprowl-cgi/ProFound.exe 
MASCOT® http://www.matrixscience.eom/cgi/searchform.pI?SEARCH=PMF 
Table 4-1: List of search engines available for protein identification from peptide mass 
fingerprint data 
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contribute to a higher degree to the score (Pappin et al 1993). The second feature of the 
MASCOT® is that it uses probability based scoring. The probability that the resultant 
match is a random event is calculated for each protein sequence in the database and the 
proteins are then ranked with decreasing probability of being a random match to the 
experimentally obtained data (Fenyo 2000). This is particularly effective in the reduction 
of false positive results (Perkins et aI1999). 
Protein identification by PMF analysis has a high degree of success (50-90%) in organisms 
with fully sequenced genomes (Mann et aI2001). However, limitation ofproteomic based 
studies becomes apparent with the poor success rate in identification of proteins from 
species whose genomes are not yet fully sequenced (Lester and Hubbard 2002). At present 
the success rate for identifying proteins from microorganisms such as E. coli with fully 
sequenced genomes (OBrien 1997) remains higher than that from mammalian studies 
(Fenyo 2000). 
4.1.2.4 Proteomic studies of milk 
The milk proteome has previously been investigated with the first reports dating back to as 
early as the 1980s. Early studies utilized the basic 2-DE system proposed by O'Farrell 
(1975) to identify the major components of bovine and human milk (Anderson et a11982; 
Holt and Zeece 1988). As this was before the use of mass-spectrometry in conjunction 
with 2-DE, identification of the proteins was based on the comparison of the Mr and pI 
values obtained for each spot to existing literature on such properties of milk proteins. 
Hence due to the limitations in the technology at this stage, there was no scope for the 
identification of novel milk proteins. However N-terminal sequence tagging has been used 
in conjunction with data-base searching to identify whey proteins of wallaby milk (Molloy 
et al 1997). The coupling of MS with 2-DE in the 1990s has revolutionized proteomic 
studies and as a result most of the publications in this field are in the last 7 years. Casein is 
the major protein component of bovine (Goldfarb 2001) and human (Goldfarb 1999) milk. 
The overpowering effect of casein on the milk proteome is evident in all 2-D images of 
whole milk that have previously been shown (Galvani et a12000; Galvani et aI2001). This 
poses a problem in identification of additional components of the bovine milk proteome, in 
particular low abundance proteins. Several studies have exploited pre-fractionation 
techniques to remove casein from the milk allowing examination of the remaining 'whey' 
proteins of lower abundance. One such study reported the identification of several minor 
proteins such as fatty acid binding protein, prealbumin, clusterin and serotransferrin by N-
terminal sequence analysis following the removal of casein, a-LA, lactoferrin and 
Caroline Hogarth, 2004 Chapter 4, 125 
secretory IgA (Murakami et al 1998). A similar approach was taken in an investigation of 
the bovine whey fraction, but IgG was also removed leading to a further depletion of the 
major proteins (Yamada et al 2002). Here albumin, serotransferrin and lactoferrin were 
found in the low abundance fraction of mature milk, though several more proteins were 
found in bovine colo strums including (3-fibrinogen, chitinase and a-antitrypsin. Although 
there have been previous investigations of the bovine milk proteome, the focus has been 
either on the caseins of the milk, which are of interest to the manufacture of cheese, or in 
the differences between the proteins expressed in whole milk from those expressed in 
colostrums. To date there is only one study using modem proteomic methods to investigate 
the changes induced in bovine milk through mastitis (Baeker et al 2002). After removal of 
casein by acid precipitation the milk from 7 quarters with sub-clinical mastitis was 
compared to milk from healthy quarters and the appearance of lipocalin-type prostaglandin 
D synthase in mastitic milk was observed and proposed as a possible biomarker of mastitis. 
It is evident from this review of the literature devoted to the field of milk proteomics that 
few studies have been performed, most of which have been in the recent past. This is 
probably due to improvements in the necessary technology that have occurred in the last 
few years and it is expected that further developments will lead to an increase in research 
activity on the analysis of the milk proteome. 
The importance of proteomic analysis is its ability to study post-transcriptional control as 
well as post-translational modifications (PTMs) such as phosphorylation, glycosylation, 
acylation and methylation. Since the major milk proteins are known to be extensively post-
translationally modified (Anderson et al 1982), a feature that is likely to influence the 
function of the protein, targeting research at the protein rather than the gene level will 
result in a better understanding of the biological phenotype in connection with a particular 
disease state. 
The aim of this study was to use proteomic methods to identify the differential protein 
expression in bovine milk during clinical mastitis. The specific objectives were: 1) to 
optimise the best solubilisation method for proteins from bovine milk 2) to maximise 
sensitivity and reproducibility of proteomic analysis 3) to determine a pre-fractionation 
method compatible with 2-DE methods and resulting in effective removal of highly 
abundant milk proteins 4) to identify changes in the protein profile of bovine milk 
associated with clinical mastitis, and finally to identify novel protein markers of clinical 
mastitis. 
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4.2 Materials and Methods 
4.2.1 General Reagents 
General chemicals and other materials were obtained from obtained from Sigma-Aldrich 
Co Ltd, Dorset, UK, unless otherwise stated. 
4.2.2 Milk Samples 
Milk samples were collected from a commercial dairy farm in the West of Scotland. 
Mastitis was identified on the basis of clinical signs (heat, pain, redness and swelling of the 
udder, or clots in the milk). 
4.2.3 Sample Preparation for 2-DE 
Sample preparation is the first step in any proteome analysis study. The solubilisation 
protocol should be optimised in order to give reproducible and clearly resolved 2-D gels. 
Whole milk was separated by centrifugation at 4000g for 20 min at 4°C, and the lipid- rich 
cream supernatant and the cell debris pellet were discarded. In the first instance the caseins 
were precipitated by acidification of skim milk to pH4.6 with 1M HCL (Molloy et a11997) 
and removed by centrifugation (4000 x g, 4°C, 20min). The pH of milk decreases with 
mastitis so the volume of HCL required, to precipitate the casein varied between samples. 
This variable was eliminated through replacing the acid precipitation method used in 
previous studies (Molloy et al 1997; Baeker et al 2002) with ammonium sulphate 
fractionation. In the final protocol the caseins, which comprise approximately 80% of the 
total protein content in milk were precipitated by ammonium sulphate fractionation by 
addition of saturated ice-cold (NH4hS04 to the milk samples in an ice bath to a final 
concentration of 35% (v/v) of (NH4)2S04. After centrifugation at 4000g for 20 min at 4°C, 
the supernatant (milk whey) was removed and dialysed against deionised water at 4°C 
overnight. The protein content of the milk whey sample was determined (bicinchoninic 
acid), using bovine serum albumin as a standard. The whey samples ranged in protein 
content from 2.5 mg/ml to 10 mg/ml. Each sample was diluted in rehydration buffer (8M 
urea; 4% w/v, CHAPS; 0.5% v/v ampholyte and 100mM DTT), to give a final sample 
volume of 300fll containing 500flg total protein. 
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4.2.4 Two-dimensional Gel Electrophoresis 
Samples were applied by rehydration on non-linear immobilized IPG strips (17cm, pH 3-
10 or 4-7 BIO-RAD, Hemel Hempstead, UK), and focussed in a BIO-RAD Protean IEF 
Cell for 747S0 volt hours (Vhrs) using the following voltage rampage programme: SOY, 
SOOVhrs; SOOV, 2S0Vhrs; 2000V, 1000Vhrs; SOOOV, SOOOVhrs; 8000V, 8000Vhrs; 
10000V,60000Vhrs. 
IPG strips were equilibrated in SDS equilibration buffer (SOmM Tris-CI pH 8.8, 6M urea, 
30% v/v glycerol, 2% w/v SDS, .001% w/v bromophenol blue) containing 1% (w/v) 
dithiothrietol for ISmins in the first step followed by 2.S% (w/v) iodoacetamide in 
equilibrium buffer for ISmins in the second step. The IPG strips were then run in the 
second dimension in 12% polyacrylamide gels using l.SM Tris-HCI, pH 8.8, as separating 
gel buffer and Tris-glycine-SDS, pH 8.3, as electrode buffer, in a BIO-RAD Dodeca Cell. 
Gels were run at 200V for 7 hours. 
4.2.5 Gel Staining and Image Acquisition 
Polyacrylamide gels were stained using colloidal Coomassie blue G dye according to 
manufacturers instructions (Sigma-Aldrich, Dorset, UK), and destained in 10% (w/v) 
acetic acid in 2S% (v/v) methanol for 60 seconds and then for a further 24 hours in 2S% 
(v/v) methanol. Gel images were acquired using a UMAX PowerLookIII scanner (UMAX 
Technologies Inc, CA, USA) under the following settings: transmissive mode, true colour 
RGB and a resolution of 600dpi. 
4.2.6 In-gel Trypsin Digestion and Mass Spectrometry 
Spots of interest were excised with a scalpel blade from the gel, and washed with 300lli of 
deionised water for ISmins to remove residual destain solution. Coomaasie blue stain was 
removed from each excised gel piece by washing with 50% (v/v) acetonitrile in 100mM 
ammonium bicarbonate and drying in a Speedvac evaporator (Jencons-PLS Leighton 
Buzzard, UK). Each gel piece was rehydrated in 12111 of 20mM ammonium bicarbonate 
containing 12.Sllg/ml of modified porcine trypsin (Promega, Southhampton, UK). After 30 
minutes, more 20mM ammonium bicarbonate was added to any gel pieces that required 
further rehydration. The gel pieces were subsequently incubated at 37°C overnight with 
shaking. The supernatants from the tryptic digests were desalted using C18- ZipTipstm, 
according to the manufacturers instructions (Millipore, Watford, UK). Two micolitres of 
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the supernatant were then crystallized in a matrix consisting of a saturated solution of (J,-
cyano-4-hydroxycinnamic acid (CHCA) prepared in 50% (v/v) acetonitrile containing 
0.1 % (v/v) aqueous trifluoroacetic acid (TF A), and applied directly to the MALDI plate. 
Samples were left to dry at room temperature before being analysed by MALDI mass 
spectrometry. MALDI-MS was performed on a Voyager DE Pro (Perseptive Biosystems, 
CA, USA). Sufficient transients were collected to give an acceptable sound to noise ratio. 
4.2.7 Protein Identification Search Engines 
The peptide mass fingerprint, obtained by MS was subjected to search by pasting the 
peptide masses into a protein database (MASCOT, Matrix Science), which uses a 
probability-based scoring system to define a significant match. The spectra were first 
baseline corrected, smoothed, calibrated against internal trypsin autolysis peptides and de-
isotoped. The threshold was set to allow approximately 15 peaks/spectra to be saved. 
Search parameters were consistent for all proteins spots that were analyzed throughout the 
study (Table 4.2). The data entry form for MASCOT® which allows selection of these 
parameters is given as an example (Figure 4-2 and Table 4.3). 
4.2.7.1 The NCBlnr database 
The NCBInr database contains the translated protein sequences from the entire collection 
of annotated DNA sequences kept at GenBank, and also protein sequences in the Protein 
data Bank (PDB). SWISS-PROT and Protein Information Resource (PIR) databases, 
covering most of the publicly available data. 
4.3 Results 
Milk whey proteins from normal cows and those with clinical mastitis, were separated by 
2-DE using two different pH range IPG strips (PH 3-10 and pH 4-7) in the first dimension, 
and 12% (w/v) polyacrylamide gels in the second dimension. After staining of the gels 
with colloidal Coomassie blue, the patterns of separated proteins were revealed. Separation 
of the milk proteome using a broad range IPG strip (pH 3-10) in the first dimension 
showed clear differences (by visual inspection) between the proteins expressed by normal 
and mastitic milk (Figure 4-3). However with complex samples, such as milk employed on 
this study, 2-DE using a broad-range pH gradient reveals only a small percentage of the 
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Parameter Selected Option 
Database NCBInr 
Enzyme Trypsin 
Protein mass range o to 3000KDa 
Tolerance 50ppm 
Missed cleavage 1 
Fixed modification Carboxymethylation 
Variable modification Oxidation of methionine 
Charge state MH+ 
Table 4-2: Parameters selected for database searches using MS data. These parameters 
were used with the MASCOT® search engine 
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MASCOT Peptide Mass Fingerprint 
Your name 1 1 
Search title 1 3 
4 Database I MSDB 3 
5 Taxonomy IAII entries 
6 Enzyme ITrypsin 3 
Fixed 
modifications 
8 
AB_old_ICATdO (C) 
AB_old_ICATdB (C) 
Acetyl (K) 
Acetyl (N-term) 
~ (C-term) 
Protein mass 1 10 kDa 
Mass values r. MH+ r M 12 
r 
Data file I 
Query I NB Contents 14 
of this field 
are ignored if 
a data file 
is specified. 
overview r 
Start Search ... 
~ 
Email 1 2 
3 
Allow up to b iJ missed cleavages 7 
Variable AB_old_ICATdO (C) 
modifications AB_old_ICATdB (C) 
Acetyl (K) 9 
Acetyl (N-term) il Amid~jC-term) 
Peptide tol. ± 11.0 I Da iJ 11 
Monoisotopic r. Average r 13 
Browse ... 
W 
~ 
-------, 
Report top 120 iJ hits 15 
Reset Form 
Figure 4-2: Peptide Mass Fingerprint search form from the MASCOT® search engine. 
Each parameter is labelled with a number and described in table 4.2. 
Reproduced from http://www.matrixscience.com 
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parameter parameter description 
number 
1 Enter your name and e-mail address. The search results will be e-mailed to you if 
the connection is lost during the search. 
2 
3 Identify the sample (e.g. spot number) to keep track of mass lists 
4 Select database, NCBI was first choice in this study 
5 Select taxonomy. Higher scores will be achieved with narrower search 
parameters. Start with closest related taxa and broaden the search as needed 
6 The enzyme used to digest the protein should be entered 
7 One missed cleavage is often observed with in-gel trypsin digestion 
8 Enter modifications that will occur on all the proteins (e.g. acetyl N-term) due to 
equ ilibration with iodoacetamide 
9 Oxidation of methionine may occur with in-gel trypsinization 
10 Enter the probable mass of the protein that generated the peptide. Preferably 
through comparison with molecular weight markers on the 2-D gel image. 
11 With internal calibration of trypsin the peptide mass accuracy is within 50ppm (0.1 
Oa) 
12 For MALOI data the peptides in the mass list are protonated (MH+) 
13 A monoisotopic mass list is generated 
14 The peptide mass list is pasted here 
15 Enter the number of hits that you would like the search engine to report. 
Table 4-3: List of parameters for selction prior to database searching. 
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b) 
Figure 4-3: 2-D gels of normal whey a) and mastitic whey b), pH 3-10. Broad range IPG strips 
(17cm) (pH 3-10) were used for isoelectric focusing in the first dimension; the gels were 
stained with colloidal coomassie. Protein spot 1 indicated by an arrow (image b) was 
differentially expressed between the two milk samples. As this spot, lies out with the 4-7 pi 
range of the images shown in Figure 4-4, it was annotated in this figure instead, and 
described in table 4.3. 
, .: ._--
! I 
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Figure 4-4: 2-D gels of normal a) and mastitic b), pH 4-7 IPG strips (17cm) were used for 
isoelectric focusing in the first dimension, the gels were stained with colloidal coomassie. 
The numbered protein spots were digested and the resultant tryptic peptides were analysed 
by MALDI-TOF MS. The identities of the spots are summarised in table 4.4. 
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whole proteome because of insufficient separation. The first proteome maps can be 
considered useful to give a general picture of the protein distributions over pH 3-10, but 
the number of protein spots resolved was limited. Improved resolution was obtained by 
using a narrower range IPG strip (PH 4-7) in the first dimension, as shown for one milk 
sample in Figure 4-4. As a result almost all of the protein identification using MALDI-MS 
was performed on the gels separated using pH 4-7 in the first dimension. One differentially 
expressed protein spot however was visible at the basic end of the mastitic milk when 
separated over a pH gradient of 3-10 (Figure 4-3b) and is indicated with an arrow (spot 1). 
This spot was the only spot excised from this gel and analysed by MALDI-MS. Mass 
spectra were acquired by MALDI-MS for spots 2 to 8 on the pH 4-7 gels (Figure 4-4), 
producing a PMF, an example of which is shown in Figure 4-5. The mono isotopic mass list 
obtained from the PMF was used to search the computer database producing a histogram 
(Figure 4-6) from which a significant score can be distinguished from an insignificant 
score. The results obtained from searching the NCBInr database from spot 1 in Figure 4-
3b and those from figures 4.4a and b are summarised in table 4.4. 
4.3.1.1 Identification of Major Proteins in Milk 
Figure 4-4 gel a) shows the 2-DE pattern of normal bovine whey. The major whey proteins 
W-Iactoglobulin and a-lactalbumin), caseins and albumin were identified in normal whey 
(Figure 4-4a). Unnumbered spots were subjected to MALDI-MS but were not successfully 
identified probably because the sequence data for these protein spots is not currently 
available in the databases, or there was insufficient concentration of protein in the sample. 
Figure 4-4b displays the changes taking place from mastitic milk. The high molecular mass 
region of the gel shows an increase in the proteins mainly of blood serum origin, including 
albumin and serotransferrin. Albumin and serotransferrin labelled as spots 2 and 8 
respectively, in both a) and b), was much increased in mastitic milk. Serotransferrin was 
not identified by MALDI-MS in the normal milk displayed in Figure 4-4 a), however it 
does appear to be present but in very low abundance in this milk sample, which explains 
why its identity was not confirmed by mass spectrometry. The large intense spot (x), at the 
acidic end of Figure 4-4, gel b, and at a similar molecular mass to albumin, and also the 
less intense chain of spots (y) seen in this area but at a slightly lower molecular mass to 
albumin, were not identified by MALDI-MS. 
Proteins in the middle molecular mass regIOn of gel a, displaying the normal milk 
proteome, were shown, to be caseins despite the precipitation of the majority of such 
protein by ammonium sulphate during sample preparation. However examination of the 
Caroline Hogarth, 2004 
100 
::-
'iii 
c 
90 
80 
70 
60 
2 50 
.E 1--- - -, 
~ 842 .5100 
40 
832.3774 
30 I 
20 .1 927.5056 
Voyager Spec #1 =>MC[BP = 1567.7, 34493] 
1567.7438 
147 .7981 
1570.7194 
: 14 4.8069 
i' , 482.7781 1 1881.9194 ., 'I 1725.8351 
;' ~94 1 . 5300 . I I f 
Chapter 4, 135 
3.4E 
10 8~t . t05 :! i. 1740. ~M5 . ~~~6.0212 
Ii 8 .4611:9455809 139~ . 65,', ~%89'reOR JJrl.ili18~:059 I I 
" \(!II 'I I ! 1 T46 .1i:ly::)'Y .$ . 2211 .1046 . 
"', iJ>wiI.~"", .... .JJ.~I.-.-,1.4~\/l!",.~~ ,l .... \ • .".,.., ............... V\,\.L.......,\,,~U.-i"'-"......,...'"" __ ~ ............... -'_ • • _ ..... _'-'-__ ~ ___ \_ 
o~--~---,---~--,---~---,,---~---,---,~-~o 
799.0 1339.4 1879.8 2420.2 2960.6 3501.0 
Mass (m/z) 
Figure 4-5: Example of a MALOI mass spectrum. The peptide mass fingerprint was derived 
from the in-gel digestion of protein spot 2. The typical spectrum was obtained by MALOI-MS 
in reflectron mode using a-cyano-4-hydroxycinnamic acid as the matrix. Two hundred laser 
shots were acquired and the resultant peptide mass fingerprint (PMF) shown above was 
internally calibrated using the porcine trypsin autolysis peptide peaks as highlighted at 
842.510 and 2211.1046 Oa [M+Hf 
l I 
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Probability Based Mowse Score 
Ions score is -1 O*Log(P), where P is the probability that the observed match is a random event. 
Protein scores greater than 57 are significant (p<0.05). 
o 
25 50 75 
Probability Based Mowse Score 
Figure 4-6: Score histogram for a typical peptide mass fingerprint. Mascot incorporates a 
probability based implementation of the Mowse algorithm (Perkins et al 1999). Only scores 
outwith the green region are significant. Reproduced from http://www.matrixscience.com/ 
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Spot ID Name pI/Mr Score 
1 Microsomal triglyceride protein 8.74/98970 53 
(Bas taurus) 
2 Bovine serum albumin 5.82/69278 155 
3 aSj Casein (Bas taurus) 4.98124523 207 
4 ~-casein A3 - bovine 5.26125082 52 
5 K-casem 6.29121269 124 
6 ~-lactoglobulin 4.93/19908 105 
7 a-lactalbumin 4.9/16246 115 
8 Serotransferrin precursor (Bas 6.8177703 116 
taurus) 
9 Lactadherin precursor 6.81147411 78 
(milk fat globule-EGF factor 8) 
10 Annexin 1 6.44/39200 55 
11 Annexin4 5.55/34938 38 
12 Apolipoprotein A-I precursor 5.71/30258 98 
(Apo-A1) (Bovine) 
13 Bactenecin 7.57/17931 104 
Table 4-4: Molecular mass (Mr), isoelectric point (pi) and database score for protein spots 
successfully identified by MALDI-MS 
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similar area of the mastitic milk (Figure 4-4b) shows that mastitis induces obvious changes 
in the caseins of milk. Two large intense spots at the lower molecular mass region of the 
gel of normal milk (Figure 4-4a) were identified by MALDI-MS as the major whey 
proteins ~-LG (spot 6) and a-LA (spot 7). In whey from cows with severe clinical mastitis, 
the concentration of both these proteins was greatly reduced (Figure 4-4b) 
4.3.2 Milk Isoforms 
The 2-DE gel images showed the presence of several proteins as multiple spots (Figure 4-
7). The appearance of such beads of spots, with similar molecular mass but different pI 
values is indicative of post-translational modifications such as glycosylation or different 
protein isoforms. 
4.3.3 Casein Pellet 
The 2-DE gel of the casein pellet after ammonium sulphate fractionation of the milk 
(Figure 4.8) shows caseins to be the major proteins, and the obscuring effects that these 
abundant proteins would have on other spots within the milk proteome. 
4.3.4 Identification of Lower Abundance Milk Proteins 
The bulk of the identified proteins are shown as intense spots, the majority of which have 
pI values within the relatively narrow range of 4-9 to 5-2. Throughout this study the major 
protein spots in the milk of both normal and infected samples were reproducible on 2-DE 
gels. However given the nature of the milk samples it was expected that a greater number 
of protein spots would have been observed. Some of the 2-D gels of milk did contain a 
greater number of protein spots, primarily of lower abundance, and higher pI values than 
the major spots observed in the milk proteome, although greater variation between samples 
was observed with such spots. Figure 4-9 examines closely the changes observed in the 
lower abundance proteins of milk during mastitis as compared to normal milk. Comparison 
to previous works show that many of these proteins are likely to be casein fragments 
(Yamada et al 2002) and bovine serum albumin fragments (Baeker et al 2002). Protein 
identification of the spots in figures 4-9 and 4-10 using MALDI-MS was only successful 
in identifying a few of the spots. The proteins identified by MALDI-MS in this region of 
the gel included annexin-I, annex in-IV, apolipoprotein A-I precursor, lactadherin 
precursor and bactenecin, all of which were only identified in the disease state, and are 
indicated by an arrow. Spot 9 in Figure 4-10 was identified as lactadherin precursor protein 
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a) 
serotransferri n 
Figure 4-7: Zoom view of 2-0E gels from normal milk (a) and mastitic milk (b) at pH 5.5 to 7 
and molecular weight 100kd to 65kd. The close-ups show the characteristic pattern of 
protein isoforms with similar molecular weight but slight variations in pl. The increased 
concentration of albumin and serotransferrin is again observed in the infected milk sample. 
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, 
Figure 4-8: 2-0E gel of casein pellet of milk after ammonium sulphate precipitation 
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a) 
b) 
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Figure 4-9: 2-0E gels from normal milk (a) and mastitic milk (b), highlighting areas of 
interest which are described in detail in Figure 4-10 
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Figure 4-10: Zoom view of 2-DE gels from normal milk (a) and mastitic milk (b) at pH 5.5 to 7 
and molecular weight 100kd to 65kd. Examination of the lower abundance proteins in milk 
reveals that there are several such proteins present in mastitic milk but not in normal milk. 
Protein spots identified by MALDI-MS are numbered and spots in the boxes are assigned 
speculative identities through comparison with previous works. 
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(PI 6.81, Mr 47411). Spots 10 and 11 were identified as bovine annex ins I and N with a 
pI/Mr of 6.44/39200 and 5.55/34938 respectively. Both of these spots were only observed 
in infected milk, and annex in N is in greater abundance than annexin 1. Apolipoprotein A-
I (ApoA-I) (PI 5.71 and Mr 30258), was identified as the very faint spot 12. It is possible 
that ApoA-I is also present in normal milk, as there was a very faint spot lying at the 
correct pI and Mr in the 2-DE gel of normal milk (Figure 4-10a), however mass 
spectrometry for this spot did not produce a significant identity. Bactenecin (PI 7.57 and 
Mr 17931), an antimicrobial peptide was identified strongly as spot 13, and is also absent 
from normal milk. 
The remainder of the spots were gIVen a speCUlative identity through comparison to 
previously published 2-DE gels of milk. Proteins in areas 1,2 and 3 of Figure 4-10 gel b 
were identified tentatively through comparison to previously resolved 2-DE gels of milk 
protein (Yamada et al 2002; Baeker et al 2002). The spots that were identified by mass 
spectrometry were used as reference markers to ensure a realistic pI and Mr was being 
associated with the protein spots in the highlighted areas. The strongly stained spots in area 
1 when compared to previously published 2-D gel images of milk (Murakami et al 1998; 
Yamada et al 2002), correspond well to both the pI and Mr of IgG heavy chain. The 
location and intensity of the spots in area 2 corresponded to IgG light chain identified 
previously in milk and colostrum by N-terminal sequencing (Murakami et al 1998; 
Yamada et al 2002). The results from MALDI-MS from the other spots in this region of 
the gel give support to assigning an identity to the unidentified spots, through considering 
their location in relation to such previously characterised spots. Additionally the spots in 
both areas 1 and 2 display similar patterns of isoform distribution to IgG heavy and light 
chains previously identified. 
A recent study of mastitic milk identified 4 spots differentially expressed at 26Kd in the 
inflamed quarter as isoforms of bovine prostaglandin D synthase (PGD-S) (Baeker et al 
2002). The 4 spots presented in area 3 of Figure 4-10 could possibly be PGD-S. 
4.4 Discussion 
The important contribution of bovine milk to human nutrition and its availability in large 
amounts have made it the subject of biochemical studies for many years. There has been 
considerable interest in milk proteomics in the recent past due to two main factors. First, 
identification ofbioactive milk-derived peptides with possible pharmaceutical applications 
has generated a commercial interest (Clare and Swaisgood 2000). Second from a health 
Caroline Hogarth, 2004 Chapter 4, 144 
perspective there have been a number of reports suggesting correlations between particular 
genetic variants of milk proteins and some disease states including diabetes (Elliott et al 
1999). For these reasons characterisation of the bovine milk proteome is timely. 
Inflammation of the mammary gland, induced by bacterial infection, results in changes in 
the composition of bovine milk. The approach of this study was to analyse the entire 
protein complement of bovine milk during mastitis and in healthy cows using 2-DE 
coupled with mass spectrometry. A method of sample preparation aiming to precipitate the 
caseins allowing the investigation of milk whey proteins was developed and resulted in 
clearly resolved 2-DE gels allowing examination of the protein changes taking place in 
milk during clinical mastitis. This has been a commonly used approach to investigating 
milk proteins in whey (Molloy et a11997; Galvani et aI2000). 
The most prevalent protein in whey is ,B-lactoglobulin, comprising 10% of the total milk 
protein, and approximately 58% of whey protein and was identified in 2-DE gels in this 
study by MALDI-MS as a series of spots with a Mr of 19.9kD and pI of 4.93. The 
biological functions of ,B-LG have been a matter of speculation however, in the early 
1970s, ,B-LG was found to bind retinol, and it may therefore have a role in the transport of 
vitamin A to neonates (Wong et al 1996). Alpha-lactalbumin, a calcium binding protein, 
accounts for about 13% of the total whey protein and was also identified by MALDI-MS in 
a series of protein spots with Mr of 16.2kD and pI of 4.9. Under physiological conditions 
in the mammary gland, a-LA functions as a specifier protein, in that it modifies the 
substrate specificity of galactosyltransferase, and in complex with this enxyme catalyzes 
the final step in the biosynthesis oflactose. Both ,B-LG and a-LA appear as a string of spots 
in the 2-DE gels demonstrating that they are present as isoforms of differing charge, 
presumably as a result of post-translational modifications, which are known to occur to 
these proteins prior to secretion (Anderson et aI1982). 
The attempt to remove from the samples, the caseins, the most abundant protein in milk, by 
pre-treatment with ammonium sulphate precipitation, was only partially successful, as 
several spots were identified as either aS1 casein, ~-casein or K-casein, indicating that the 
process had not removed all the casein proteins present. A 2-DE gel of the casein 
precipitate was run which showed by MALDI-MS caseins to be the only abundant spots, 
indicating that this process removed no other major proteins. Caseins are a series of 
proteins unique to milk that comprise approximately 80% of the total protein content. They 
are phosphorylated proteins that undergo substantial post-translational modification. Of 
these, a-casein is the major protein in bovine milk, so that the absence of identified protein 
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spots following mass spectrometry indicates that this casein isoform had been removed by 
the pre-treatment (Wong et al1996). 
Bovine serum albumin, with Mr of 69.2 kD and pI of 5.82 which is known to be a 
component of normal milk at low concentration (Auldist and Hubble 1998) was the only 
other protein identified in normal milk by MALDI-MS. Defence mechanisms of the 
mammary gland against invasion of infectious agents are complex. Stimulation of 
neutrophil migration from the blood to the mammary gland is achieved through the 
production of inflammatory mediators at the local site of infection, including: cytokines, 
chemokines, complement fragments and arachidonic acid metabolites. Mastitis-induced 
disruption of normal secretory functions of the mammary gland leads to a break down of 
the blood-mammary barrier and the appearance of various serum compounds such as 
albumin, serotransferrin, complement proteins and Hp have previously been reported 
(Baeker et al 2002). Proteomic examination of the major proteins in whey from dairy cows 
with clinical mastitis in this study (Figure 4-4) confirmed that, in this condition, there is a 
major increase in serum albumin, presumably due to the increased leakage from the 
circulating blood, as described above. Serotransferrin (Mr 77.7 kD, pI 6.8) was also 
identified in mastitic whey again probably due to passive leakage from the serum, across 
the blood- mammary barrier and into the milk as the infection progressed. 
In addition to revealing that proteins such as albumin and serotransferrin are increased in 
concentration in milk whey during clinical mastitis, it was clear from a comparison of the 
2-DE gels that the major normal milk proteins were virtually absent from the whey of 
clinically mastitic udders. Thus there were minimal protein spots corresponding to ~-LG, 
a-LA or the casein remnants. Previous work has shown that there is a decrease in casein 
and whey protein concentrations during mastitis (Munro et al 1984). The phenomenon is 
possibly due to post-secretory degradation of the proteins by proteinases originating from 
bacteria or, leukocytes (Moussaoui et al 2002). The main proteolytic enzyme in milk is 
plasmin, which originates in the blood. However somatic cell proteases including cathepsin 
G, elastase and collagenase all display increased activity in milk during inflammation of 
the mammary gland (Moussaoui et al 2003). However, if this were the case, protein and 
peptide fragments, identifiable as such by MALDI-MS would be expected on the 2-DE gel 
and these were not found to be present. An alternative explanation is that the reduction in 
~-LG, a-LA and casein remnant concentrations in mastitic whey is due to a reduction in 
the synthesis and secretion of the proteins (Mcfadden et al 1988), either as a result of the 
physical damage to the mammary epithelial cells by bacterial toxins or as a 
Caroline Hogarth, 2004 Chapter 4, 146 
pathophysiological response of the mammary tissue to the presence of intramammary 
infection. The host response to toxins or to secondary mediators such as cytokines, nitric 
oxide or prostaglandins may playa role. Indeed ~-LG, the protein in milk with an ability 
to bind retinol, could be responding in the same way as the major serum protein with the 
same activity (retinol binding protein, RBP), which is known to be downregulated, during 
the cytokine-mediated acute phase response to infection (Ingenbleek and Bernstein 1999). 
It has been confirmed that the major proteins of milk do not vary widely in pI (Holt and 
Zeece 1988), as the 2-DE gels of normal milk whey clearly show ~-LG, a-LA and the 
casein remnants focus in a relatively narrow range of pH 4.5-5.3. This suggests an 
alternative approach to removing these abundant proteins, which could be applied in future 
investigation of less concentrated proteins in milk. Immobilised pH gradients strips with a 
narrow pH range of pH 5.0-7.0, pH 6.0-8.0 or pH 7-10 could be used in the first dimension 
of2-DE to examine milk proteins with low abundance and pI > 5.0, as with these gradients 
the maj or milk proteins would not focus but would instead migrate towards the anode, 
allowing examination of lower abundance proteins without interference from the major 
milk proteins. 
Identification of lower abundance proteins differentially expressed in mastitic milk was 
achieved for a small number of protein spots by MALDI-MS. Differences in the 2-DE 
patterns of the low-abundance proteins between normal and mastitic milk (Figure 4-9) 
were found in a number of mastitic samples. Such spots however were not detected in 
close proximity to any of the major spots, as highlighted by the zoom images shown 
(Figure 4-10). These differences in the low abundance milk proteins showed more 
variation between animals than was observed with the major protein spots. Further 
investigation of the functions of the low-abundance protein spots, (spots 1,9-13, Table 4.4) 
which were upregulated in infected milk revealed a possible association of the proteins in 
inflammatory disease processes. 
The annexins (spots 10 and 11, Table 4-4) consist of a family of at least 20 structurally 
related proteins. They all share a core structure containing phosolipid and calcium binding 
sites, and have been linked with intracellular signalling processes through protein kinase C 
(PKC) receptors (Andersen et al 2002). Macrophages and neutrophils are rich in these 
proteins. Annexins have previously been detected in the mammary glands of lactating 
cows. These proteins are thought to play a role in the suppression of inflammation, and 
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have previously been implicated as having a role in fatty liver, pneumonia and mastitis in 
cattle (Katoh 1995). 
The bovine glycoprotein lactadherin (spot 9, Table 4-4) is an abundant peripheral protein 
associated with the milk fat globular membrane but is also found in a wide range of tissues 
and is present in several body fluids (Andersen et al 2000). Bovine lactadherin precursor 
protein was identified in this study as a low-abundance protein in mastitic milk with a pI of 
6.81 and an Mr of 47411 Da. Structurally, the protein consists of two epidermal growth 
factor (EGF) - like domains, one of which (domain 2) contains the presence of an arginine 
- glycine - aspartic acid (RGD) sequence motif which was identified on examination of the 
amino acid sequence, and this motif is known to bind to integrin receptors, hence inferring 
a role for this protein in cell adhesion and motility. 
Apolipoprotein A-I (ApoA-I) (spot 12, Table 4-4) is the major protein of plasma high 
density lipoprotein and plays an important role in lipid transport and metabolism the 
protein interacts specifically with lipoprotein and endothelial cell protein annex in 
II.(Kanno and Katoh 2001). This protein was identified as a very faint spot as indicated by 
an arrow in Figure 4-7. Interestingly, the APP, Hp is synthesized extrahepatically by 
adipocytes (Friedrichs et al 1995), and has recently been shown as being distributed in the 
lipoprotein fractions (Katoh and Nagakawa 1999), and may have a role in the regulation of 
lipid metabolism (Porta et aI1999). Haptoglobin has previously been analyzed in serum by 
2-DE, followed by subsequent detection by either immunoblot or silverstaining (Kanno 
and Katoh 2001). From the outset it was expected that Hp would have been identified by 2-
DE methods, in mastitic milk samples as previous chapters have used immunoassay to 
measure the increased concentrations of this protein in milk during infection (chapter 3) 
(Eckersall et al 2001). With a known Mr of 20Kda (a-subunit) and 35Kda (~-subunit) 
(Morimatsu et al 1991) and pI of 5.27 (a-subunit) and 5.8 W-subunit), if the Hp subunits 
were present they should have focused within the pH range of the IPG strips used in the 
experiment. However Kanno et al (2001) used 2-DE to detect Hp in serum where 
concentrations are much higher than in milk and used the more sensitive silver stain, and 
Hp was still only shown as a minor component in comparison to other protein spots 
including APO-Al. Therefore it is likely that milk Hp may need more sensitive methods 
for detection. 
By comparison to previously published data showing 2-DE patterns of bovine milk, the 
number of protein spots detected on the 2-DE gels for milk presented here is low, with 
previous studies reporting the presence of up to several hundred proteins (Galvani et al 
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2000; Galvani et al 2001). It has been noted however that although the protein numbers are 
high, only a few genes are responsible for them and so the majority probably represent 
proteolytic products (Holland et al 2004). All the recommended steps were included in the 
sample preparation protocol to obtain a high level of protein extraction and therefore the 
detection of a maximum number of protein spots by 2-DE (Rabilloud 1998; Molloy 2000; 
Lanne et al 2001). These included the use of chaotropes for the disruption of hydrogen 
bonds, prevention of hydrophobic interactions by surfactants and destruction of 
intramolecular and intermolecular disulphide bonds by reducing agents. Use of staining 
methods of greater sensitivity than colloidal Coomassie, such as silver stain or sypro-ruby 
would probably have led to an increase in the number of proteins being detected, however 
there are drawbacks associated with the use of such stains. Silver staining gives poor 
reproducibility, a limited dynamic range, and selective staining of protein spots with some 
staining negatively or not at all. In addition, low detection limits often occur in mass 
spectrometry because the stain modifies cysteine residues and the gluteraldehyde and 
formaldehyde used in the procedure alkyl ate protein amino groups making the protein 
spots unsuitable for mass spectrometric analysis (Patton 2002). The fluorescent stain Sypro 
ruby can detect in the range of 1-2ng of protein per spot, and the linear range is over three 
orders of magnitude (Gorg et al 2000). However, being a fluorescent stain, Sypro ruby 
renders the manual excision of protein spots from the 2-DE gel and requires special 
equipment such as the Amersham Ettan robotic workstation, which was not available at the 
time of this study. 
The known association of bovine mastitis with the accumulation and activation of 
inflammatory mediators and immune cells within the milk and udder (Holland et al 2004) 
would suggest the likelihood of detecting secretory products such as IL-8, tumour necrosis 
factor-a and Hp and M-SAA3 would be high (Barber et al 1999). However in this study no 
such products were identified in either normal or mastitic milk, probably because they are 
present in low concentrations. It can be difficult to elucidate low abundance proteins of 
interest in the presence of relatively abundant proteins using 2-DE (Corthals et al 2000). 
Such proteins could possibly be identified by 2-DE and MALDI-MS after enrichment of 
the crude sample, for example by using high affinity antibodies to the proteins of interest 
(Oda et al 2001). Alternatively immunoblotting could be used to confirm the presence of 
low abundance proteins on 2-DE gels. 
A number of proteins giving clear spots or strings of spots in the 2DE gel of mastitic milk 
were not identified. The bioinformatic approach of matching proteins from peptide mass 
fingerprinting to published protein sequence databases is reliant upon the 'unknown' 
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protein being partially, or ideally, fully represented in a current database. However there 
are still many species whose genomes are not sequenced, and are unlikely to be sequenced 
in the near future. This poses a problem in current proteomic studies, but for such 
organisms whose genomes are not yet fully sequenced it may be possible to use cross-
species identification (Lester and Hubbard 2002). Due to the limited number of Bas taurus 
database entries, identification of the unknown protein spots may have to be performed by 
cross-species matching. Identification of marsupial milk proteins using a mammalian 
database has previously been employed successfully to identify wallaby casein, ~-LG and 
a-LA (Molloy et al 1997). Entry number and content varies largely between databases, so 
database selection within the search engine (Molloy et al 1997), can also strongly influence 
the success of the identification procedure, in combination with human judgement and 
selection criteria selected within the database. 
Comparison to previously published 2DE gels of bovine milk gives support to both IgG 
heavy and light chains being present in mastitic milk. Immunoglobulin G is present in the 
database, but was not identified by MALDI-MS and database searching in this study. 
There are a number of reasons as to why this can happen. It is possible that the spots 
analyzed were a mixture of proteins, either from the gel or with keratin contaminations. In 
that situation protein mixtures score poorly on Mascot® due to the high number of proteins 
that do not match, and hence a mixture often fails to be identified correctly. It is also 
possible that an insufficient number of peptides were identified to get a significant match 
on Mascot®, and there are a variety of reasons that can lead to this happening. Presence of 
a high number of trypsin cleavage sites results in the peptides produced being too small, 
but if the number of trypsin cleavage sites is too low then the peptides produced are to 
large. Additionally many peptides do not ionize well, and many do not bind strongly to the 
carbon resin present within the ZipTipstm, leading to a low concentration of peptides being 
extracted from the gel. Finally it is possible that there was a problem with the tryptic digest 
itself, for example proteins with a complex tertiary structure are often resistant to 
proteolysis. 
Two-dimensional electrophoresis coupled with MALDI-MS represents a powerful method 
to identify the changes induced by mastitis on the bovine milk proteome. However it 
remains that milk is a very complex fluid and the number of proteins within, that have not 
experienced post-translational modifications or proteolysis is rather limited (Galvani et al 
2001). Post-translational modifications in proteins are of immense importance for protein 
folding and function. Such proteins remain the most difficult to characterise, and further 
steps should be taken in future studies to tackle this problem. Traditionally this is achieved 
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using methods that can identify the mass increment or mass deficit relative to the known 
molecular mass of the protein followed by amino acid sequencing of the modified protein 
by tandem mass spectrometry (MS/MS) (Jensen 2004). However, determination of PTMs 
by mass spectrometry may require additional preparative steps such as enrichment of the 
protein of interest using immunoprecipitation (Mann et al 2001). The complete 
characterization of the primary structure of proteins will remain a laborious and 
challenging task for proteomics for many years to come (Mann and Jensen 2003). 
Chapter V 
A Proteomic Approach to Study the Bovine 
Milk Proteome during an Experimental 
Staphylococcus Aureus Model of Mastitis 
5.1 Introduction 
151 
In the previous chapter a proteomics approach was developed and used, to successfully 
investigate differentially expressed proteins in bovine milk during naturally occurring 
bovine mastitis. However, by definition samples were from cases of clinical mastitis in 
which major changes were found. In addition, as all samples were from established 
disease, the alteration to the milk proteome during the early or sub-clinical stages was not 
examined. The objective therefore, of the study described in this chapter was to monitor 
the proteome in an experimental infection designed to mimic the condition frequently 
encountered on farm, of subclinical or early infection periods. 
This was achieved by collaboration with an ongoing project with the University of 
Glasgow Veterinary School and the Hannah Research Institute (Ayr) in which an 
experimental model of S. aureus mastitis was established. The objective of the model was 
to examine the alteration to the milk concentrations ofHp and M-SAA3 during subclinical 
and early mastitis. However, milk collected from the in vivo experimental model which 
would allow examination of the milk protein during the development of mastitis was 
available. Specialist software for identification of protein altering from sample to sample 
had the potential to identify changes in major and minor protein during the disease process. 
Having made minor modification to the previously described method (section 4.2.4) the 
optimal conditions for analysis of the milk proteome were established and samples were 
analysed from selected time points from the infected and control quarters of the 
experimental infection with S. aureus. Milk samples from 7 selected time points were 
analysed with the objective of identifying consistent differences as the disease progressed. 
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5.2 Materials and Methods 
5.2.1 Cows 
Twenty Holstein dairy cows from the herd at the Hannah Research Institute, with low see 
«100,000 cells/ml) in previous lactations were selected for the experiment. The cows were 
grouped as either control cows (n=10) or infected cows (n=10). The infected cows were 
challenged by intramammary infusion of S. aureus mastitis. The control cows were infused 
with sterile phosphate buffered saline (PBS). 
5.2.2 Infection 
The 10 cows in the experimental infection group were infused with a low virulence strain 
of S. aureus isolated from a case of subclinical mastitis (Young et al 2001) at a dose of 5 x 
106 organisms in 10ml of sterile PBS. Each of the 10 cows was challenged on 2 occasions. 
First, a single quarter in each cow was infected. Second, on day 28 after the first infusion, 
two quarters of the same cow were infused, 1 of which was the previously infused quarter 
and which will therefore be undergoing re-challenge. The cows were then euthanased 3 
days after the second infection (day 31 after initial treatment). 
5.2.3 Milk Samples 
Milk samples (20ml) from each quarter of the 20 cows were collected weekly, for the 4 
weeks preceding infection. On the day of infusion (day 1), and for the following 3 days 
milk samples (20ml) were collected from each quarter of all cows at both daily milkings. 
Thereafter, milk samples were collected daily on days 4-7 post-infection (p.i.), and then on 
days 9, 12, 15, 19, 23 and 26 p.i. On day 28 (day of re-challenge), 29, 30 and 31 milk 
samples were collected at both daily milkings. Milk samples were stored at -20oe until 
analysis. 
Milk samples from 1 quarter of 3 control cows and 1 quarter (the quarter of double 
challenge) from 3 experimentally infected cows showing the highest acute phase response, 
were analysed using 2-DE at the following time points days -7, 1,2,3, 7, 28, and 29. 
5.2.3.1 Somatic cell count 
Milk sees were determined as described in section 3.2.5. 
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5.2.3.2 Acute phase protein analysis 
Milk samples were assayed for Hp and SAA as described in section 3.2.6 
5.2.3.3 Sample preparation 
The milk samples were prepared prior to 2-DE as described in chapter 4, section 4.2.3 
5.2.4 Two-dimensional Gel Electrophoresis 
Samples (120~g in total volume of 125 ~l of rehydration buffer) were applied by 
rehydration on non-linear immobilized IPG strips (7cm, pH 4-7) (BIO-RAD, Hemel 
Hempstead, UK), and focussed in a BIO-RAD Protean IEF Cell for 26000 volt hours 
(Vhrs) using the following voltage rampage programme: 50V, 600Vhrs; 2000V, 2000Vhrs; 
4000V, 24000Vhrs. The IPG strips were then equilibrated as described in chapter 4, 
section 4.2.4 and then run in the second dimension in 12% polyacrylamide gels using 1.5M 
Tris-HCl pH 8.8 as separating gel buffer and Tris-glycine-SDS pH 8.3 as electrode buffer, 
in a Mini-PROTEAN 3 Dodeca cell (BIO-RAD, Hemel Hempstead, UK). Gels were run at 
200V for Ih. The mini-PROTEAN 3 Dodeca cell has the capacity to run up to 12 mini-gels 
simultaneously. 
The gels were then stained and scanned as described in chapter 4 section 4.2.5. 
5.2.5 Image Analysis 
Phoretix software (Nonlinear Dynamics, Newcastle, UK) was used to create a 'difference 
map' based on the pre-infection samples, to highlight any spots that exhibited different 
expression levels across the course of the infection. The creation of the difference map 
required a process of optimisation of spot detection, editing and filtering, background 
subtraction and creation of a reference gel. 
The computer analysis of the gels was carried out on a time series of 2-DE gels for 3 of 
the infected cows. The 7 time-points (days -7, 1, 2, 3, 7, 28, and day 29) from each cow 
were analysed together in 1 experiment using the tools outlined below. 
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5.2.5.1 Spot detection 
Spot detection is the first step in the computer analysis of a 2-D gel. It is designed to 
automatically identify the maximum number of spots on the gel, however some degree of 
manual editing is necessary to achieve accurate detection. 
The spot detection parameters were optimised visually using the detection Wizard on a 
representative part of the gel image. The spot detection wizard works by performing 
several detections on the same area of the image using a combination of sensitivity and 
operator size parameters. It then displayed 9 different combinations of these two 
parameters. The aim in this operation was to achieve a similar appearance in all 9 panels. 
Stringency of spot detection was altered by adjusting the sensitivity, noise, operator size 
and background parameters. Once the spot detection was optimised, the selected 
parameters were applied to the entire gel. 
5.2.5.2 Spot editing and filtering 
The removal of spots that were not required for reasons of size, shape or relevance can be 
achieved by a combination of manual editing and by use of the automated 'Spot Filtering 
Facility'. Spots below a certain area, peak height, volume and/or spots displaying poor 
circularity could be filtered out. The circularity filter is a very useful way of removing 
streaks detected on the image. A threshold volume was set in each experiment, to enable 
the removal of low volume spots, which are usually background noise. 
5.2.5.3 Background subtraction 
Background subtraction is necessary to ensure that low intensity spots can be distinguished 
from background, and also so that a true pixel intensity value can be calculated for a given 
spot. "Mode of non-Spot", was used to subtract the background from the gels. This works 
by calculating the pixel intensity between the background and a selection of the least 
intense spots. 
5.2.5.4 Creating a reference gel 
Before any expression changes can be explored using the software, a reference gel must 
first be created from 1 of the gels in the experiment. In this project, the day -7 gel was 
chosen as the reference gel for each cow, as it is the within-cow control. 
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5.2.5.5 Creating a difference map 
In order to explore either an increase or a decrease in the expression levels of the milk 
proteins, across the time series of infection, a difference map is created. Spots showing 
more than a two-fold increase or decrease in spot volume than the equivalent spot on the 
reference gel are highlighted in green. Differentially expressed spots can be further 
explored by creating a table that will display the volume for the spot in each gel being 
analysed in the experiment. 
5.3 Results 
An experimental model of S aureus mastitis was successfully established in dairy cows 
infused with Saureus, judged by conventional criteria of raised Sec. The results for see 
and APP in the 3 selected infected animals are shown (Figures 5-1 to 5-6), to demonstrate 
that the cows developed sub-clinical mastitis. The milk from 1 quarter of three infected 
cows with the greatest increase in APP and 1 quarter of three control cows was subjected 
to proteomic analysis at 7 time points: days -7,1,2,3, 7, 28, 29. 
5.3.1 Somatic Cell Count 
The see increased rapidly following infection, from ~30 xl03 cells/ml pre-infection, to ~5 
xl06 cells /ml within 15h of infection. In the infected udder see remained elevated until 
the time ofthe second infusion with S aureus on day 28. 
5.3.2 Acute Phase Proteins 
In milk from the infused quarter of infected cows, increases in Hp and M-SAA3 were 
present within 15h of infusion reaching an initial peak at 48h post infusion. Milk Hp rose 
from 0.22 ± 0.07 flg/ml to 7.2 ± 13.7 flg/ml and M-SAA3 increased from 0.19 ± 0.37 
flg/ml to 8.8 ± 2.3 flg/ml. Elevated levels of these APPs were present until the time of 
second infusion. Thereafter both Hp and M-SAA3 rose again to highest level (Hp: 0.8 ± 
49.0 flg/ml, M-SAA3: 0.35 ± 73.5 flg/ml). It was not possible to determine whether there 
was a difference between the onset of the APP response in milk and the rise in see as both 
analytes were elevated in the first samples of milk taken after the first infusion (at 15h). 
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Figure 5-1: Profiles for somatic cell count (SCC) and mammary-associated serum amyloid 
A3 (M-SAA3) for cow 1, following inoculation on days 0 and 28 with S. aureus 
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Figure 5-2: Profiles for somatic cell count (SCC) and mammary-associated haptoglobin (Hp) 
for cow 1, following inoculation on days 0 and 28 with S. aureus 
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Figure 5-3: Profiles for somatic cell count (SCC) and mammary-associated serum amyloid 
A3 (M-SAA3) for cow 2, following inoculation on days 0 and 28 with S. aureus 
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Figure 5-4: Profiles for somatic cell count (SCC) and mammary-associated haptoglobin (Hp) 
for cow 2 following inoculation on days 0 and 28 with S. aureus 
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Figure 5-5: Profiles for somatic cell count (SCC) and mammary-associated serum amyloid 
A3 (M-SAA3) for cow 3, following inoculation on days 0 and 28 with S. aureus 
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for cow 3 following inoculation on days 0 and 28 with S. aureus 
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5.3.3 Two-dimensional Electrophoresis 
Milk whey proteins from 3 control cows and 3 cows with experimentally induced S. aureus 
mastitis were separated by 2-DE, at 7 time points (d -7, 1,2,3, 7, 28, 29). Gel images were 
first analysed manually by eye. The major milk proteins, casein, {3-LG, a-LA and albumin, 
were present in all gels and were identified by comparison to the results in chapter 4. 
Examination of the gels from the 7 different time-points within the infected cows did show 
differences in the proteins expressed (Figures 5-7 to 5-9). However, there were no obvious 
changes to the major milk proteins. There was a much less dramatic reduction in {3-LG and 
a-LA in the experimental samples compared to the clinically mastitic milk samples, used 
for optimisation of the method in chapter 4. Greater variation was observed in the less 
abundant proteins in milk but no consistent changes in the expression of a particular 
protein or subset of proteins were apparent through visual examination of the gels. 
Similarly, these differences were not consistent between animals, ruling out comparison 
between animal subsets. 
Differences in the gels from the control milk samples (Figures 5-10 to 5-12) were also 
observed, and again no consistent differences are obvious. 
5.3.4 Image Analysis using Phoretix Software 
Visual examination of the gels showed that there were pattern differences in the milk 
proteome in response to the infection, however no consistent changes were obvious. Much 
of the useful information in 2-DE is quantitative, such as changes in protein expression 
patterns and response. However, quantitative data can only be derived from gel analysis 
with computer assistance (Mahon and Dupree 2001). One infected cow, from this 
experiment was analysed by 'Phoretix 2D' image analysis software (Nonlinear Dynamics, 
Newcastle, UK), to try and quantify the changes taking place in the milk proteome 
throughout the course of infection, and to yield data on protein quantity. The pre-infection, 
(day -7) milk sample was used as the reference gel, and the milk samples from the other 
time-points (days, 1, 2, 3, 7, 28 and 29) were compared to the reference gel through 
creation of a difference map. Before the difference maps were created, all gels in the 
experiment first had to undergo spot detection, editing and filtering. The results for the 
computer analysis of the gels are detailed below. 
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Figure 5-7: Two-dimensional gels for infected cow 1, for 7 selected time-points (days -7,1, 
2, 3, 7, 28 and 29) during the course of infection 
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Figure 5-8: Two-dimensional gels for infected cow 2, for 7 selected time-points (days -7, 1, 
2, 3, 7, 28 and 29) during the course of infection 
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Figure 5-9: Two-dimensional gels for infected cow 3, for 7 selected time-points (days -7, 1, 
2, 3, 7,28 and 29) during the course of infection 
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Figure 5-10: Two-dimensional gels for control cow 1, for 7 selected time-points (days -7,1, 
2, 3, 7, 28 and 29) during the course of the experiment 
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Figure 5-11: Two-dimensional gels for control cow 2, for 7 selected time-points (days -7, 1, 
2,3, 7, 28 and 29) during the course of the experiment 
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Figure 5-12: Two-dimensional gels for control cow 3, for 7 selected time-points (days -7,1, 
2, 3, 7, 28 and 29) during the course of the experiment 
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5.3.4.1 Spot detection 
Spot detection was performed for all gels that were included in the analysis, (Figures 5-13 
and 5-14). The automated spot detection wizard was used but all gel images were also 
scrutinised manually by eye for undetected or incorrectly detected spots. Some degree of 
manual intervention was required for accurate spot detection in most of the images. 
5.3.4.2 Spot editing and filtering 
Figure 5-15 shows an example of a gel image during spot filtering. All spots highlighted in 
blue will be removed from the selection, leaving only the spots highlighted in green, 
(Figure 5-16). 
5.3.4.3 Reference gel and difference map 
The milk sample taken on day -7 was used as the reference gel for the infected cow, 
selected for computer analysis. All other time-points included in the analysis were 
compared to the reference gel resulting in the creation of a difference map, which 
highlights all spots showing a differential increase in expression by two-fold or more, in 
green and those showing a differential decrease of two-fold or more, in yellow. 
Comparisons of spot intensity among the gels were made on the basis of spot volume, as 
described in section 5.2.5.5. Spot volumes reflect the relative abundance of a given 
polypeptide in milk. A small number of proteins spots, were highlighted using this tool 
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Figure 5-13: The spot detection wizard as used to determine the optimal sensitivity of spot 
detection for the entire gel. The aim was to achieve a similar appearance in all 9 panels . 
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Figure 5-14: Spot detection for the entire gel is achieved after optimisation using the spot 
detection wizard 
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Figure 5-15: Spot filtering was used to remove all spots below the threshold volume (shown 
in blue) 
Figure 5-16: Final spot selection after editing and filtering has been performed 
~I 
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Figure 5-17: A difference map was created to highlight the spots that show more than a 
two-fold increase (green)or decrease (yellow) in volume at day 2 post-infection to the 
equivalent spot in the reference gel. 
Figure 5-18: A difference map was created to highlight the spots that show more than a 
two-fold increase (green) in volume at day 3 post-infection to the equivalent spot in the 
reference gel. 
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Figure 5-19: A difference gel was created to highlight the spots that show more than a two-
fold increase (green) in volume at day 7 post-infection to the equivalent spot in the 
reference gel. 
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Figure 5-20: A difference gel was created to highlight the spots that show more than a two-
fold increase (green) in volume at day 29 post-infection to the equivalent spot in the 
reference gel. 
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5.4 Discussion 
Chapter 5, 171 
Previous work (chapter 4) showed that there were obvious differences in the milk proteins 
of healthy cows and those suffering severe clinical mastitis. Major whey proteins such as 
a-LA and {3-LG were diminished, while other proteins, notably serum protein such as 
albumin and serotransferrin were increased. 
The goal of this study was to extend this work to the examination of an experimental 
model of S. aureus mastitis, designed to induce a mild form of infection that did not cause 
visible signs of the disease. Changes to the milk proteome during the course of 
experimental infection in quarters of dairy cows with a defined strain of S. aureus were 
investigated by comparing the whey proteome prior to and during intramammary infection, 
to identify protein spots in the 2-D gels that change in concentration in a way that 
correlates with disease status or progression. 
The changes obtained in this experimental infection model equated to a mild sub-clinical 
disease as confirmed by the results for milk APP and SCC. As a result the changes in the 
milk proteome of healthy and infected milk were much less obvious than those previously 
seen during severe clinical mastitis. 
Detailed image analysis of the 2-DE gels was carried out with Phoretix 2-D advanced 
software. Two-dimensional electrophoresis induces unavoidable technical differences from 
gel run to run, arising from sample preparation, gel preparation and staining. For this 
reason gel analysis could not be performed between animal subsets. Computer analysis 
was therefore, only performed as a time-course experiment within the one animal. After 
spot detection, and background subtraction, 2-D gels were edited, filtered and the 
quantitative determination of the spot volumes was performed. To compare spot volumes 
across different gels, the protein spots detected in each experimental gel were matched to 
the corresponding protein spots within the reference protein gel. Background intensity was 
subtracted from the spot volumes. Computer analysis of the gels confirmed that there was 
little variation in concentration of the major milk proteins between the different time-points 
of infection. Some differences were observed, but these did not show correlation to the 
infection status ofthe gland. 
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The proteomic method used in this study was developed and optimised for the study of 
severely mastitic milk. It is likely that the method requires further optimisation to increase 
the sensitivity and enable the analysis of smaller changes occurring as seen with 
subclinical infection. A number of approaches could be considered in future studies that 
should lead to improvement of the current method. 
Many of the emerging technologies for the global evaluation of protein expression are 
being applied in the field of biomarker discovery for disease progression. However, these 
analyses can be made difficult by variation between samples that arises from both technical 
and non-disease related physiological causes (Steel et al 2003). Indeed, the main obstacle 
in this study was that there was an inherent variability in the resolution of proteins from the 
milk samples across cows. 
This issue of inter-animal variation could be addressed through adopting a different 
experimental approach in future studies. A possible approach could be to use composite 
gels, generated from pooling samples from animals in the infected and control groups, in 
which robust biomarkers should still stand out. Protein spots showing significant variation 
when comparing the composite gels would then be further investigated. 
Second, consistency in the method could be improved through the use of plastic-backed 
pre-cast gels for the second dimension. Variations in casting of SDS-P AGE gels can 
contribute to difficulties in gel comparison studies (Wang et al 2003). Additionally 
automated staining would eliminate any differences in exposure times to the stain, and 
hence standardise the background levels of the gels (Wang et aI2003). 
The very wide range of protein abundance found in milk samples makes separation by 2-
DE of unfractionated samples complicated particularly on mini gels. Although the caseins 
were partially removed, it is evident that this approach must be extended for future studies. 
Although they were not consistent, pattern changes were observed to a greater degree in 
the low molecular weight «15,000 KDa) and more basic pI (PH 7 to 10) region of the gels. 
However examination of such proteins and thereby the changes within is made difficult 
due to the obscuring effect by the major milk proteins. 
This study has further emphasised that pre-fractionation of milk is a prerequisite prior to 
examination of its minor proteins and further preliminary investigations have demonstrated 
approaches as to how this can be achieved. This could be achieved through use of a pre-
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fractionation apparatus, based on pI, that has recently become available. Pre-treatment of 
milk samples by isoelectric separation in solution using an IEF, zoom fractionator 
(Invitrogen) can subdivide whole milk samples into 5 fractions and as the major milk 
proteins have similar pIs in the region of pH 4.5 to 5.5, these can be isolated in one or at 
most two fractions. By effectively concentrating the major milk proteins into fractions 
containing proteins of low pI (PH 4.7 to 6.1), disease related alteration in low abundance 
proteins with pI's outside this range could be more easily identified. 
Matching and comparing hundreds of protein spots across gel images taken from a large 
number of different cows is extraordinarily time-consuming, even with specialized 
software designed to accommodate some variation. 
The ease of use of the software is an important criterion in any proteomics experiment, 
since gel analysis can be a very slow and laborious procedure. The user must make many 
choices in operation of 2-D gel analysis software. Editing is one of the most labour-
intensive aspects of gel analysis. There is always variability in values of spot volumes 
determined from samples analyzed in duplicate gels. Some variation will result from gel 
preparation, and sample handling; some will arise from the analysis procedure. 
Quantitation and observation errors are the 2 most common problems in 2-D gel image 
analysis. First, there are spots that are not detected by the software. Second there are spots 
that are reproducibly observed and yet their spot volumes have some intrinsic variation 
between the two gels. Background noise from scanning of the images can disrupt spot 
detection and thus smaller spots are more likely to be undetected (Mahon and Dupree 
2001). 
It is important to note that there is a large variability in the relationship between the spot 
volume derived from Phoretix 2-D and the protein quantity in the original sample, because 
of variable recovery in the gel and variable staining, in addition to software derived 
differences in spot measurement. 
The original goal of this study was to identify protein spots in the 2-D gels of milk that 
change in abundance in a way that correlates with disease status or progression, during 
experimentally induced S. aureus mastitis. 
Significant biological sample variation from cow to cow, lengthy steps in performing 2-DE 
and intricate gel analysis, all contributed to the difficulties encountered in trying to 
differentiate authentic differences caused by disease, with those artefacts caused by sample 
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variations, running conditions of 2-DE and staining. In conclusion, the variation in sample 
from cow to cow was too wide to permit conclusive associations between time-points of 
infection and disease progression. 
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Chapter VI 
Expression of Mammary-associated Serum 
Amyloid A3 in Bovine Mammary Tissue 
6.1 Introduction 
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The plasma concentration of the APPs SAA and Hp have been shown to be elevated during 
mastitis (Conner et al 1986; Hirvonen et al 1996; Hirvonen et al 1999; Eckersall et al 
2001). Eckersall and others (2001) were first to demonstrate that the concentration ofSAA 
and Hp increased not only in the plasma during mastitis but also in the milk. There has 
since been a number of studies investigating milk APPs, all of which discuss the likelihood 
of SAA being produced locally (Pedersen et al 2003; Gronlund et al 2003a; Nielsen et al 
2004). Serum amyloid A present in mastitic milk may be a result of locally produced M-
SAA3 pooled with hepatically derived SAA present in the milk through leakage across the 
blood-mammary barrier. 
Extra-hepatic expression of SAA has been documented in a variety of tissues and these are 
detailed in section 1.3.12. The SAA genes are highly conserved through evolution and 
have been identified in a wide range of vertebrate species including higher mammals, 
marsupials, birds and fish (Uhlar et a11994; Thorn and Whitehead 2002). 
Serum amyloid AI, SAA2 and SAA3 isotypes all show profound increases in expression 
during inflammation (Marhaug et al 1997). All 3 isotypes are expressed in the liver, but, 
SAA3 appears to be the predominant isoform expressed extrahepatic ally (Marhaug et al 
1997). Serum amyloid A 3 synthesis has been reported at extra-hepatic sites including the 
ovary, spleen, kidney and lung (Meek et aI1994). 
Recent studies have reported the presence of genes expressing SAA in the epithelium of 
involuting mammary tissue (Kho et al 2000; McDonald et al 2001), and during infection 
(Molenaar et al 2002). The milk isoform has a unique 4 residue aa motif TFLK within the 
first 8 residues and is termed mammary-associated serum amyloid A 3 (M-SAA3). This 
motif has not been reported in hepatically produced SAA. A number of roles have been 
suggested for SAA. The constitutive expression of SAA in non-hepatic cell lines may 
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suggest a housekeeping role for the protein. Additionally it could have a role as an 
immunological defence molecule, produced at local sites to protect against injury caused 
by inflammation. Rabbit SAA produced by synovial cells has been implicated in tissue 
repair. Hence it is very interesting and timely to study the expression of M-SAA3 in the 
bovine mammary gland during the inflammatory condition of mastitis. 
The study presented herein investigates the presence of M-SAA3 in bovine mammary 
tissue during infection, and exploits the small difference in amino acid sequence of this 
isoform to design primers that have the ability to distinguish between M -SAA3 and 
hepatically derived SAA. 
6.1.1 Reverse Transcription Polymerase Chain Reaction 
Reverse transcription polymerase chain reaction (RT-peR) represents a powerful tool for 
analysing ribonucleic acid (RNA) (Erlich et al 1991; Freeman et al 1999). The polymerase 
chain reaction (peR) is a technique that allows the amplification of a specific sequence of 
DNA and is effective even when the target DNA is present in very low concentration. The 
technique was developed by Mullis et al (1986), and allows large amounts of a single copy 
gene to be generated from genomic or viral DNA (Mullis et al 1986; Mullis and Faloona 
1987). The initial procedure used the Klenow fragment of DNA polymerase 1. This 
enzyme needed to be replaced at each cycle as it was denatured by the high temperature 
reaction conditions. Efficiency was greatly improved by introduction of a thermostable Taq 
polymerase isolated from Thermus aquaticus, as this allowed automation of the procedure 
(Saiki et aI1988). 
peR allows the amplification of any unknown DNA sequence by the simultaneous 
extension of primer pairs flanking the unknown sequence, each complementary to opposite 
strands of the DNA. An overview of peR and its applications is available (Innis and 
Gelfand 1990). 
6.1.1.1 The coding region of the gene 
In eukaryotes most of the gene protein coding region is not a continuous DNA sequence 
reading out co-linearly into messenger RNA (mRNA) but is composed of an alternating 
array of coding sequence, called exons separated by intervening pieces of non-protein 
coding DNA referred to as introns. The removal of these intronic sequences from the initial 
RNA transcript and the joining of all exons in a head to tail arrangement occurs, through a 
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precise mechanism mediated by the splicing machinery in the nucleus (Weiner 1993), to 
form a mRNA molecule. Genomic DNA containing introns can be used to express the gene 
of interest but these sequences can span up to hundreds of kilobases and are therefore 
impossible to clone into the currently available mammalian expression vectors. 
Alternatively cDNA, which is a direct copy of the mRNA transcript, can be made in vitro, 
and used to directly transcribe and translate genes to a functional protein. Thus, the cDNAs 
encoding the bovine genes SAA and M-SAA3 have been used in this chapter. 
6.1.1.2 The immediate 5' UTR 
The 5' untranslated region (UTR) of the gene is important for the initiation of gene 
transcription. The process of transcription involves the binding of RNA polymerase to the 
initiation site, under the influence of the 5' regulatory region, followed by the addition of 
nucleotides in a 5' to 3' fashion to form the primary RNA transcript. The most 5' 
nucleotide of the transcript is usually modified post-transcriptionally by the addition of a 
methylated G (guanine) residue linked by a 5' -to 5'- triphosphate bridge. This feature, 
referred to as a 'Cap' structure, is essential for efficient initiation of protein synthesis. 
The 5' UTR is also important in the translation process of most mammalian mRNAs to 
protein. Translation is initiated by the binding of the numerous protein factors including 
the 40S ribosomal subunit to the region 5' to the AUG. The ribosomal component moves to 
the first AUG where the 60S ribosomal subunit joins to produce the first peptide bond 
(Kozak, 1991). Translation initiation from the mRNA template is the rate limiting step in 
protein synthesis and is controlled by the context and position of the AUG initiation codon 
with its surrounding secondary structure and length of 5' untranslated region (UTR). The 
optimal context for initiation is 5' GCC(A/G)CCAUGG 3' where the A of the AUG codon 
is referred to as the +1 nucleotide. The most critical residues controlling the efficiency of 
initiation are purines at positions -3 and +4, usually an 'A' and 'G' respectively. The 
presence of multiple upstream initiation sites serves to suppress the initiation efficiency 
from the correct site. Position of the AUG codon is also extremely important since 
approximately 90% of vertebrate mRNAs are initiated from the first AUG codon without 
giving preference to an optimal context. 
179 
6.1.1.3 The immediate 3' UTR 
The 3' UTR, defined as the mRNA sequence following the termination codon (TAA, TAG) 
is thought to playa role in mRNA transcript stability, providing a determinant of mRNA 
levels and also plays a role in protein synthesis through the control of translation (Jackson 
and Standart 1990). The half-life of a mRNA molecule determines the length of time that 
the template is available for protein synthesis (Peltz et al 1991), which can vary from 
several minutes for some cytokines to 100 hours for stable mRNAs. However, the half-life 
may not always be constant and will change with the conditions of the cell. The rapid 
turnover of mRNA has been linked to cis-acting instability elements present within the 
RNA sequence. One of these instability elements is in the class of AU-rich elements 
(ARE) and contains the pentameric motif AUUUA in a U-rich context sufficient for rapid 
mRNA degradation (Vakalopoulou et aI1991). This rapid degradation process is important 
for transient induction of molecules and rapid cellular changes that occur in response to the 
environment providing the fine-tuning of protein levels within the cell. 
The minimal, mammalian poly(A) signal, located in the 3' UTR, is composed of an 
AAUAAA motif 20-30 nucleotides and serves to control the termination and processing of 
the primary RNA transcript with the formation of the poly(A) tail on the mRNA transcript 
(Proudfoot and O'Sullivan 2002). 
6.2 Materials and Methods 
6.2.1 Sample material 
The tissue samples used in this experiment were obtained from an experiment using a S. 
aureus experimental infection at Glasgow Veterinary School, taken 24h after the second 
inoculation. The experimental infection is described in detail in chapter 5. 
6.2.1.1 Mammary tissue 
Udder tissue samples were collected aseptically from slaughtered cows within 5 to 10 
minutes after killing. The udder skin was washed with hibiscrub and incised with a 
disinfected knife (70% alcohol). A small tissue section (1 by 1 by lcm) was removed from 
the epithelial lining of the gland and preserved in 'RNA later' (Qiagen, Hilden, Germany) 
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for RNA analysis. 100 mg of tissue (wet weight) was used as the starting material for 
RNA isolation. 
6.2.1.2 Isolation of total RNA 
The total RNA was isolated from mammary tissue usmg TRIzol (Gibco Bri., Life 
Technologies Inc., NY, USA). RNA concentrations were determined by UV 
spectrophotometry. Two ILg of isolated RNA was separated on a 1 % agarose gel to assess 
the integrity of the 28S and 18S ribosomal RNA as an indication of RNA quality. 
6.2.1.3 Dnase treatment 
Prior to first strand cDNA synthesis the total RNA was treated with Dnase I (DNA-free kit, 
Invitrogen, Breda, The Netherlands) to prevent amplification of genomic DNA. In a simple 
two-step reaction 1 ILg of total RNA was incubated for 15mins at room temperature with 
the DNAse I and the enzyme - specific reaction buffer. The reaction was terminated by 
adding 1 ILl of 25mM EDT A and heating for 10min at 65°C. 
6.2.1.4 First strand eDNA synthesis 
Analysis of gene expression requires accurate determination of mRNA levels, but as PCR 
is based on amplification of DNA, the process of amplifying RNA sequence requires an 
initial step of conversion of RNA to cDNA by reverse transcription. The Molony-Murine 
Leukaemia Virus (M-MLV) reverse transcriptase enzyme (Invitrogen, Breda, The 
Netherlands) was used to carry out this conversion (Brooks et al 1995). Oligo-dT primers 
(Amersham Biosciences, NJ, USA) pair with the poly A sequence found at the 3' end of 
most eukaryotic mRNA molecules and initiate the synthesis of cDNA strands in the 
presence of dNTPs. 
The specific conditions used involved a 3-step reaction as follows: 
1) 1 ILg of total RNA, 1 ILl of oligo (dT)12-18 primers, 1 ILl of 10mM dNTP were added to 
a nuclease-free microcentrifuge tube, made up to a total reaction volume of 12 ILl with 
ddH20 and heated for 5 min at 65°C. 
2) 2) 4 ILl 5X first-strand buffer, 2 ILl of O.IM DTT and 1 ILl of RNaseOUT recombinant 
ribonuclease inhibitor (40 units/ ILl) were added to the tube and incubated for 2 min at 
37°C. 
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3) 3) The contents of the tube were mixed and 1 ILl of M-MLV RT was added and the 
mixture was heated for 50 min at 37°C. Finally the reaction was terminated by heating 
for 15 min at 70°C. 
6.2.2 peR amplification of M-SAA3 cDNA in bovine mammary 
tissue 
RT-PCR analysis on RNA extracted from mammary gland epithelium of 4 control cows 
and 4 with experimentally induced S. aureus mastitis was carried out to determine a) if the 
SAA or M -SAA3 genes are expressed in the mammary tissue and b) if they are expressed, 
is their expression up or down-regulated during mastitis. 
6.2.2.1 Primer design 
Primers were designed following the guidance of a standard text (Innis and Gelfand 1990). 
The goal of primer design is to produce an oligonucleotide that will hybridise efficiently 
with the DNA sequence of interest, and not hybridise with any other sequence. The amount 
of sequence permissible between primers is flexible, and up to 10kb is possible, however 
beyond 3kb efficiency is decreased (Jeffreys et al 1988). The annealing portion of primers 
should generally be between 18 and 30 nucleotides in length; any increase in size beyond 
this is unlikely to improve primer specificity significantly and this size of primer is 
sufficient for sequence as complex as the human genome. Primer GC content should 
match that of the template as closely as possible. For any given pair of primers, the 
annealing temperatures ™ and GC content were balanced. 
It was essential that primers were designed that could distinguish between hepatically 
derived SAA and the mammary isoform M-SAA3. Mammary-associated serum amyloid 
A3 contains a unique four amino acid motif TFLK within the first 8 residues (McDonald et 
aI2001). The M-SAA3 primer was designed by back-translating this amino acid sequence 
to include the nucleotides encoding for this motif in the M-SAA3 forward primer (bovM-
SAA3) (Table 6.1). Serum amyloid A has a high degree of conservation across species 
(Uhlar and Whitehead 1999), so SAA primers was designed according to regions of 
sequence homology between different species. A sequence alignment was performed on 
the cDNA sequences of horse, human, mouse, dog and cat using the Seqman computer 
programme (DNASTAR Inc.,WI, USA) (Figure 6-1). A degenerate primer was designed 
for the SAA forward primer (bov SAAF) (Table 6.1) as they allow a degree of flexibility 
when the exact sequence of the target gene being amplified is not known 
--I 
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Primer name Primer sequence (5' to 3') 
bovMAAF GATGGGGGACATTCCTCA 65.5°C 
boy SAAF CGAATGGTWTTCRTTYTTTGGC 65.1°C 
bovSAAconR ATCACTTTAGCAGCCCAGGC 65.3°C 
Table 6-1: Sequence and melting points for the primers used for RT -peR 
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Figure 6-1: An alignment with the nucleotide sequences of serum amyloid A (SAA) for 
horse, human, mouse, dog and cat. 
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(Kwok et al 1994; Linhart and Shamir 2002). The difference in the sequence ofM-SAA3 
occurs at the 5' end of the sequence and as a result the same reverse primer (bovSAAconR) 
(Table 6.1) designed from the consensus sequence can be used in both reactions. A final 
alignment of the bovM-SAA3 primer sequence against the consensus sequence was carried 
out to check that the M-SAA3 primer did not match. The primer sequences are detailed in 
table 6.1. With these primers, a M-SAA3 specific cDNA product of 169bp was expected. 
6.2.2.2 RT -peR reaction 
The sensitive nature of PCR means that very stringent steps must be taken if contamination 
is to be avoided. First, physical separation of the PCR area from bench space used for other 
work is recommended. In the case of PCRs carried out in this project, a dedicated PCR 
suite isolated from the main laboratory was used. In addition, a set of instruments used to 
aliquot reagents (micropipettes and their tips) were kept within the PCR suite and restricted 
to PCR use. Filter tip pipette tips were used to reduce the chance of carryover from one 
step to the next, and master mixes of reagents were used whenever possible to reduce the 
number of pipetting steps required per reaction. Reaction components, including primers, 
were aliquoted prior to use and stored at -20°C. PCR reactions were performed using 1~1 of 
bovine cDNA sample in a total volume of 50~1 containing 1 ~l (10pmol) of both sense 
primer (bovMAAF or bov SAAF) and anti-sense primer (bovSAAconR), 1~1 of dNTPs, 
0.2~1 of Taq DNA polymerase (Prom ega, WI, USA) and 5~1 ofMgClz containing reaction 
buffer (Promega, WI, USA) . The mixture was placed in a Perkin-Elmer 480 thermal 
cycler. Samples were subjected to an initial denaturation at 94°C for 2min followed by 40 
cycles of amplification, each cycle consisting of a denaturation step of 94°C for 2min and 
annealing temperature of 60°C for 30s, followed by an elongation step of 72°C for 30s. A 
final extension step at 72°C for 7mins completed the reaction. Samples were kept at 4°C 
after the reaction finished. A negative control containing all PCR components (primers, 
dNTPs, PCR buffer and Taq polymerase) but using ddH20 instead of template was 
included to ensure that there was no contamination of the PCR reactions. 
As an internal endogenous control for mRNAlcDNA integrity, an RT-PCR of the house-
keeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was performed. 
186 
6.2.2.3 Assessment of peR products 
An aliquot of the PCR product was assessed by 1 % agarose gel electrophoresis, stained 
with ethidium bromide, and photographed under ultraviolet light. The molecular weight of 
the fragments was deduced through comparison to a ladder of molecular weight markers 
(SmartLadder, Eurogentec, The Netherlands). 
6.2.2.4 Extraction and sequence analysis 
The resulting PCR products were extracted from the gel usmg the QIAEX II Gel 
Extraction Kit (Qiagen, CA, USA), and ligated in a PGEM-T Easy vector (Promega, WI, 
USA) at 16°C overnight following manufacturer's instructions. E. Coli bacteria were 
transformed by electroporation of the ligated vector. After gel purification the gel products 
were directly sequenced with an ABI 310 Prism Genetic Analyzer (Perkin Elmer Applied 
Biosystems, CA, USA), using the Big Dye Terminator Cycle Sequencing Ready Kit 
(Perkin Elmer Applied Biosystems, CA, USA). 
The 'BLAST' search engine within the NCBI database (www.ncbi.nih.govIBLAST/) was used 
to analyse sequence data. 
6.3 Results 
6.3.1 Analysis of RNA quantity and quality 
Full-length, total RNA was isolated from bovine mammary tissue from 4 control cows and 
4 cows inoculated with S. aureus. Good quality RNA samples were obtained as determined 
by ultraviolet spectrophotomtery (A260/ A280 value> 1.6) and agarose gel electrophoresis 
assessment (Figure 6.2); the RNA migrated through the 1 % agarose gel revealing intact 
l8s and 28s ribosomal RNA components. 
6.3.2 peR amplification of bovine M-SAA3 cDNA 
RNA samples (lllg) were subj ected to first strand synthesis using M -ML V reverse 
transcriptase and random primers to produce bovine cDNA. The cDNA samples were used 
as the template for the amplification of M-SAA3 using sense (bovMAAF) and antisense 
(bovSAAconR) oligonucleotide primers and Taq DNA polymerase. The PCR products 
obtained migrated on a 1 % agarose gel to show a DNA fragment of approximately 160 bp 
I. 
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Figure 6-2: Ethidium bromide stained agarose gel showing the integrity of the 18s and 28s 
ribosomal RNA components. I I 
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(Figure 6-3). The expected product visualised in lanes 3 and 4 corresponds to the portion of 
M-SAA3 amplified by RT-PCR using primers specific for M-SAA3. Lanes 1 and 2 show 
that there was no amplification of hepatically derived SAA or M-SAA3 when the bov 
SAAF primer was used in the reaction instead of the bovMAAF. Lane 4 shows that the 
PCR product is upregulated in mastitic udder tissue as compared to the control tissue (lane 
3). There were no bands present in the negative control reaction (not shown). 
Variation in the level of RNA between samples was assessed by using an endogenous 
RNA internal control GAPDH was used to assess the quality of the cDNA, but no 
significant changes in GAPDH levels were observed (not shown). Bovine mammary 
cDNA was amplified byRT-PCR to produce a 169bp product. 
6.3.2.1 Sequencing of peR product 
The nucleotide sequences determined from the genetic analyzer were assessed using the 
'BLAST' search engine within the NCBI database. The nucleotide sequence was compared 
to every gene sequence within the data bank to identify those genes which shared the 
greatest homology with the 169 bp fragment obtained in this experiment. The results 
revealed that the nucleotide sequence showed 100% homology to bovine SAA3 (Figure 6-
4), and therefore confirmed the local production ofM-SAA3 in the bovine mammary gland 
and its up-regulation during bovine mastitis. 
6.4 Discussion 
RT-PCR analysis was performed on RNA extracted from the mammary gland epithelium 
of 4 control cows and 4 cows with experimentally induced S. aureus mastitis. The aim of 
the study was to determine if the M -SAA3 gene was expressed in bovine mammary tissue 
and if so, is its expression up or down-regulated during mastitis. 
Primers were carefully designed, to include the nucleotide bases encoding for the unique 4 
amino acid motif, TFLK present within the first 8 residues of the M-SAA3 sequence 
(McDonald et al 2001). No product was visible when the primers derived from the 
consensus sequence of SAA were used in the RT-PCR reaction, indicating that only the 
unique M-SAA3 isoform is produced locally in the bovine mammary gland. Mammary-
associated serum amyloid A3 mRNA, was detected in epithelial tissue from control cows, 
but was up-regulated during mastitis. 
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Figure 6-3: Ethidium bromide stained agarose gel electrophoresis showing the RT -peR 
products of total RNA from control (lanes 1 and 3) and mastitic mammary tissue (lanes 2 
and 4) amplified using primers that can distinguish between SAA and M-SAA3. The SAA 
primers were used in the reaction shown in lanes 1 and 2 and the M-SAA3 primers were 
used in the reaction shown in lanes 3 and 4. Markers of a DNA ladder are shown in lane m. 
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gatgggggacattcctcaaggaagctggtcaaggggctaaagacatgtggagagcttacc 60 
111111111111111111111111111111111111111111111111111111111111 
gatgggggacattcctcaaggaagctggtcaaggggctaaagacatgtggagagcttacc 118 
aagacatgaaagaagccaactacaggggtgcagacaaatacttccacgcccgtggaaact 120 
111111111111111111111111111111111111111111111111111111111111 
aagacatgaaagaagccaactacaggggtgcagacaaatacttccacgcccgtggaaact 178 
atgacgctgcccgaaggggacctgggggtgcctgggctgctaaagtgat 169 
1111111111111111111111111111111111111111111111111 
atgacgctgcccgaaggggacctgggggtgcctgggctgctaaagtgat 227 
Figure 6-4: The nucleotide sequence of the 169-bp fragment amplified by RT-PCR showed 
100% homology to bovine M-SAA3 Genbank accession number: AF335552. Underlined in 
red are the forward and reverse primers used for the RT -PCR 
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Previous studies examining the extrahepatic expression of SAA in mice, reported increased 
expression of SAA mRNA in extra-hepatic sites following LPS stimulation, but SAA 
mRNA was either not detectable or present in low levels in all saline infused control tissue 
sites (Meek and Benditt 1986; Kalmovarin et al 1991). The results in this study were in 
agreement with these previous findings, with M -SAA3 mRNA expression being detected 
at low levels in mammary tissue from control cows as compared to tissue from S. aureus 
infused cows (McDonald et al 2001; Molenaar et al 2002). 
The high nucleotide sequence conservation between different species directly reflects the 
amino acid sequence and the latter is closely related to biological function. Therefore it is 
predicted that M-SAA3 will share the same basic biological functions as the SAA3 isoform 
in other species. M-SAA3 has considerable amino acid homology to rabbit SAA3 
produced extrahepatically by synovial fibroblasts (Brinckerhoff et al 1989), which has 
been shown to induce the production of collagenase and stromelysin. This assigned 
function to rabbit SAA3 may be important in localized tissue remodelling during tissue 
regeneration and repair that occurs in wound healing. McDonald et al (2001), speculate 
that M-SAA3 may playa role in mammary gland tissue remodelling during lactation-
associated changes. During mastitis the integrity of the blood-mammary barrier can be 
severely disrupted and it is possible that M-SAA3 may playa role in modulation of 
connective tissue repair. 
The principal function of SAA remains elusive, and little is known concerning the precise 
localization of SAA bio-synthesis outside the liver in mammals (Marhaug et al 1997). 
However SAA expression in the mucosa of the intestine (Meek et al 1989), as well as in 
the endometrium may reflect a role in surface epithelial protection for this protein. 
Additionally, evidence that SAA is expressed in endothelial cells (Meek et al 1994) lends 
support to the theory that SAA may be a factor in barrier functions of epithelial and 
endothelial cells. 
The APP, SAA has been considered to be expressed primarily in the liver until recent years 
(Urieli-Shoval et al 1998). Why these extrahepatic tissues express mRNA encoding the 
SAA genes is unclear, but the induced expression probably results from the reaction of 
certain cytokines or hormones with their cellular receptors in response to inflammatory 
signals. Although the extrahepatic expression of the SAA3 isoform is usually in 
association with inflammation, its high abundance in colostrum of healthy cows suggests 
that M-SAA3 may play an important functional role associated with the well-being of the 
newborn and possibly mammary tissue remodelling (McDonald et aI2001). 
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Additional studies will be necessary to clarify further the role of M-SAA3 in the bovine 
mammary gland, but based on the sequence homology of M-SAA3 with SAA3 it is 
possible that it may have a role in the modulation of numerous immunological responses 
that are essential to protect the host and restore homeostasis. Expression of M-SAA3 on 
surface epithelia indicates a defensive role for the protein, situated in a position to 
communicate with the external environment and protect local tissues from potential threats 
such as microorganisms. 
This important APP, M-SAA3 has been shown to be produced locally in the bovine 
mammary gland and there is evidence that it is up-regulated during mastitis. Additional 
work is needed to further investigate this finding. In-situ hybridisation should be 
performed to give a more detailed analysis of the tissue localization of M -SAA3 in the 
bovine udder. Quantitative real-time peR could be used to measure the degree of up-
regulation ofM-SAA3 in the bovine mammary gland during mastitis. 
Chapter VII 
General Discussion 
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The aims of this thesis were outlined in chapter 1 and the relevant conclusions have been 
detailed in the appropriate chapters. This chapter serves to summarise the most significant 
findings and highlight the areas which have been recognised as worthy of future research. 
Acute phase proteins are produced in response to a variety of disease conditions stimulated 
by the pro-inflammatory cytokines and in response to infection, trauma or inflammation. 
The measurement of APPs in serum of animals has been widely used over the past two 
decades, for disease diagnosis in the field of veterinary medicine (Gruys et al 1994; 
Eckersall 1995b; Horadagoda et al 1999). Eckersall et al (2001) were first to demonstrate 
significant increases in the concentration of APPs in the milk of cows with clinically 
mastitis. This initial finding spurred the research described in this thesis, during the period 
of which there have been further studies carried out involving investigations of milk APP 
(Pedersen et a12003; Gronlund et a12003a; Gronlund et a12003b; Nielsen et a12004). 
Many gaps exist in our knowledge and understanding of mastitis, as a result it remains a 
major source of economic lose to the dairy industry worldwide. Increasing the insight into 
the pathogenesis of mastitis will help to develop new strategies for control and prevention 
of bovine mastitis. Early diagnosis of mastitis is paramount if economic loses arising from 
this disease are to be reduced. There are a number of strategies currently employed for the 
diagnosis of mastitis, and these were reviewed comprehensively in chapter 3. It was 
recognised that there are many limitations surrounding the use of standard parameters such 
as see and bacteriology for mastitis diagnosis. Therefore the potential of measuring APP 
in milk as a diagnostic tool for bovine mastitis was investigated in this study. 
In validation of any new diagnostic test, it is essential to compare the new method with the 
existing method. It was therefore fundamental in this thesis to establish the association of 
APP in milk with see, the conventional markers of mastitis and a large proportion of the 
work undertaken focussed on this. The analysis of APP in milk demonstrated that they are 
comparable to and complementary to see. Many farmers now measure composite-quarter 
milk sees, however this means that a moderate see increase in one quarter may go 
unnoticed if the other three have normal sees. Analysis of quarter milk see, is a 
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possibility to monitor udder health closely and to investigate subclinical mastitis, but 
would be very expensive. 
The methods used to analyse APPs have developed considerably over the past few years 
and commercial tests are now available for all the major APPs (Eckersa1l2004). Mammary 
associated SAA3 was measured in milk by modification of the commercially available 
ELISA for SAA. However, an ELISA based method had to be developed to measure milk 
Hp as the existing method for measuring serum Hp was not suitable and the SRID method 
used previously for the measurement of milk Hp lacked sensitivity. The work carried out in 
chapter 2 of this thesis has led to the development of the first ELISA to measure milk Hp. 
The method described is sensitive even at low levels and is more expeditious than existing 
methods. 
This newly developed milk Hp assay was employed to measure the concentration of Hp in 
milk from an experimental model of S. aureus mastitis. In the experimental model both M-
SAA3 and Hp were sensitive markers of acute clinical mastitis, but it was concluded that 
only M-SAA3 could be used to detect chronic subclinical mastitis. Haptoglobin reached 
higher values in the milk during the acute phase of infection than M-SAA3. 
Chapter 3 investigated further the pathophysiology of the milk APR using a field study of 
naturally occurring mastitis designed to establish the earliest time-point of appearance of 
APP in the milk. The results showed that both M-SAA3 and Hp showed similar kinetics to 
SCC and can be concluded as sensitive and reliable markers of clinical mastitis. 
Furthermore, this study showed that the APP responses differ significantly between 
individuals. In some cows the concentration of M-SAA3 reaches higher levels than that of 
Hp, whereas in others the situation is reversed and Hp reaches higher concentrations than 
M-SAA3, the latter being in agreement with previous studies (Eckersall et al 2001; 
Pedersen et a12003; Gronlund et a12003a; Nielsen et aI2004). 
Of greater relevance to clinical practice is the possibility that once the presence of 
inflammation has been identified, assays for the APPs can indicate the nature of the 
condition, including pathogen type, severity and whether it is a clinical or subclincal 
infection that is present. Acute phase protein measurement in serum has the ability to 
differentiate between chronic and acute inflammation (Horadagoda et al 1999). 
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The implication from the results of the work in chapter 3, that the levels of APP in milk 
may be indicative of the pathogen responsible for mastitis is very encouraging. Much 
interest in deciphering pathogen type has been generated in mastitis research by awareness 
that different pathogens require different treatment. Additionally knowledge of pathogen 
type is useful as it may help predict and influence the probability of infection or cure rate. 
Of further interest was the kinetics of APP observed across a time-course and the 
pathogen-specific effects. In E. coli mastitis both Hp and M-SAA3 increased sharply prior 
to the onset of clinical signs and decreased rapidly post-infection. Acute phase proteins in 
milk display similar kinetics to see and it has previously been shown that different 
mastitis causing pathogens are associated with different baseline levels for see (de Haas 
et al 2002). The kinetics of see in E. coli infections have been investigated and a similar 
pattern of response to that seen for APPs was reported (Peeler et al 2003). 
Although for veterinarians and skilled stockmen, clinical mastitis is not difficult to 
diagnose, a more refined approach is needed to detect chronic subclinical mastitis. At 
present, increased see is often the only characteristic of chronic subclinical mastitis. 
Acute phase proteins, M-SAA3 and Hp were also detected in subclincal mastitis but at 
much lower concentrations to those found in clinical mastitis. Further study is required to 
confirm the ability of milk APPs in identification of subclinical mastitis. 
The increased use of automatic milking systems has created a need for new monitoring 
systems for early and accurate detection of mastitis. Electrical conductivity of milk has 
been used for the automatic detection of mastitis, but is not considered sufficiently 
sensitive or reliable for use routinely in robotic milking systems for the detection of both 
clinical and subclinical mastitis in dairy cows (Nielen et al 1995; Mottram 1997). Further 
field studies are needed to see whether measurement of APP in milk might meet the 
requirement. 
Prevention of mastitis is preferable over cure especially in developed countries where 
consumer concern over animal welfare and food safety is an issue. Reducing the use of 
antibiotics would be beneficial for the health and welfare of humans and cows alike, and 
early diagnosis could contribute to this being achieved. Dairy farming is an economic 
activity, so a diagnostic test is only successful when it is cost-effective. 
The ready availability of milk offers excellent opportunity for its analysis in disease 
diagnosis. The mammary glands can be accessed with ease keeping stress levels to a 
minimum which is a very important consideration when lactating dairy cows are involved. 
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Acute phase protein research in milk is at an early stage but there is considerable scope for 
further development. Extending the investigation of the pathophysiology of the APP 
response in milk should be undertaken to determine for example the relation between 
severity of infection and type of pathogen, and also to assess the effects of concurrent 
inflammatory diseases common in dairy cows e.g. lameness and metritis. It would be of 
value to establish if the response in individual cows is variable between individuals and 
consistent within an individual, and if this has a significant genetic component. Further 
fundamental questions should be addressed relating to function of the APPs in milk during 
mastitis, for instance do they have an anti-bacterial role and do they affect mammary cell 
function. If the outcomes of such studies are positive then the next logical and feasible 
step would be the development of new, robust, rapid and inexpensive methods of analysis, 
suitable for use in on-line milking systems. 
Changes taking place in milk during mastitis have been well documented (Kitchen 1981; 
Watanabe et al 2000). In an effort to identify milk polypeptides whose presence or absence 
correlates with the presence of mastitis, a proteomic strategy was developed. The entire 
protein complement of bovine milk during severe clinical mastitis was compared to that of 
milk from healthy cows using 2-DE and MALDI-MS. The advantage of this approach was 
that all the proteins in milk could be analysed at once. Obvious differences were apparent 
in the milk proteins of healthy cows and those suffering from mastitic infection. During 
mastitis the major milk proteins were diminished while other proteins, notably serum 
protein such as albumin and serotransferrin were increased. Although this research 
produced no new findings as such, the investigations herein are among the first few 
attempts reported to analyse bovine milk using proteomic methods and in particular to use 
proteomics to investigate the differential changes induced in bovine milk during mastitis. 
Moreover the optimisation of a method for proteomic investigation of milk during mastitis 
was a valuable outcome of the project. This study has successfully established the 
methodology for studying the milk proteome in mastitis and may be used for further 
studies in different disease states. Such studies would also be of value in relation to the 
assessment of milk quality and in cheese production. 
The extension of the proteomic method developed in chapter 4 was applied to analyse the 
changes taking place during a mild form of experimentally induced S. aureus mastitis. It 
was anticipated from the previous work that differentially expressed proteins would be 
observed in response to infection. However the mild subclinical nature of the infection 
model meant that alteration to the major protein fractions in milk were only minimal and 
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consequently changes in the minor fractions were difficult to identify. Whilst the results of 
this study (Chapter 5) were disappointing in that infection did not have any discemable and 
consistent effect on the major milk proteins, this was in effect a pilot study and lays the 
groundwork for possible future investigations. The next logical step would be to analyse 
the changes in milk proteins during a moderate experimental model of mastitis. 
Investigations into the bovine milk proteome are in their initial stages and common to other 
systems the over abundance of a few major proteins cause a problem in detecting and 
monitoring changes in less abundant proteins in milk such as APP. Consequently the 
proteomic analysis performed in this study was biased towards highly abundant and 
soluble proteins. The limitation of spatial resolution which causes spots to overlap in 2-D 
gels was first reported in 1982 for albumin (Bjellqvista et aI1982). The use of narrow pH 
range IPG strips has been shown to increase the separation and resolution of protein spots. 
However even the use of narrow range pH strips has been reported to still only allow 
detection of abundant proteins (Gorg et al 2000). Proteomic study has further emphasised 
that pre-fractionation of milk is a pre-requisite prior to examination of its minor proteins 
and there are possible approaches as to how this might be achieved. 
To overcome the problem of the overabundance of the major milk proteins during 
investigation of mastitis, pre-treatment of the milk samples with a recently available 
apparatus would be desirable. The IEF Zoom Fractionator (Invitrogen, Paisley, UK) can 
subdivide the whole milk samples into 5 fractions and as the major milk proteins have 
similar pIs in the region of pH 4.5 to 5.5; these can be isolated in one or at most 2 
fractions. Subsequently the fractions would then be examined by 2-DE using narrow range 
IPG strips over the pH range appropriate to each fraction. The benefit of this method is that 
spatial resolution should be greatly enhanced and with the confinement of the highly 
abundant milk proteins to, at most 2 fractions, identification of the more minor proteins in 
milk should become feasible. 
Small peptides are notoriously difficult to analyse in conventional 2-DE based proteomic 
approaches (Jenkins and Pennington 2001). Surface enhanced laser desorption/ionisation 
time-of flight mass spectrometry (SELDI-TOF-MS) provides a methodology to extend 
examination of the milk proteome and to include these smaller peptides which are likely to 
be the product of bacterial proteases but could still have value as biomarkers of disease. 
Unlike MALDI-MS the surface in SELDI-MS plays an active role in the extraction, 
presentation and enrichment of the sample eliminating the need for meticulous sample 
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preparation including desalting, that IS necessary pnor to MALDI-MS (Jenkins and 
Pennington 2001). 
The complete proteome analysis suffers from a number of technical limitations. Briefly, 
the process is time-consuming, labour intensive and requires significant technical expertise 
if reproducible gels and quantitative data are to be generated. It is probable that a number 
of differentially expressed proteins between the infected and control samples were not 
identified. Fluorescent two-dimensional difference gel electrophoresis (DIGE) allows 
samples labelled with different dyes to be co-separated simultaneously on the same gel, 
thereby eliminating the gel to gel variation. Images of the 2D gels are acquired using as 
many as three different filters and the ratio of the differently coloured fluorescent signals is 
used to identify protein differences between the samples (Patton 2002). This technique 
would be very useful in quantitative and comparative proteomic studies and should be 
employed in future studies to enhance the analysis of differentially expressed proteins in 
bovine milk during mastitis. 
Unfortunately, the proteomic methods developed lacked the sensitivity to detect APPs in 
the milk. It is likely that Hp and M-SAA3 were not identified on the 2-DE gels because 
they are present at concentrations below the limit of sensitivity of the colloidal Coomassie 
stain employed in this investigation. As antibodies are available to these proteins it is 
possible that immunoblotting ofthe 2-D gels could be used in future studies to locate these 
proteins. 
The extrahepatic expression of APP, now documented in a wide variety of tissue opens a 
further field of investigation into both the local control mechanisms and the functions of 
the locally produced APPs. The recent recognition of a milk isoform of SAA, namely M-
SAA3 (McDonald et al 2001) required further investigation to elucidate the implications 
this protein may have on the pathogenesis of bovine mastitis. Our studies, confirm the local 
production of M-SAA3 in the bovine mammary gland and its up-regulation during bovine 
mastitis, providing further insight into a possible role for this protein. Future work in this 
area should employ in situ hybridisation to define the precise location of this protein in the 
bovine mammary gland. 
There is a very real need for the discovery of markers that will detect disease at an earlier 
stage. The discovery of biomarkers in milk would be a very desirable achievement due to 
the ease with which this fluid can be collected. All of the work detailed within this thesis 
strives towards this similar goal. The emergence of new methodologies for the large-scale 
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analysis of differentially expressed proteins in body fluids is presenting opportunities in the 
search for novel diagnostic markers of disease. The development of proteomic 
technologies with improved sensitivity could be applied to identify APPs as biomarkers of 
mastitis in milk, hence linking the major findings in this thesis and demonstrating the close 
connection between this laboratory research and the potential for commercial application. 
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